
<html lang="en"     class="pb-page"  data-request-id="b24525e9-02ad-454a-9974-da5ffb9f7438"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2010.53.issue-3;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm901284w"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of (Thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer" /></meta><meta name="dc.Creator" content="Daniel P.  Sutherlin" /></meta><meta name="dc.Creator" content="Deepak  Sampath" /></meta><meta name="dc.Creator" content="Megan  Berry" /></meta><meta name="dc.Creator" content="Georgette  Castanedo" /></meta><meta name="dc.Creator" content="Zhigang  Chang" /></meta><meta name="dc.Creator" content="Irina  Chuckowree" /></meta><meta name="dc.Creator" content="Jenna  Dotson" /></meta><meta name="dc.Creator" content="Adrian  Folkes" /></meta><meta name="dc.Creator" content="Lori  Friedman" /></meta><meta name="dc.Creator" content="Richard  Goldsmith" /></meta><meta name="dc.Creator" content="Tim  Heffron" /></meta><meta name="dc.Creator" content="Leslie  Lee" /></meta><meta name="dc.Creator" content="John  Lesnick" /></meta><meta name="dc.Creator" content="Cristina  Lewis" /></meta><meta name="dc.Creator" content="Simon  Mathieu" /></meta><meta name="dc.Creator" content="Jim  Nonomiya" /></meta><meta name="dc.Creator" content="Alan  Olivero" /></meta><meta name="dc.Creator" content="Jodie  Pang" /></meta><meta name="dc.Creator" content="Wei Wei  Prior" /></meta><meta name="dc.Creator" content="Laurent  Salphati" /></meta><meta name="dc.Creator" content="Steve  Sideris" /></meta><meta name="dc.Creator" content="Qingping  Tian" /></meta><meta name="dc.Creator" content="Vickie  Tsui" /></meta><meta name="dc.Creator" content="Nan Chi  Wan" /></meta><meta name="dc.Creator" content="Shumei  Wang" /></meta><meta name="dc.Creator" content="Christian  Wiesmann" /></meta><meta name="dc.Creator" content="Susan  Wong" /></meta><meta name="dc.Creator" content="Bing-Yan  Zhu" /></meta><meta name="dc.Description" content="The PI3K/AKT/mTOR pathway has been shown to play an important role in cancer. Starting with compounds 1 and 2 (GDC-0941) as templates, (thienopyrimidin-2-yl)aminopyrimidines were discovered as pote..." /></meta><meta name="Description" content="The PI3K/AKT/mTOR pathway has been shown to play an important role in cancer. Starting with compounds 1 and 2 (GDC-0941) as templates, (thienopyrimidin-2-yl)aminopyrimidines were discovered as pote..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 5, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm901284w" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm901284w" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm901284w" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm901284w" /></link>
        
    
    

<title>Discovery of (Thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm901284w" /></meta><meta property="og:title" content="Discovery of (Thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0012.jpeg" /></meta><meta property="og:description" content="The PI3K/AKT/mTOR pathway has been shown to play an important role in cancer. Starting with compounds 1 and 2 (GDC-0941) as templates, (thienopyrimidin-2-yl)aminopyrimidines were discovered as potent inhibitors of PI3K or both PI3K and mTOR. Structural information derived from PI3Kγ−ligand cocrystal structures of 1 and 2 were used to design inhibitors that maintained potency for PI3K yet improved metabolic stability and oral bioavailability relative to 1. The addition of a single methyl group to the optimized 5 resulted in 21, which had significantly reduced potency for mTOR. The lead compounds 5 (GNE-493) and 21 (GNE-490) have good pharmacokinetic (PK) parameters, are highly selective, demonstrate knock down of pathway markers in vivo, and are efficacious in xenograft models where the PI3K pathway is deregulated. Both compounds were compared in a PI3Kα mutated MCF7.1 xenograft model and were found to have equivalent efficacy when normalized for exposure." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm901284w"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm901284w">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm901284w&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm901284w&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm901284w&amp;href=/doi/10.1021/jm901284w" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1086-1097</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm901272d" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm901371v" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of (Thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+P.++Sutherlin">Daniel P. Sutherlin</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Deepak++Sampath">Deepak Sampath</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Megan++Berry">Megan Berry</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Georgette++Castanedo">Georgette Castanedo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhigang++Chang">Zhigang Chang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Irina++Chuckowree">Irina Chuckowree</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jenna++Dotson">Jenna Dotson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adrian++Folkes">Adrian Folkes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lori++Friedman">Lori Friedman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Goldsmith">Richard Goldsmith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tim++Heffron">Tim Heffron</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leslie++Lee">Leslie Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Lesnick">John Lesnick</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cristina++Lewis">Cristina Lewis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simon++Mathieu">Simon Mathieu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jim++Nonomiya">Jim Nonomiya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan++Olivero">Alan Olivero</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jodie++Pang">Jodie Pang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei+Wei++Prior">Wei Wei Prior</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laurent++Salphati">Laurent Salphati</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steve++Sideris">Steve Sideris</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qingping++Tian">Qingping Tian</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vickie++Tsui">Vickie Tsui</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nan+Chi++Wan">Nan Chi Wan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shumei++Wang">Shumei Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christian++Wiesmann">Christian Wiesmann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan++Wong">Susan Wong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bing-Yan++Zhu">Bing-Yan Zhu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Piramed Pharma, 957 Buckingham Avenue, Slough, Berks SL1 4NL, United Kingdom</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. E-mail: <a href="/cdn-cgi/l/email-protection#d1a2a4a5b9b4a3bdb8bfffb5b0bf91b6b4bfb4ffb2bebc"><span class="__cf_email__" data-cfemail="2f5c5a5b474a5d434641014b4e416f484a414a014c4042">[email protected]</span></a>; phone: 650-225-2061; fax: 650-225-3171.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm901284w&amp;href=/doi/10.1021%2Fjm901284w" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1086–1097</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 5, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 August 2009</li><li><span class="item_label"><b>Published</b> online</span>5 January 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 February 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm901284w" title="DOI URL">https://doi.org/10.1021/jm901284w</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1086%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDaniel%2BP.%2BSutherlin%252C%2BDeepak%2BSampath%252C%2BMegan%2BBerry%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D3%26contentID%3Djm901284w%26title%3DDiscovery%2Bof%2B%2528Thienopyrimidin-2-yl%2529aminopyrimidines%2Bas%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BAvailable%2BPan-PI3-Kinase%2Band%2BDual%2BPan-PI3-Kinase%252FmTOR%2BInhibitors%2Bfor%2Bthe%2BTreatment%2Bof%2BCancer%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1097%26publicationDate%3DFebruary%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm901284w"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5779</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">90</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm901284w" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of (Thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;P. Sutherlin&quot;},{&quot;first_name&quot;:&quot;Deepak&quot;,&quot;last_name&quot;:&quot;Sampath&quot;},{&quot;first_name&quot;:&quot;Megan&quot;,&quot;last_name&quot;:&quot;Berry&quot;},{&quot;first_name&quot;:&quot;Georgette&quot;,&quot;last_name&quot;:&quot;Castanedo&quot;},{&quot;first_name&quot;:&quot;Zhigang&quot;,&quot;last_name&quot;:&quot;Chang&quot;},{&quot;first_name&quot;:&quot;Irina&quot;,&quot;last_name&quot;:&quot;Chuckowree&quot;},{&quot;first_name&quot;:&quot;Jenna&quot;,&quot;last_name&quot;:&quot;Dotson&quot;},{&quot;first_name&quot;:&quot;Adrian&quot;,&quot;last_name&quot;:&quot;Folkes&quot;},{&quot;first_name&quot;:&quot;Lori&quot;,&quot;last_name&quot;:&quot;Friedman&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Goldsmith&quot;},{&quot;first_name&quot;:&quot;Tim&quot;,&quot;last_name&quot;:&quot;Heffron&quot;},{&quot;first_name&quot;:&quot;Leslie&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Lesnick&quot;},{&quot;first_name&quot;:&quot;Cristina&quot;,&quot;last_name&quot;:&quot;Lewis&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;Mathieu&quot;},{&quot;first_name&quot;:&quot;Jim&quot;,&quot;last_name&quot;:&quot;Nonomiya&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;Olivero&quot;},{&quot;first_name&quot;:&quot;Jodie&quot;,&quot;last_name&quot;:&quot;Pang&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Wei Prior&quot;},{&quot;first_name&quot;:&quot;Laurent&quot;,&quot;last_name&quot;:&quot;Salphati&quot;},{&quot;first_name&quot;:&quot;Steve&quot;,&quot;last_name&quot;:&quot;Sideris&quot;},{&quot;first_name&quot;:&quot;Qingping&quot;,&quot;last_name&quot;:&quot;Tian&quot;},{&quot;first_name&quot;:&quot;Vickie&quot;,&quot;last_name&quot;:&quot;Tsui&quot;},{&quot;first_name&quot;:&quot;Nan&quot;,&quot;last_name&quot;:&quot;Chi Wan&quot;},{&quot;first_name&quot;:&quot;Shumei&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;Wiesmann&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;Wong&quot;},{&quot;first_name&quot;:&quot;Bing-Yan&quot;,&quot;last_name&quot;:&quot;Zhu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;1086-1097&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm901284w&quot;},&quot;abstract&quot;:&quot;The PI3K/AKT/mTOR pathway has been shown to play an important role in cancer. Starting with compounds 1 and 2 (GDC-0941) as templates, (thienopyrimidin-2-yl)aminopyrimidines were discovered as potent inhibitors of PI3K or both PI3K and mTOR. Structural information derived from PI3Kγ−ligand cocrystal structures of 1 and 2 were used to design inhibitors that maintained potency for PI3K yet improved metabolic stability and oral bioavailability relative to 1. The addition of a single methyl group to the optimized 5 resulted in 21, which had significantly reduced potency for mTOR. The lead compounds 5 (GNE-493) and 21 (GNE-490) have good pharmacokinetic (PK) parameters, are highly selective, demonstrate knock down of pathway markers in vivo, and are efficacious in xenograft models where the PI3K pathway is deregulated. Both compounds were compared in a PI3Kα mutated MCF7.1 xenograft model and were found to have equivalent efficacy when normalized for exposure.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901284w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901284w" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901284w&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901284w" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901284w&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901284w" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm901284w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901284w&amp;href=/doi/10.1021/jm901284w" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm901284w" /></input><a href="/doi/pdf/10.1021/jm901284w" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm901284w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm901284w%26sid%3Dliteratum%253Aachs%26pmid%3D20050669%26genre%3Darticle%26aulast%3DSutherlin%26date%3D2010%26atitle%3DDiscovery%2Bof%2B%2528Thienopyrimidin-2-yl%2529aminopyrimidines%2Bas%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BAvailable%2BPan-PI3-Kinase%2Band%2BDual%2BPan-PI3-Kinase%252FmTOR%2BInhibitors%2Bfor%2Bthe%2BTreatment%2Bof%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D3%26spage%3D1086%26epage%3D1097%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901284w&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The PI3K/AKT/mTOR pathway has been shown to play an important role in cancer. Starting with compounds <b>1</b> and <b>2</b> (GDC-0941) as templates, (thienopyrimidin-2-yl)aminopyrimidines were discovered as potent inhibitors of PI3K or both PI3K and mTOR. Structural information derived from PI3Kγ−ligand cocrystal structures of <b>1</b> and <b>2</b> were used to design inhibitors that maintained potency for PI3K yet improved metabolic stability and oral bioavailability relative to <b>1</b>. The addition of a single methyl group to the optimized <b>5</b> resulted in <b>21</b>, which had significantly reduced potency for mTOR. The lead compounds <b>5</b> (GNE-493) and <b>21</b> (GNE-490) have good pharmacokinetic (PK) parameters, are highly selective, demonstrate knock down of pathway markers in vivo, and are efficacious in xenograft models where the PI3K pathway is deregulated. Both compounds were compared in a PI3Kα mutated MCF7.1 xenograft model and were found to have equivalent efficacy when normalized for exposure.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58014" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58014" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The PI3K/Akt/mTOR<a class="ref internalNav" href="#fn100" aria-label="a">a</a> pathway plays a central role in cell proliferation, migration, survival, and angiogenesis upon activation by growth factor or integrin receptors. PI3Ks are lipid kinases, which can be divided into three classes: Class I, II, and III. Class I PI3Ks are activated by growth factor receptors or G-protein coupled receptors that are subdivided into Class IA and Class IB enzymes, respectively.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Class IA PI3Ks exist as heterodimers that contain one of three PI3K catalytic subunits (PI3Kα, PI3Kβ, and PI3Kδ) and a p85 regulatory subunits, whereas Class IB PI3Ks consist of a PI3Kγ catalytic subunit and a p101 regulatory subunit.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Class I PI3Ks convert the membrane bound substrate PIP2 (4,5-phosphatidyl-inositolbisphosphate) to PIP3 (3,4,5-phosphatidylinositoltrisphosphate), which provides lipid docking sites for the pleckstrin homology domains of the effector kinases PDK1 and Akt.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> PTEN and other phosphatases negatively regulate PI3K by dephosphorylation of PIP3 to PIP2, attenuating further downstream signaling.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Class II PI3Ks display the ability to phosphorylate phosphatidylinositol and phosphatidylinositol 4-phosphate and are generally resistant to class I inhibitors. Class III PI3Ks phosphorylate only phosphatidylinositol to generate phosphatidylinositol 3-phosphate. The sole member of this class, known as Vps34, functions in protein trafficking and autophagy.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> A fourth class of PI3K-related enzymes (PIKK), which contains a catalytic core similar to the PI3Ks, is involved in tumor growth and DNA-damage response as mediated by mTOR and DNA-dependent protein kinase, respectively.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a><div class="NLM_fn" id="fn100">a<p class="last">Abbreviations: Akt, protein kinase B; DMF, dimethylformamide; DMSO, dimethylsulfoxide; EGFR, epidermal growth factor receptor 1; HER2, epidermal growth factor receptor 2; PEG, polyethylene glycol; PRAS40, proline-rich Akt substrate of 40 kDa; PI3K, phosphoinositide 3-kinase; PDK1, pyruvate dehydrogenase kinase isoform 1; PTEN, phosphatase and tensin homologue; pS6 RP, phosphorylated S 6 ribosomal protein; mTOR, mammalian target of rapamycin; TFA, trifluoroacetic acid; THF, tetrahydrofuran; DCE, dichloroethane; SAR, structure activity relationships.</p></div></div><div class="NLM_p">Upon formation of PIP3 by class I PI3Ks, PDK1 is recruited to the plasma membrane and in turn phosphorylates Akt, a serine/threonine kinase that integrates multiple signaling pathways involved in growth and metabolism regulation.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The activation of Akt results in phosphorylation of several proximal substrates, including mTOR and PRAS40, which triggers a cascade of signaling events that culminates in the activation of mTOR, a serine/threonine kinase that regulates cellular growth, nutrient metabolism, and protein translation. Class IA PI3Ks, and PI3Kα in particular, are promising therapeutic targets for cancer based on the identification of activating mutations in the PI3Kα catalytic subunit and loss of function of its negative regulator PTEN in a notable percentage of solid human tumors representing, breast, prostate, ovarian, colorectal cancer, and glioblastoma.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In addition, PI3Ks are activated upstream by known oncogenes such as HER2, EGFR, and Ras, all of which lead to aberrant activation of the pathway. Accordingly, pharmaceutical and academic laboratories are actively pursuing inhibitors of the central nodes of the PI3K/Akt/mTOR pathway, and PI3Kα inhibitors in particular, for the treatment of human cancers.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Deregulation of the mTOR pathway has also been strongly implicated in cancer and inhibitors of this pathway are currently under clinical development.<a onclick="showRef(event, 'cit3b'); return false;" href="javascript:void(0);" class="ref cit3b">(3b)</a> In addition, mTOR is a validated target in humans as demonstrated by the clinical use of Torisel (temsirolimus), approved for the treatment of advanced renal cell. Because both PI3K and mTOR are known to activate Akt independently, developing dual inhibitors of both PI3Kα and mTOR is a potential strategy for generating more effective therapeutics for the treatment of human cancer.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0013.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Discovery of compounds <b>5</b> and <b>21</b>, starting from phenols <b>1</b> and <b>2 </b>(<b>GDC-941</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901284w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The discovery of the pan isoform (α, β, δ, γ) PI3K inhibitor, <b>2</b>, starting from the simple morpholino thienopyrimidine <b>1</b> has previously been described.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Key discoveries leading to the clinical compound <b>2</b> were the identification of an indazole as a phenolic isostere which significantly improved the oral bioavailability of the class and the addition of a piperazino-methane sulfonamide substituent to the C-6 position of the thienopyrimidine core that improved potency and metabolic stability relative to compound <b>1</b>.</div><div class="NLM_p">Herein we describe our efforts to identify novel PI3K inhibitors that are structurally diverse from <b>2</b> and that have varying activity toward mTOR. In order to do this, we examined nonisostere replacements of the phenol resulting in new interactions within the same binding site, highlighted by the aminopyrimidine <b>4</b>, a compound that possessed increased mTOR potency relative to <b>2</b>. We also strove to remove potential sites of metabolism and reduce the molecular weight of the lead, resulting in tertiary alcohol <b>3</b>. These two directions of research were continued, culminating in the discovery of <b>5</b>, a low molecular weight, potent dual inhibitor of pan-PI3 kinases and mTOR. Following this, we discovered <b>21</b>, a structurally similar compound to <b>5</b>, which lacked mTOR but maintained pan-PI3K inhibitory activity.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0014.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of compounds found in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>−<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901284w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) nBuLi, THF, −78 °C, DMF; (b) <i>N</i>-sulphonylpiperazine, 1,2-DCE, HC(OCH<sub>3</sub>)<sub>3</sub>, Na(OAc)<sub>3</sub>BH; (c) boronic acid/ester, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, NaHCO<sub>3</sub>, H<sub>2</sub>O, CH<sub>3</sub>CN, microwave, 150−140 °C, 15−30 min; (d) NaBH<sub>4</sub>, MeOH; (e) PBr<sub>3</sub>, benzene, 80 °C, 1 h; (f) phthalimide, K<sub>2</sub>CO<sub>3</sub>, DMF, 20 h; (g) N<sub>2</sub>H<sub>4</sub>, MeOH, 65 °C, 1 h; (h) AcCl, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h; (i) nBuLi, THF, −78 °C, acetone; (j) MeMgBr, THF, 0 °C.</p></p></figure></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Synthesis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43425" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43425" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Compounds were prepared generally in a two-step process from common intermediate <b>6</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). In all cases, the C-6 position of the thienopyrimidine was functionalized prior to performing a Suzuki coupling with the C-2 aryl chloride and the corresponding boronic ester or acid to yield the 2-aryl thienopyrimidines. Compounds <b>4</b> and <b>10</b>−<b>16</b> were prepared following similar procedures previously described in this journal, where DMF was used as an electrophile to prepare aldehyde <b>7</b> followed by reductive amination and Suzuki coupling.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Aldehyde <b>7</b> was also used to prepare compounds <b>17</b> and <b>18</b> by either reduction with sodium borohydride or addition of methyl Grignard to give the primary and secondary alcohols, respectively. The alcohol intermediate <b>9</b> could be converted to the acylated amine <b>19</b> through a series of steps that include bromination, transformation to an amine, acylation, and coupling. Alternatively, the anion of <b>6</b> could be trapped with acetone to give a tertiary alcohol which was subsequently used in a cross coupling reactions to generate compounds <b>3</b> and <b>5</b>.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31568" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31568" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The potency of each compound for inhibition of purified, recombinant PI3K isoforms α, β, γ, δ was determined using a competitive displacement fluorescence polarization assay monitoring formation of the PIP3 product (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_p">Despite some minor differences in potency for the isoforms, the compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>−<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> were generally pan-inhibitors of the class I PI3-Kinases, with the greatest fold-selectivity for PI3Kα of approximately 20-fold versus other PI3K isoforms. The antiproliferative activity was compared in the PTEN-null human tumor prostate cancer cell line PC3 and the PI3Kα mutant breast cancer cell line MCF7.1. The clinical lead <b>2</b> has biochemical potencies of 3 nM, 32 nM, 3 nM, and 66 nM, versus PI3K α, β, δ, and γ, respectively, and cellular antiproliferative potencies in the PC3 and MCF7.1 cell lines of 0.39 μM, and 0.34 μM, respectively.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal Structure of <b>2</b> in PI3Kγ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901284w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In order to design phenol replacements, we relied on X-ray crystal structures of <b>1</b> and <b>2</b> bound to PI3Kγ to observe the interactions that were contributing to the potency of these compounds as well as to evaluate the potential for other beneficial interactions. All four Class I PI3K isoforms are highly homologous within the active site and all residues discussed herein are conserved. As previously described, the morpholine in both molecules makes a key contact with the backbone NH of the hinge and is critical for potency.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The thienopyrimidine core can direct substituents toward solvent-exposed regions of the binding site from the C-6 position of the heterocycle as seen in <b>2</b>, and can position a C-2 aryl group into an affinity pocket, (exemplified by the indazole of <b>2</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). From the X-ray cocrystal structure of PI3Kγ and <b>2</b> it was observed that the indazole 2-nitrogen makes a key hydrogen bond with the OH of Tyr 867 and the indazole NH forms an interaction with Asp 841. We recognized that there were a number of potential hydrogen bonding interactions that were not utilized by the indazole of <b>2</b> or the phenol of compound <b>1</b>. We theorized that these residues, Asp 836 as an example (PI3Kγ numbering), could form productive binding partners with a variety of structures that were neither phenols nor phenol isosteres.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition of PI3Kα, β, γ, δ, and Cancer Cell Proliferation for Phenol Replacements for Compounds <b>2</b>, <b>4</b>, and <b>10</b>−<b>16</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0002.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table single-image "><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0003.gif" alt="" id="fx2" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">ND = not determined.</p></div></div></div><div class="NLM_p">Synthetically, the C-2 aryl group was installed at the last step of the synthesis and could easily be modified with a large number of boronic acids or esters. As a comparison to <b>2</b>, compound <b>10</b> was very potent (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), but as previously described,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> lacked oral bioavailability. In contrast to <b>10</b>, the unsubstituted phenyl derivative <b>13</b> was over 400-fold less potent, highlighting the critical interaction that the phenol has with Asp 841. Potency was regained by 3-hydroxymethyl phenyl <b>14</b> and demonstrated that activity could be attained without directly mimicking the phenol. 3-Substituted pyridyl <b>11</b> was also capable of recovering activity whereas the 4-pyridyl <b>12</b> could not. On the basis of this SAR, it was thought that 3-pyridyl <b>11</b> could be making contacts to Tyr867 and Asp841 through a water-mediated H-bond. Interestingly, the crystal structure of <b>14</b> shows a clear interaction with the benzylic alcohol and Tyr 867 and Asp 841, anticipating the position of a potential water molecule bound to a pyridyl ring and this same tyrosine, strengthening this hypothesis (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structures of <b>14</b> (panel A) and <b>16</b> (panel B) bound to PI3Kγ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901284w&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Aminopyridine <b>16</b> and aminopyrimidine <b>4</b> had excellent potencies, and analysis of crystal structures revealed potential H-bonding interactions with Asp 841 and Asp 836 (H-bonding distances are 3.2 and 3.6 Å, respectively for <b>16</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B). These two compounds maintain the heterocyclic ring nitrogen/s similar to 3-pyridyl <b>11</b> while also increasing the acidity of the hydrogen on the para amino group relative to aniline <b>15</b>, a molecule that was 100-fold less potent than aminopyrimidine <b>4</b> (p<i>K</i><sub>a</sub>’s for the -NH<sub>2</sub> of aniline, 2-aminopyridine, and 2-aminopyrimidine are 30.6, 27.7, and 25.3, respectively).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The substitutions of the phenol with either the aminopyridine or aminopyrimidine, in <b>16</b> and <b>4</b>, also greatly improved the PK profile in rodents, leading to good exposure, in contrast to the primary alcohol <b>14</b> which had 0% oral bioavailability. As an example, when dosed as a solution at 5 mg/kg in the rat, aminopyrimidine <b>4</b> had a moderate clearance of 24 mL/min/kg, a volume of distribution of 5.6 L/kg, and 75% oral bioavailability. However, both <b>4</b> and <b>16</b> had moderate to high clearance in male beagle dogs (22 and 16 mL/min/kg, respectively) that were not predicted by in vitro microsomal stability data (predicted hepatic clearance of 4.8 and 0.5, respectively) nor could they be explained via phase II metabolism. Thus, metabolic stability was an area for further optimization.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibition of PI3Kα and PC3 Cancer Cell Proliferation; Hepatic Clearance Calculated from in Vitro Rat Liver Microsome Incubations; and Pharmacokinetic Results for Compounds Intravenously and Orally Dosed in Rats for Alcohol Analogues<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0005.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0006.gif" alt="" id="fx4" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Male Sprague−Dawley rats were dosed with mono TFA salts of each compound intravenously at 1 mg/kg and orally at 2 mg/kg as a solution in 5% DMSO/76% PEG400. Hepatic clearance was predicted from liver microsome incubations using the “in vitro <i>t</i><sub>1/2</sub> method”.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></p></div></div></div><div class="NLM_p">In parallel, we were also interested in modifying the physiochemical and phamacodynamic (PD) properties of the molecule by modifying the 6 position of the thienopyrimidine, a region that was both exposed to solvent and had the greatest degree of flexibility in terms of SAR. Primary, secondary, and tertiary alcohols <b>17</b>,<b> 18</b>, and <b>3</b> were targeted as substitutions that were both small and would maintain some degree of solubility. Each had similar potencies in the biochemical assays but had in vitro and in vivo clearance that improved with increased steric bulk around the hydroxyl, presumably decreasing the likelihood of oxidation or conjugation of the alcohol (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Comparable potency and microsomal stabilities could also be obtained with the secondary amide <b>19</b>, but the clearance in the rat remained high in contrast to that of the tertiary alcohol, <b>3</b>.</div><div class="NLM_p">The potency seen previously with the aminopyrimidine <b>4</b> along with the favorable pharmacokinetic properties of <b>3</b> prompted us to make <b>5</b>. This compound had improved potency and overall pharmacokinetic parameters relative to <b>3</b>. The increase in potency gained in going from an indazole to the aminopyrimidine was consistent with most compounds that had matched R1 substituents other than the optimized piperazine-sulfonamide found in <b>2</b>. The promising PK in rat translated well across species resulting in low to moderate clearances and good oral bioavailability in mice, dogs, and Cynomolgus monkeys (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. IV and PO PK Data for <b>5</b> in Mouse, Rat, Cynomolgus Monkey, and Dog<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0007.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th align="center" char="."> </th><th class="rowsep1" colspan="2" align="center" char=".">IV (1 mg/kg)</th><th class="rowsep1" colspan="4" align="center" char=".">PO</th><th align="center" char="."> </th></tr><tr valign="top"><th align="center">species</th><th align="center" char=".">in vitro Cl (mL/min/kg)</th><th align="center" char=".">in vitro Cl (mL/min/kg)</th><th align="center" char=".">Vss (L/kg)</th><th align="center" char=".">dose (mg/kg)</th><th align="center" char="."><i>C</i><sub>max</sub> (μM)</th><th align="center" char=".">AUC (μM*h)</th><th align="center" char="."><i>F</i>%</th><th align="center" char=".">PPB%</th></tr></thead><tbody><tr valign="top"><td align="left">mouse</td><td align="char" char=".">45</td><td align="char" char=".">17</td><td align="char" char=".">2.8</td><td align="char" char=".">5</td><td align="char" char=".">2.1</td><td align="char" char=".">14</td><td align="char" char=".">100</td><td align="char" char=".">64</td></tr><tr valign="top"><td align="left">rat</td><td align="char" char=".">23</td><td align="char" char=".">9</td><td align="char" char=".">2.8</td><td align="char" char=".">5</td><td align="char" char=".">2.2</td><td align="char" char=".">21</td><td align="char" char=".">83</td><td align="char" char=".">49</td></tr><tr valign="top"><td align="left">cyno</td><td align="char" char=".">5.4</td><td align="char" char=".">15</td><td align="char" char=".">3.0</td><td align="char" char=".">2</td><td align="char" char=".">1.1</td><td align="char" char=".">3.8</td><td align="char" char=".">62</td><td align="char" char=".">79</td></tr><tr valign="top"><td align="left">dog</td><td align="char" char=".">1.8</td><td align="char" char=".">1.6</td><td align="char" char=".">1.6</td><td align="char" char=".">2</td><td align="char" char=".">4.4</td><td align="char" char=".">63</td><td align="char" char=".">100</td><td align="char" char=".">73</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Female nu/nu mice were dosed orally with compounds as a solution in 60% PEG.</p></div></div></div><div class="NLM_p">Male Sprague−Dawley rats were dosed orally with compounds as a solution in 5% DMSO/76% PEG400. Male Cynomolgus monkeys and male beagle dogs were dosed orally with the HCl salt of the compounds as a suspension in 0.5% methylcellulose/0.2% Tween-80.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibition of PI3K Isoforms, mTOR, and Cancer Cell Proliferation for Selected Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0008.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0009.gif" alt="" id="fx7" /></img></td></tr></tbody></table></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> mTOR Activity</h3><div class="NLM_p">In addition to potency against PI3K, we discovered that several compounds had increased potency for mTOR relative to <b>2</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). For the indazoles, <b>2</b> and <b>3</b>, reduction in the size of the left-hand portion of the molecule from the sulfonyl piperazine to the tertiary alcohol increased mTOR potency slightly while reducing PI3Kα potency. On the other hand, <b>4</b> and <b>5</b> showed similar and increased mTOR inhibition regardless of the left-hand side group, suggesting that for these compounds the aminopyrimidine is driving most of the potency for both PI3K and mTOR inhibition. Further evaluation of the R2 position led to the 6-methyl substituted <b>20</b> and <b>21</b> which had >200 fold selectivity for mTOR while maintaining identical potency for PI3Kα relative to their unsubstituted precursors. Overall, potency in the PC3 cell line appeared to correlate well with the PI3Kα biochemical potency and was not dramatically influenced by mTOR potency.</div><div class="NLM_p">To better understand the potency and selectivity of our compounds, we examined the residue differences between mTOR and PI3K isoforms in the vicinity of the inhibitors. All of the PI3Kγ residues discussed throughout are identical to those found in PI3Kα. Our analysis suggests that mTOR has identical residues corresponding to Tyr867 and Asp841 and a homologous Glu in the place of Asp836 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The binding site of the two enzymes also differ in the upper portion of the ATP binding pocket where Met804 and Ile831 of PI3Kγ align to Ile2163 and Leu2186 in mTOR, respectively, potentially altering the hydrophobic surface in this region.</div><div class="NLM_p">The increased potency for mTOR in compounds with an aminopyrimidine relative to those with an indazole is possibly because this portion of the molecule is adjacent to Asp836(PI3Kγ)/Glu2190(mTOR). This residue resides on a loop which is one amino acid longer in mTOR than in PI3Kγ. mTOR’s Glu2190 likely adopts different conformations and experiences different flexibility compared to PI3Kγ’s Asp836, such that its favorable interactions with the aminopyridine are disrupted by the indazole, giving rise to the observed SAR.</div><div class="NLM_p">To rationalize the dramatic shifts in selectivity derived from the addition of a single methyl group onto the aminopyrimidine, we examined a crystal structure of <b>20</b> with PI3Kγ (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The 4-methyl group, as expected, twists the amino pyrimidine ring out of the plane of the thienopyrimidine in contrast to the unsubstituted aminopyrimidine analogues (not shown). Furthermore, steric clashes with Tyr867 cause the 4-methyl to point away from that residue and toward the upper surface of the ATP binding pocket where differences in mTOR and PI3K exist, presumably resulting in the observed selectivity.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0010.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure of <b>20</b> bound to PI3Kγ. Residues labeled in blue are identical in mTOR, while residues in black align to different amino acids in mTOR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901284w&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Kinase Selectivity</h3><div class="NLM_p last">Compound <b>2</b>, the pan-PI3K inhibitor currently in clinical oncology trials, displays an excellent selectivity profile relative to other Ser/Thr and Tyr kinases.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The highly optimized <b>5</b> and <b>21</b>, which each display approximately equipotent inhibition of Class I PI3K isoforms, were submitted for screening in a 142 kinase panel provided by Invitrogen’s SelectScreen service. Of these kinases, only three were subject to greater than 50% inhibition by <b>5</b>, and none were inhibited greater than 80% when tested at 1 μM. Subsequently measured IC50s demonstrated that <b>5</b> is more than 100-fold selective for PI3Kα over these three unrelated kinases (Aurora A IC50 > 10 μM, MLK1 IC50 = 591 nM and SYK IC50 = 371 nM). In the same panel, all kinases displayed less than 50% inhibition at 1 μM (or IC50’s > 1 μM) by <b>21</b>. Several members of the related PIK family kinases were also screened at Invitrogen: <b>5</b> displayed relatively weak inhibition of PIK3 C2 alpha and PIK3 C2 beta (65 and 78% inhibition at 1 μM, respectively), but no significant inhibition of hVPS34 or PI4K beta was seen. Similarly, <b>21</b> caused no significant inhibition of PIK3 C2 alpha, hVPS34, or PI4K beta, and 81% inhibition of PIK3 C2 beta at 1 μM (data not shown). Thus, both of these molecules were deemed sufficiently selective for PI3Kα or PI3Kα and mTOR to warrant further evaluation in human tumor xenograft efficacy studies.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Pharmacokinetic Data</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75311" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75311" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Two representative compounds, <b>5</b> and <b>21</b>, were chosen as examples of a dual pan-PI3K + mTOR inhibitor and a pan-PI3K inhibitor (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Each of these compounds displayed promising PK parameters in mice, suggesting that both molecules could achieve sufficient exposure to warrant testing their antitumor efficacy in human tumor xenograft models. Compound <b>5</b> achieved an almost 2.5-fold greater exposure in vivo than <b>21</b> when dosed at 5 mg/kg, exposure differences which seemed to be maintained at higher doses. Additionally, <b>21</b> showed 2 and 0.5 times less potency on PC3 and MCF7.1 cells lines, respectively, than <b>5</b>. These important differences in cellular potency and in vivo exposure were taken into consideration as we designed and interpreted results from in vivo efficacy studies.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Potency and Mouse PK Data for <b>5</b> and <b>21</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0011.gif" alt="" id="fx8" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th class="rowsep1" colspan="5" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="rowsep1" colspan="6" align="center" char=".">mouse PK (1 mg/kg iv/5 mg/kg po)</th></tr><tr valign="top"><th align="center">compd</th><th align="center" char=".">PI3Kα</th><th align="center">PI3Kβ/δ/γ</th><th align="center" char=".">mTOR</th><th align="center" char=".">PC3</th><th align="center" char=".">MCF7.1</th><th align="center" char=".">Cl (mL/min/kg)</th><th align="center" char=".">Vss (L/kg)</th><th align="center" char=".">AUC (μM*h, po)</th><th align="center" char="."><i>T</i> 1/2 (h, po)</th><th align="center" char="."><i>F</i>%</th><th align="center" char=".">PPB% mouse</th></tr></thead><tbody><tr valign="top"><td align="left"><b>5</b></td><td align="char" char=".">3.4</td><td align="left">12/16/16</td><td align="char" char=".">32</td><td align="char" char=".">330</td><td align="char" char=".">180</td><td align="char" char=".">17</td><td align="char" char=".">2.8</td><td align="char" char=".">13.7</td><td align="char" char=".">3.6</td><td align="char" char=".">100</td><td align="char" char=".">64</td></tr><tr valign="top"><td align="left"><b>21</b></td><td align="char" char=".">3.5</td><td align="left">25/5.2/15</td><td align="char" char=".">740</td><td align="char" char=".">490</td><td align="char" char=".">280</td><td align="char" char=".">51</td><td align="char" char=".">3.0</td><td align="char" char=".">4.8</td><td align="char" char=".">4.6</td><td align="char" char=".">100</td><td align="char" char=".">73</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Female nu/nu mice were dosed orally with the HCl salt of each compound as a solution intraveneously in 5% DMSO/5% cremophor. Compound <b>5</b> was dosed orally as a solution in 60% PEG and <b>21</b> was dosed orally in 0.5% methylcellulose/0.2% Tween-80. AUCs for <b>5</b> when dosed in MCT were equivalent to the AUC reported in PEG.</p></div></div></div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Anti-Tumor In Vivo Efficacy</h3><div class="NLM_p">The favorable in vitro potency and PK profiles of <b>5</b> and <b>21</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) prompted us to test these compounds in vivo against the same human cancer cell lines used in the in vitro cellular assays, but grown as subcutaneous xenografts in nude mice. For PC3, a human prostate cancer cell line that is PTEN −/−, once daily oral dosing with 10 mg/kg of <b>5</b> for 14 continuous days resulted significant in tumor regressions, with 6 partial regressions (50−99% tumor inhibition) and 1 complete regression (100% tumor inhibition) out of 10 animals (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A). The mean reduction in tumor volume at day 14 compared to vehicle-treated animals was 89%. At a 10-fold lower dose of 1 mg/kg, <b>5</b> showed no statistically significant efficacy in the PC3 prostate cancer xenograft model. All doses tested were tolerated and did not cause significant body weight loss (data not shown).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0015.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo efficacy of <b>5</b> versus PC3 prostate cancer xenografts and compounds <b>5</b> and <b>21</b>, versus MCF7.1 breast cancer xenografts. (A) Nu/nu (nude) female mice bearing PC3 tumors established from human prostate cancer cells implanted subcutaneously were dosed orally either with <b>5</b> at the indicated concentrations as a solution/suspension in vehicle (0.5% methylcellulose/0.2% Tween-80) or with vehicle daily (QD) for 14 days. (B) Nu/nu (nude) female mice bearing tumors established from MCF7.1 breast cancer cells implanted subcutaneously were dosed orally with vehicle, or as a solution/suspension of <b>5</b> or <b>21</b> at the indicated concentrations in the aforementioned vehicle daily (QD) for 21 days. Dunnett <i>t</i> test was used to calculate <i>p</i>-values comparing the drug-treated groups with vehicle control group at the end of dosing either on day 14 or 21.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901284w&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To confirm and compare in vivo efficacy, <b>5</b> and <b>21</b> were examined in the human MCF7.1 breast cancer xenograft model that harbors a PI3Kα activating mutation. Mice bearing xenografts were dosed orally once daily with 10 mg/kg of <b>5</b> or escalating doses of <b>21</b> from 6.25 mg/kg to 50 mg/kg for 21 continuous days. Similar to observations made in the PC3 prostate cancer xenograft model, 10 mg/kg of <b>5</b> resulted in 73% tumor growth inhibition at day 21 when compared to vehicle control animals (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B). Compound <b>21</b> also displayed 88% tumor growth inhibition at 50 mg/kg and doses as low as 6.25 mg/kg were also efficacious (28% tumor growth inhibition; <i>p</i> < 0.05) (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B). Comparable efficacy was observed with 10 mg/kg of <b>5</b> and 25 mg/kg of <b>21</b> and was attributed to both compounds showing similar drug exposures at these doses (data not shown). All doses of <b>21</b> and <b>5</b> tested were tolerated with insignificant body weight loss observed (data not shown).</div><div class="NLM_p">The similar efficacy profiles of <b>21</b> and <b>5</b> suggested that the effect on PI3K/Akt pathway markers might be similar in vivo. Upon completion of continuous dosing (up to day 21), MCF7.1 tumors were collected and analyzed to assess the PD regulation of the primary PI3K/Akt/mTOR pathway markers, phospho-Akt (pAkt), phospho-PRAS40 (pPRAS40) and phospho-S6RP, (pS6RP), relative to total protein marker levels, respectively. Doses as low as 6.25 mg/kg of <b>21</b> caused significant suppression of all three pathway markers within 1 h of treatment (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A−C) and was comparable to 10 mg/kg of <b>5</b>. However, at 4 h, maximum suppression of all three markers was observed only at 25 mg/kg of <b>21</b> and at 10 mg/kg of <b>5</b>. These same doses showed equivalent antitumor responses for both compounds versus the MCF7.1 xenograft, suggesting that in this model the PI3K/Akt pathway must be suppressed for at least 4 h in order to achieve maximum efficacy. Furthermore, as observed in the efficacy study, the PD response to <b>21</b> and <b>5</b> correlated well with plasma drug levels (data not shown). Thus, when achieving comparable levels of drug exposure, <b>5</b> and <b>21</b> showed a similar suppression of the PI3K pathway and consequently, a similar efficacy profile against MCF7.1 breast tumors.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0016.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of <b>5</b> and <b>21</b> on PD markers in the MCF7.1 breast cancer xenograft model after 21 days of continuous dosing. Tumors were excised from animals 1 and 4 h after the last administered dose on day 21 and processed for analysis of PI3K/Akt pathway markers as described in Methods. (A) Levels of pAkt (Ser<sup>473</sup>) and total Akt were measured by electrochemiluminescence using Meso Scale Discovery according to manufacturer’s instructions (Gaithersburg, MD). (B) Levels of pPras40 (Thr<sup>246</sup>) and total Pras40 were measured by ELISA at an absorbance of 450 nm as described in Methods. (C) pS6RP(Ser<sup>235/236</sup>) and total S6RP were assessed using assays measuring electrochemiluminescence from Meso Scale Discovery (Gaithersburg, MD) according to manufacturer’s instructions. (%) = % of phospho-protein suppression compared to vehicle control groups (100%); <i>p</i>-values determined by Student’s <i>t</i> test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901284w&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74663" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74663" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Two potent, selective, and efficacious pan-PI3K inhibitors have been discovered. Using <b>1</b> as a template, SAR was developed that led to the replacement of a phenol with an aminopyrimidine resulted in improved exposure in rodents. Additionally, the piperazine-sulfonamide of <b>4</b> was replaced with a tertiary alcohol to give <b>5</b>, reducing the molecular weight and increasing the metabolic stability relative to <b>4</b>. Compound <b>5</b> has excellent pharmacokinetic properties in all species tested and is remarkably selective against >130 kinases. Evaluation of structure−activity relationships around this series revealed a method for modulating potency against mTOR, offering a significant opportunity to expand upon the therapeutic potential of this chemical series. Specifically, the addition of a 4-methyl group on the pyrimidine modulated the mTOR potency, resulting in <b>21</b>. Compound <b>5</b> was profiled in tumor models in which the PI3K pathway is activated such as PC3 prostate cancer and MCF7.1 breast cancer xenograft models and was highly efficacious in vivo at 10 mg/kg when administered orally on a daily schedule. The mTOR selective <b>21</b> was also profiled in the MCF7.1 tumor model and was found to have equivalent efficacy and PD responses to the dual PI3K/mTOR inhibitor <b>5</b> when differences in exposure were taken into account. The fact that MCF7.1 cells possess an activating mutation of PI3Kα and are likely more dependent on this pathway may be one explanation for the apparent equivalency for these two compounds in this particular xenograft model, regardless of differences in mTOR potency. Both <b>21</b> (GNE-490) and <b>5</b> (GNE-493) are excellent tools to further evaluate the therapeutic potential of PI3K and dual PI3K/mTOR inhibitors in the treatment of cancer.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73808" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73808" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemistry</h3><div class="NLM_p">All solvents and reagents were used as obtained. <sup>1</sup>H NMR spectra were recorded with a Bruker Avance DPX400 Spectrometer or a Varian Inova 400 NMR spectrometer, and referenced to tetramethyl silane. chemical shifts are expressed as δ units using tetramethylsilane as the external standard (in NMR description, s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; and br, broad peak). Mass spectra were measured with a Finnigan SSQ710C spectrometer using an ESI source coupled to a Waters 600MS HPLC system operating in reverse mode with an X-bridge Phenyl column of dimensions 150 mm by 4.6 mm, with 5 μm sized particles.</div><div class="NLM_p last">Compounds <b>2</b>, <b>6</b>−<b>8</b>, and intermediates in route to compounds <b>10</b>−<b>16</b> have been previously described in this journal.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 2-(2-Chloro-4-morpholinothieno[3,2-<i>d</i>]pyrimidin-6-yl)propan-2-ol</h3><div class="NLM_p last">4-(2-Chlorothieno[3,2-<i>d</i>]pyrimidin-4-yl)morpholine (20.0 g, mmol) was combined with THF (300 mL) and cooled to −78 °C prior to slow addition of 2.5 M <i>n</i>-BuLi in hexane (40.6 mL) via an addition funnel to maintain a temperature below −70 °C. The reaction was brought to −60 °C and allowed to stir for 1 h. The reaction mixture was recooled to −78 °C and acetone was added slowly via an addition funnel to maintain the temperature below −70 °C. After stirring for 2 h, the reaction was quenched into a mixture of 1 N HCl (100 mL), water (600 g), and ice (600 g). The slurry was filtered and washed with water (150 mL) and dried in a vacuum oven overnight at 50 °C to yield 22.3 g of 2-(2-chloro-4-morpholinothieno[3,2-<i>d</i>]pyrimidin-6-yl)propan-2-ol (83.5% yield).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2-(2-(2-Aminopyrimidin-5-yl)-4-morpholinothieno[3,2-<i>d</i>]pyrimidin-6-yl)propan-2-ol (<b>5</b>)</h3><div class="NLM_p last">2-(2-Chloro-4-morpholinothieno[3,2-<i>d</i>]pyrimidin-6-yl)propan-2-ol (26.0 g), 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine (23 g), Na<sub>2</sub>CO<sub>3</sub> (17.6 g), dioxane (390 mL), and water (156 mL) were combined to give a light yellow suspension. The reaction mixture was degassed through several vacuum and purge cycles with N<sub>2</sub>. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (1.116 g) was added followed by additional vacuum and purge cycles with N<sub>2</sub>. The reaction was then heated for 12 h at an internal temperature of 90 °C and then cooled to room temperature. Water (400 mL) was added and the mixture was allowed to stir for 1 h prior to filtration and an additional water wash (100 mL). The resultant gray solid was combined with THF (1 L), water (100 mL), and finally Florisil (52 g, 60−100 mesh) and stirred for 15 min prior to filtration. The Florisil was washed with two portions of THF (300 and 200 mL) and the filtrate was evaporated, suspended in EtOAc, heated to 80 C for 1 h, and cooled to room temp. The resultant solid was filtered to give 25.8 g of <b>5</b> (85.5% yield). <sup>1</sup>H NMR (400 MHz, DMSO) δ 9.28 (s, 2H), 7.78 (bs, 1H), 7.52 (s, 1H), 4.11 (m, 4H), 3.80 (m, 4H), 1.60 (s, 6H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 373. Analytical LC-MS on an Agilent (1100/MSD) using a 3 mm × 100 mm SD-C18 analytical column and H<sub>2</sub>O/MeCN modified with 0.05% trifluoroacetic acid running a linear gradient from 5% MeCN to 95% MeCN monitored by UV wavelength 254 nm and ESI+ TIC MS showed 99% purity.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-(2-(2-Aminopyrimidin-5-yl)-4-morpholinothieno[3,2-<i>d</i>]pyrimidin-6-yl)propan-2-ol hydrochoride (<b>5</b>)</h3><div class="NLM_p last">2-(2-(2-Aminopyrimidin-5-yl)-4-morpholinothieno[3,2-<i>d</i>]pyrimidin-6-yl)propan-2-ol (15.8 g) was suspended in 160 mL of methanol and combined with a solution of HCl in ethanol (1.25 M, 36 mL), stirred for 2 h, cooled to 0 °C, and filtered to give 14.8 g of the HCl salt of <b>5</b> (85.5% yield). <sup>1</sup>H NMR (400 MHz, DMSO) δ 9.28 (s, 2H), 7.78 (bs, 1H), 7.52 (s, 1H), 4.11 (m, 4H), 3.80 (m, 4H), 1.60 (s, 6H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 373. Analytical LC-MS on an Agilent (1100/MSD) using a 3 mm × 100 mm SD-C18 analytical column and H<sub>2</sub>O/MeCN modified with 0.05% trifluoroacetic acid running a linear gradient from 5% MeCN to 95% MeCN monitored by UV wavelength 254 nm and ESI+ TIC MS showed 99% purity. Anal. (C<sub>17</sub>H<sub>21</sub>ClN<sub>6</sub>O<sub>2</sub>S) C, H, N, Cl.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 3-[6-(4-Methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidin-2-yl]-phenol (<b>10</b>)</h3><div class="NLM_p last">A mixture of 4-morpholin-4-yl-2-[3-(1,1,2,2-tetramethyl-propylsilanyloxy)-phenyl]-thieno[3,2-<i>d</i>]pyrimidine-6-carbaldehyde<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> (0.101 g, 0.221 mmol), 1-methanesulphonyl-piperazine hydrochloride (0.06 g, 1.3 equiv), acetic acid (13 μL, 1.0 equiv), and triethylamine (42 μL) was stirred in 1,2-dichloroethane (6 mL) at room temperature. To this was added sodium triacetoxyborohydride (0.074 g, 1.6 equiv), and the reaction mixture was stirred for 1 day. The reaction mixture was then quenched with aqueous sodium bicarbonate solution, extracted exhaustively with chloroform, dried (MgSO<sub>4</sub>), and the solvent was removed in vacuo to yield an oil. This was purified using flash chromatography (silica, ethyl acetate/hexane to ethyl acetate to yield 2-[3-(<i>tert</i>-butyl-dimethyl-silanyloxy)-phenyl]-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine. To a solution of 2-[3-(<i>tert</i>-butyl-dimethyl-silanyloxy)-phenyl]-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine in THF (10 mL) cooled to 0 °C was added a 1.0 M solution of tetrabutyl ammonium fluoride in THF (84 μL). After 30 min, the solvent was removed in vacuo and the residue was purified using flash chromatography (silica, 2% methanol in dichloromethane) and then triturated using dichloromethane/hexane to yield the title compound as a white solid (21 mg, 21%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.59 (m, 4H), 2.72 (s, 3H), 3.20 (m, 4H), 3.80 (m, 6H), 3.94−3.97 (m, 4H), 6.87 (d, <i>J</i> = 7.8 Hz 1H), 7.19−7.27 (m, 2H), 7.88 (m, 2H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 490. Analytical LC-MS using Waters XBridge Phenyl analytical column and H<sub>2</sub>O/MeCN modified with 0.1% formic acid running a linear gradient from 10% MeCN to 100% MeCN monitored by UV wavelength 210 nm and ESI+ TIC MS showed 100% purity.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 6-(4-Methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-2-pyridin-3-yl-thieno[3,2-d]pyrimidine (<b>11</b>)</h3><div class="NLM_p last">A mixture of 2-chloro-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> (100 mg, 0.23 mmol), pyridine-3-boronic acid (57 mg, 2 equiv), sodium carbonate (95 mg, 3 equiv), water (1 mL), acetonitrile (3 mL), and PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (0.1 equiv) was heated to 140 °C for 30 min in the microwave. The reaction mixture was cooled, diluted with dichloromethane, washed with brine, dried (MgSO<sub>4</sub>), and the solvent was removed in vacuo. The residue was purified using flash chromatography (3% methanol in ethyl acetate) and then trituration with ether yielded the desired title compound as a white solid (84 mg, 77%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.68−2.72 (m, 4H), 2.82 (s, 3H), 3.29−3.33 (m, 4H), 3.90 (s, 2H), 3.90−3.94 (m, 4H), 4.05−4.10 (m, 4H),7.33 (s, 1H), 7.34−7.38 (m, 1H), 8.68 (d, <i>J</i> = 5.6 Hz, 1H), 9.64 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 475. Analytical LC-MS using Waters XBridge Phenyl analytical column and H<sub>2</sub>O/MeCN modified with 0.1% formic acid running a linear gradient from 10% MeCN to 100% MeCN monitored by UV wavelength 210 nm and ESI+ TIC MS showed 100% purity.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 6-(4-Methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-2-pyridin-4-yl-thieno[3,2-d]pyrimidine (<b>12</b>)</h3><div class="NLM_p last">Compound <b>12</b> was prepared from 2-chloro-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> according to a similar Suzuki coupling procedure as described for compound <b>11</b>, using 4-pyridyl boronic acid. Yield = 71%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.68−2.70 (m, 4H), 2.81 (s, 3H), 3.29−3.32 (m, 4H), 3.89−3.91 (m, 6H), 4.06−4.08 (m, 4H), 7.35 (s, H), 8.26 (dd, <i>J</i> = 4.5, 3.0 Hz, 2H), 8.72 (dd, <i>J</i> = 4.66, 3 Hz, 2H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 475. Analytical LC-MS using Waters XBridge Phenyl analytical column and H<sub>2</sub>O/MeCN modified with 0.1% formic acid running a linear gradient from 10% MeCN to 100% MeCN monitored by UV wavelength 210 nm and ESI+ TIC MS showed 100% purity.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (4-(6-((4-(Methylsulfonyl)piperazin-1-yl)methyl)-2-phenylthieno[3,2-<i>d</i>]pyrimidin-4-yl)morpholine (<b>13</b>)</h3><div class="NLM_p last">Compound <b>13</b> was prepared from 2-chloro-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> according to a similar Suzuki coupling procedure as described for compound <b>11</b>, using phenyl boronic acid and purified on reversed phase HPLC. Yield = 59%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.33 (d, <i>J</i> = 7.2 Hz, 2H), 7.98 (s, 1H), 7.64 (t, <i>J</i> = 7.3 Hz, 1H), 7.57 (t, <i>J</i> = 7.4, 2H), 4.30−4.22 (m, 4H), 4.17(s, 2H), 3.99−3.92 (m, 4H), 3.43 (br s, 4H), 2.96−2.89 (m, 4H), 2.85 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> (M+H)<sup>+</sup> 474.2. Analytical LC-MS on an Agilent (1100/MSD) using a 3 mm × 100 mm SD-C18 analytical column and H<sub>2</sub>O/MeCN modified with 0.05% trifluoroacetic acid running a linear gradient from 5% MeCN to 95% MeCN monitored by UV wavelength 254 nm and ESI+ TIC MS showed 97% purity.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (3-(6-((4-(Methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinothieno[3,2-<i>d</i>]pyrimidin-2-yl)phenyl)methanol (<b>14</b>)</h3><div class="NLM_p last">Compound <b>14</b> was prepared from 2-chloro-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> according to a similar Suzuki coupling procedure as described for compound <b>11</b>, using 3-(hydroxymethyl)phenylboronic acid and purified on reversed phase HPLC. Yield = 62%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.35 (s,1H), 8.26 (t, 1H), 7.59 (s, 1H), 7.47 (m, 1H), 4.61 (s, 2H), 4.04 (d, 2H), 3.83 (d, 2H), 3.31 (d, 2H), 2.96 (d, 2H), 2.96 ppm (s, 2H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 504.2. Analytical LC-MS on an Agilent (1100/MSD) using a 3 mm × 100 mm SD-C18 analytical column and H<sub>2</sub>O/MeCN modified with 0.05% trifluoroacetic acid running a linear gradient from 5% MeCN to 95% MeCN monitored by UV wavelength 254 nm and ESI+ TIC MS showed 98% purity.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 4-[6-(4-Methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidin-2-yl]-phenylamine (<b>15</b>)</h3><div class="NLM_p last">Compound <b>15</b> was prepared from 2-chloro-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> according to a similar Suzuki coupling procedure for compound <b>11</b>, using 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline. Yield = 83% <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.67−2.71 (m, 4H), 2.81 (s, 3H), 3.29−3.33 (m, 4H), 3.89 (s, 2H), 3.89−3.93 (m, 4H), 4.08−4.12 (m, 4H), 6.75 (d, <i>J</i> = 8.6 Hz, 2H), 7.30 (s, 1H), 8.29 (d, <i>J</i> = 8.6 Hz, 2H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 489 Analytical LC-MS using Waters XBridge Phenyl analytical column and H<sub>2</sub>O/MeCN modified with 0.1% formic acid running a linear gradient from 10% MeCN to 100% MeCN monitored by UV wavelength 210 nm and ESI+ TIC MS showed 100% purity.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 5-[6-(4-Methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidin-2-yl]-pyridin-2-ylamine (<b>16</b>)</h3><div class="NLM_p last">Compound <b>16</b> was prepared from 2-chloro-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> according a similar Suzuki coupling procedure for compound <b>11</b>, using 2-amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine. Yield = 39%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.67−2.71 (m, 4H), 2.81 (s, 3H), 3.29−3.33 (m, 4H), 3.89 (s, 2H), 3.89−3.93 (m, 4H), 4.08−4.12 (m, 4H), 4.60−4.65 (br s, 2H), 6.57 (d, <i>J</i> = 8.6 Hz,1H), 7.40 (s, 1H), 8.45 (dd, <i>J</i> = 8.6, 2.2 Hz, 1H), 9.17 (d, <i>J</i> = 2.2 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 490. Analytical LC-MS using Waters XBridge Phenyl analytical column and H<sub>2</sub>O/MeCN modified with 0.1% formic acid running a linear gradient from 10% MeCN to 100% MeCN monitored by UV wavelength 210 nm and ESI+ TIC MS showed 99% purity.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-(2-(1<i>H</i>-indazol-4-yl)-4-morpholinothieno[3,2-<i>d</i>]pyrimidin-6-yl)propan-2-ol (<b>3</b>)</h3><div class="NLM_p last">Compound <b>3</b> was prepared from 2-chloro-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> according a similar Suzuki coupling procedure for compound <b>11</b>. Mesylate salt <sup>1</sup>H NMR (400 MHz, DMSO) δ 8.66 (s, 1H), 8.30 (d, <i>J</i> = 8.0 Hz, 1H), 7.82 (d, <i>J</i> = 8.8 Hz, 1H), 7.58 (dd, <i>J</i> = 8.8, 8.0 Hz, 1H), 7.42 (s, 1H), 4.14 (m, 4H), 3.86 (m, 4H), 2.33 (s, 3H), 1.63 (s, 6H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 396. Analytical LC-MS on an Agilent (1100/MSD) using a 3 mm × 100 mm SD-C18 analytical column and H<sub>2</sub>O/MeCN modified with 0.05% trifluoroacetic acid running a linear gradient from 5% MeCN to 95% MeCN monitored by UV wavelength 254 nm and ESI+ TIC MS showed 99% purity.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 5-(6-((4-(Methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinothieno[3,2-d]pyrimidin-2-yl)pyrimidin-2-amine (<b>4</b>)</h3><div class="NLM_p last">Compound <b>4</b> was prepared from 2-chloro-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> according a similar Suzuki coupling procedure for compound <b>11</b>, using 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine. (41 mg, 57%). <sup>1</sup>H NMR (500 MHz, DMSO) δ 9.11 (s, 2H), 7.34 (s, 1H), 7.10 (s, 2H), 3.95−3.91 (m, 4H), 3.90 (s, 2H), 3.84−3.73 (m, 4H), 3.20−3.07 (m, 4H), 2.91 (s, 3H), 2.63−2.54 (m, 4H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 164.04, 162.99, 161.92, 157.77, 157.25, 156.88, 150.01, 123.06, 120.04, 111.55, 65.97, 56.09, 51.78, 45.80, 45.34, 33.76. MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 491. Analytical LC-MS on an Agilent (1100/MSD) using a 3 mm × 100 mm SD-C18 analytical column and H<sub>2</sub>O/MeCN modified with 0.05% trifluoroacetic acid running a linear gradient from 5% MeCN to 95% MeCN monitored by UV wavelength 254 nm and ESI+ TIC MS showed 100% purity.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (2-Chloro-4-morpholinothieno[3,2-<i>d</i>]pyrimidin-6-yl)methanol (<b>9</b>)</h3><div class="NLM_p last">A solution of 4-morpholin-4-yl-2-[3-(1,1,2,2-tetramethyl-propylsilanyloxy)-phenyl]-thieno[3,2-<i>d</i>]pyrimidine-6-carbaldehyde <b>7</b><a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> (0.2 g, 0.7 mmol) in MeOH (10 mL) at 0 °C was treated with sodium borohydride (0.1 g, 6 mmol). The solution was allowed to warm to room temperature and stirred for 15 min. The reaction mixture was quenched with water and extracted with ethyl acetate. The organic layer was dried with magnesium sulfate, filtered via Buchner funnel, and concentrated in vacuo to dryness. Crude yield = 100%. <sup>1</sup>H NMR (500 MHz, DMSO) δ 7.23 (s, 1H), 5.94 (t, <i>J</i> = 5.6 Hz, 1H), 4.82 (d, <i>J</i> = 4.9 Hz, 2H), 4.01−3.83 (m, 4H), 3.83−3.60 (m, 4H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 286.1. Analytical LC-MS on an Agilent (1100/MSD) using a 3 mm x 100 mm SD-C18 analytical column and H<sub>2</sub>0/MeCN modified with 0.05% trifluoroacetic acid running a linear gradient from 5% MeCN to 95% MeCN monitored by UV wavelength 254 nm and ESI+ TIC MS showed 100% purity.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 1-(2-(1<i>H</i>-Indazol-4-yl)-4-morpholinothieno[3,2-<i>d</i>]pyrimidin-6-yl)ethanol (<b>18</b>)</h3><div class="NLM_p last">Compound <b>18</b> was prepared from 1-(2-chloro-4-morpholinothieno[3,2-d]pyrimidin-6-yl)ethanol (167 mg, 5.6 mmol) according to a similar Suzuki coupling procedure as described for compound <b>11</b>, using 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H indazole and purified via reverse phase HPLC. Yield = 20%. <sup>1</sup>H NMR (500 MHz, DMSO) δ 13.17 (s, 1H), 8.90 (s, 1H), 8.24 (dd, <i>J</i> = 7.2 Hz, 0.6, 1H), 7.67 (d, <i>J</i> = 8.2 Hz, 1H), 7.53−7.46 (m, 1H), 7.43 (t, <i>J</i> = 3.4 Hz, 1H), 5.99 (d, <i>J</i> = 4.9 Hz, 1H), 5.15 (p, <i>J</i> = 5.5 Hz, 1H), 4.10−3.97 (m, 4H), 3.94 − 3.73 (m, 4H), 1.55 (d, <i>J</i> = 6.4 Hz, 3H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 382.1. Analytical LC-MS using Waters XBridge Phenyl analytical column and H<sub>2</sub>O/MeCN modified with 0.1% formic acid running a linear gradient from 5% MeCN to 95% MeCN monitored by UV wavelength 210 nm and ESI+ TIC MS showed 100% purity.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 2-[2-(2-Amino-4-methyl-pyrimidin-5-yl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidin-6-yl]-propan-2-ol (<b>19</b>)</h3><div class="NLM_p last">Compound <b>19</b> was prepared from 1-(2-chloro-4-morpholinothieno[3,2-d]pyrimidin-6-yl)ethanol (70 mg, 0.2 mmol) according to a similar Suzuki coupling procedure as described for compound <b>11</b>, using 4-methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyrimidin-2-ylamine and purified via reverse phase HPLC. (15 mg, 20%) MS: 387.2 (M + H); <sup>1</sup>H NMR (400 MHz, DMSO) δ 8.84 (s, 1H), 7.42 (s, 1H), 4.08 (m, 4H), 3.81 (m, 4H), 1.61(m, 9H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 387. Analytical LC-MS on an Agilent (1100/MSD) using a 3 mm x 100 mm SD-C18 analytical column and H<sub>2</sub>O/MeCN modified with 0.05% trifluoroacetic acid running a linear gradient from 5% MeCN to 95% MeCN monitored by UV wavelength 254 nm and ESI+ TIC MS showed 100% purity.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 5-[6-(4-Methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidin-2-yl]-4-methyl-pyrimidin-2-ylamine (<b>20</b>)</h3><div class="NLM_p last">2-Chloro-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (80 mg, 0.2 mmol), 4-methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyrimidin-2-ylamine (65 mg, 0.28 mmol), and bis(triphenylphosphine)palladium(II) dichloride (9.0 mg, 0.01 mmol) in 1 M aqueous sodium carbonate (0.8 mL) and acetonitrile (0.8 mL) were heated to 130 °C in a sealed microwave reactor for 15 min. Upon completion, the organic layer was separated and the aqueous layer was extracted with dichloromethane. The combined organic layers were concentrated in vacuo. The product was purified by reverse phase HPLC to yield 5-[6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidin-2-yl]-4-methyl-pyrimidin-2-ylamine (10 mg, 10%). MS: 505.2 (M + H); <sup>1</sup>H NMR (400 MHz, DMSO) δ 8.83 (s, 1H), 7.48 (s, 1H), 3.98 (m, 4H), 3.80 (m, 4H), 3.24 (m, 4H), 2.93 (m, 2H), 2.82 (m, 4H), 2.66 (m, 6H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 505. Analytical LC-MS on an Agilent (1100/MSD) using a 3 mm × 100 mm SD-C18 analytical column and H<sub>2</sub>O/MeCN modified with 0.05% trifluoroacetic acid running a linear gradient from 5% MeCN to 95% MeCN monitored by UV wavelength 254 nm and ESI+ TIC MS showed 100% purity.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Synthesis of <i>N</i>-[2-(1<i>H</i>-Indazol-4-yl)-4-morpholin-4-yl-thieno[3,2-<i>d</i>]pyrimidin-6-ylmethyl]-acetamide (<b>19</b>)</h3><div id="sec5_18_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 6-(Bromomethyl)-2-chloro-4-morpholinothieno[3,2-<i>d</i>]pyrimidine</h4><div class="NLM_p last">To a solution of (2-chloro-4-morpholinothieno[3,2-<i>d</i>]pyrimidin-6-yl)methanol (100 mg, 0.4 mmol) in benzene (3.0 mL) at 0 °C was added PBr<sub>3</sub> (30 μL, 0.4 mmol). The reaction was heated at reflux for 1 h. After cooling to room temperature, the reaction was quenched by the addition of water. The aqueous layer was extracted with EtOAc. The combined organics were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The crude material was not purified further (115 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.32 (s,1H), 4.71 (s, 2H), 3.99−3.97 (m, 4H), 3.85−3.83 (m, 4H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 347.9</div></div><div id="sec5_18_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (2-Chloro-4-morpholinothieno[3,2-<i>d</i>]pyrimidin-6-yl)methanamine</h4><div class="NLM_p last">To a solution of 6-(bromomethyl)-2-chloro-4-morpholinothieno[3,2-<i>d</i>]pyrimidine (0.3 g, 0.9 mmol) in DMF (10 mL) was added K<sub>2</sub>CO<sub>3</sub> (0.2 g, 1.3 mmol), and phthalimide (0.1 g, 0.9 mmol). The resulting solution was stirred 20 h at room temperature. The reaction was concentrated in vacuo and diluted with water (10 mL). The heterogeneous mixture was filtered and the solid intermediate was carried onto the next step without purification. MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 415. To the solid phtalimide intermediate (100 mg, 0.24 mmol) in MeOH (7 mL) was added H<sub>2</sub>NNH<sub>2</sub>·H<sub>2</sub>O (24 μL, 0.48 mmol). The reaction was heated 1 h at reflux. After cooling to room temperature, the reaction was quenched with water (10 mL) and extracted with EtOAc. The combined organics were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to afford (2-chloro-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methanamine (0.05 g). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.15 (s,1H), 4.20 (s, 2H), 4.00−3.96 (m, 4H), 3.84−3.82 (m, 4H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 285.1</div></div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> N-((2-Chloro-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)acetamide</h3><div class="NLM_p last">To a solution of 4-morpholinothieno[3,2-<i>d</i>]pyrimidin-6-yl)methanamine (50 mg, 0.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (4 mL) was added Et<sub>3</sub>N (84 μL, 0.6 mmol) and acetyl chloride (0.3 mmol). The reaction was stirred overnight at room temperature before being quenched with water. The aqueous layer was extracted with EtOAc. The combined organics were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo and used in the next step without purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.17 (s,1H), 4.68 (d, <i>J</i> = 6.1 Hz, 2H), 3.98−3.95 (m, 4H), 3.84−3.81 (m, 4H), 2.07 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 327.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-[2-(1<i>H</i>-Indazol-4-yl)-4-morpholin-4-yl-thieno[3,2-<i>d</i>]pyrimidin-6-ylmethyl]-acetamide (<b>19</b>)</h3><div class="NLM_p last">Compound <b>19</b> was prepared from <i>N</i>-((2-chloro-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)acetamide according a similar Suzuki coupling procedure as described above for <b>16</b>, using 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole. (41 mg from 50 mg of 4-morpholinothieno[3,2-<i>d</i>]pyrimidin-6-yl)methanamine). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.00 (s, 1H), 8.27 (d, <i>J</i> = 7.1 Hz, 1H), 7.60 (d, <i>J</i> = 8.3 Hz, 1H), 7.53−7.47 (m, 2H), 4.76 (d, <i>J</i> = 5.9 Hz, 2H), 4.09−4.07 (m, 4H), 3.92−3.90 (m, 4H), 2.62 (s, 1H), 2.10 (s, 3H), 3.90 (s, 2H), 3.84−3.73 (m, 4H), 3.20−3.07 (m, 4H), 2.91 (s, 3H), 2.63−2.54 (m, 4H). MS (ESI): <i>m</i>/<i>z</i> (M + H)<sup>+</sup> 409.1.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-(2-(2-Amino-4-methylpyrimidin-5-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)propan-2-ol (<b>20</b>)</h3><div class="NLM_p last">To a solution of 2-(2-chloro-4-morpholinothieno[3,2-d]pyrimidin-6-yl)propan-2-ol (1.0 g) in acetonitrile (6 mL) and 1 M aq Na<sub>2</sub>CO<sub>3</sub> (6 mL) was added Pd(PPh<sub>3</sub>)<sub>4</sub> (180 mg) and the reaction mixture was heated 15 min in a microwave reactor (300 W) at 140 °C. The reaction mixture was concentrated in vacuo and the desired product was purified by silica gel chromatography (2−8% MeOH in DCM) followed by recrystallization from EtOAc to afford <b>20</b> (650 mg). <sup>1</sup>H NMR (500 MHz, DMSO): δ 8.77 (s, 1H), 7.38 (br s, 2H), 7.29 (s, 1H), 4.01 (app t, 4H), 3.80 (app t, 4H), 2.64 (s, 3H), 1.60 (s, 6H). MS (ESI): <i>m</i>/<i>z</i> 387.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Characterization of Biochemical and Cellular Activity In Vitro</h3><div class="NLM_p">Enzymatic activity of the Class I PI3K isoforms was measured using a fluorescence polarization assay that monitors formation of the product 3,4,5-inositoltriphosphate molecule as it competes with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidyl inositide-3-phosphate product results in a decrease in fluorescence polarization signal as the labeled fluorophore is displaced from the GRP-1 protein binding site. Class I PI3K isoforms were purchased from Perkin-Elmer or were expressed and purified as heterodimeric recombinant proteins (ref original JACS PI3K paper). Tetramethylrhodamine-labeled PIP3 (TAMRA-PIP3), di-C8-PIP2, and PIP3 detection reagents were purchased from Echelon Biosciences. PI3K isoforms were assayed under initial rate conditions in the presence of 10 mM Tris (pH 7.5), 25 μM ATP, 9.75 μM PIP2, 5% glycerol, 4 mM MgCl<sub>2</sub>, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, 2% (v/v) DMSO at the following concentrations for each isoform: PI3Kα,β at 60 ng/mL; PI3Kγ at 8 ng/mL; PI3Kδ at 45 ng/mL. After assay for 30 min at 25 °C, reactions were terminated with a final concentration of 9 mM EDTA, 4.5 nM TAMRA-PIP3, and 4.2 μg/mL GRP-1 detector protein before reading fluorescence polarization on an Envision plate reader. IC50s were calculated from the fit of the dose−response curves to a 4-parameter equation.</div><div class="NLM_p">Human recombinant mTOR(1360−2549) was expressed and purified from insect cells and assayed using a Lanthascreen fluorescence resonance energy transfer format from Invitrogen in which phosphorylation of recombinant green fluorescent protein (GFP)-4-EBP1 is detected using a terbium-labeled antibody to phospho-threonine 37/46 of 4-EBP1. Reactions were initiated with ATP and conducted in the presence of 50 mM Hepes (pH 7.5), 0.25 nM mTOR, 400 nM GFP-4E-BP1, 8 μM ATP, 0.01% (v/v) Tween 20, 10 mM MnCl<sub>2</sub>, 1 mM EGTA, 1 mM dithiothreitol, and 1% (v/v) DMSO. Assays were conducted under initial rate conditions at room temperature for 30 min before terminating the reaction and detecting product in the presence of 2 nM Tb-anti-p4E-BP1 antibody and 10 mM EDTA. Dose−response curves were fit to an equation for competitive tight-binding inhibition and apparent <i>K</i><sub>i</sub>’s were calculated using the determined <i>K</i><sub>m</sub> for ATP of 6.1 μM.</div><div class="NLM_p last">Antiproliferative cellular assays were conducted using PC3 and MCF7.1 human tumor cell lines provided by the ATCC or Genentech Research laboratories, respectively. MCF7.1 is an in vivo selected line developed at Genentech and originally derived from the parental human MCF7 breast cancer cell line (ATCC, Manassas, VA). Cell lines were cultured in RPMI supplemented with 10% fetal bovine serum, 100 units/mL penicillin, and 100 μg/mL streptomycin, 10 mM HEPES, and 2 mM glutamine at 37 °C under 5% CO<sub>2</sub>. MCF7.1 cells or PC3 cells were seeded in 384-well plates in media at 1000 cells/well or 3000 cells/well, respectively, and incubated overnight prior to the addition of compounds to a final DMSO concentration of 0.5% v/v. MCF7.1 cells and PC3 cells were incubated for 3 and 4 days, respectively, prior to the addition of CellTiter-Glo reagent (Promega) and reading of luminescence using an Analyst plate reader. For antiproliferative assays, a cytostatic agent such as aphidicolin and a cytotoxic agent such as staurosporine were included as controls. Dose−response curves were fit to a 4-parameter equation and relative IC50s were calculated using Assay Explorer software.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> In Vivo Xenograft Studies</h3><div class="NLM_p">Human prostate cancer PC3 cells obtained from the National Cancer Institute (Frederick, MD) were resuspended in Hank’s Balanced Salt Solution and 3 × 10<sup>6</sup> cells implanted subcutaneously into the right hind flank of athymic nu/nu (nude) mice. Tumors were monitored until they reached a mean tumor volume of 150−200 mm<sup>3</sup> prior to the initiation of dosing. MCF7.1 cells resuspended in a 1:1 mixture of Hank’s Buffered Salt Solution and Matrigel Basement Membrane Matrix (No. 356237, BD Biosciences; Santa Cruz, CA), were 5 × 10<sup>6</sup> subcutaneously implanted into the right hind flank of athymic nu/nu (nude) mice. Prior to cell inoculation, 17 β-estradiol (0.36 mg/pellet, 60-day release, No. SE-121) obtained from Innovative Research of America (Sarasota, FL) were implanted into the dorsal shoulder blade area of each nude mouse. After implantation of cells, tumors were monitored until they reached a mean tumor volume of 250−350 mm<sup>3</sup> prior to initiating dosing. Compound <b>5</b> and <b>21</b> were dissolved in 0.5% methylcellulose with 0.2% Tween-80 (MCT). Female nude (nu/nu) mice that were 6−8 weeks old and weighed 20−30 g were obtained from Charles River Laboratories (Hollister, CA). Tumor bearing mice were dosed daily for 14 to 21 days depending on the xenograft model with 100 μL of vehicle (MCT) or test agent orally.</div><div class="NLM_p last">Tumor volume was measured in two dimensions (length and width) using Ultra Cal-IV calipers (model 54-10-111; Fred V. Fowler Company; Newton, MA) and was analyzed using Excel version 11.2 (Microsoft Corporation; Redmond, WA). The tumor volume (mm<sup>3</sup>) = (longer measurement × shorter measurement<sup>2</sup>) × 0.5. Animal body weights were measured using an Adventurer Pro AV812 scale (Ohaus Corporation; Pine Brook, NJ). Percent weight change = [1 − (new weight /initial weight)] × 100. Tumor sizes were recorded twice weekly over the course of the study (14−21 days). Mouse body weights were also recorded twice weekly and the mice were observed daily. Mice with tumor volumes ≥ 2000 mm<sup>3</sup> or with losses in body weight ≥ 20% from their initial body weight were promptly euthanized per IACUC guidelines. Mean tumor volume and SEM values (<i>n</i> = 10) were calculated using JMP statistical software, version 5.1.2 at end of treatment. % Tumor inhibition = 100(mean volume of tumors in vehicle treated animals − mean volume of tumors in test article treated animals given the test article)/mean volume of tumors in vehicle treated animals. Data were analyzed and <i>p</i>-values were determined using the Dunnett <i>t</i> test with JMP statistical software, version 5.1.2 (SAS Institute; Cary, NC).</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Pharmacodynamic Analysis of the PI3K/Akt Pathway in Vivo</h3><div class="NLM_p last">MCF7.1 tumors were excised from animals and immediately snap frozen in liquid nitrogen. Frozen tumors were weighed and lysed with a pestle PP (Scienceware; Pequannock, NJ) in cell extract buffer (Biosource; Carlsbad, CA) supplemented with protease inhibitors (F. Hoffman-LaRoche, Ltd.; Mannheim, Germany), 1 mM phenylmethysufonyl fluoride, and phosphatase inhibitor cocktails 1 and 2 (Sigma; St. Louis, MO). Protein concentrations were determined using the Pierce BCA Protein Assay Kit (Rockford, IL). Levels of pAkt (Ser<sup>473</sup>) and pS6RP(Ser<sup>235/236</sup>) were assessed using kits measuring electrochemiluminescence from Meso Scale Discovery (Gaithersburg, MD). Levels of pPras40 (Thr<sup>246</sup>) was determined using an ELISA measuring absorbance at 450 nm from Biosource (Carlsbad, CA).</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78164" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78164" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel P. Sutherlin</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#542721203c3126383d3a7a30353a1433313a317a373b39"><span class="__cf_email__" data-cfemail="99eaecedf1fcebf5f0f7b7fdf8f7d9fefcf7fcb7faf6f4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deepak Sampath</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Megan Berry</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Georgette Castanedo</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhigang Chang</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irina Chuckowree</span> - <span class="hlFld-Affiliation affiliation">Piramed Pharma, 957 Buckingham Avenue, Slough, Berks SL1 4NL, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jenna Dotson</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adrian Folkes</span> - <span class="hlFld-Affiliation affiliation">Piramed Pharma, 957 Buckingham Avenue, Slough, Berks SL1 4NL, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lori Friedman</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Goldsmith</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tim Heffron</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leslie Lee</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Lesnick</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristina Lewis</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon Mathieu</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jim Nonomiya</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan Olivero</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jodie Pang</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Wei Prior</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurent Salphati</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steve Sideris</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qingping Tian</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vickie Tsui</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nan Chi Wan</span> - <span class="hlFld-Affiliation affiliation">Piramed Pharma, 957 Buckingham Avenue, Slough, Berks SL1 4NL, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shumei Wang</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian Wiesmann</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan Wong</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bing-Yan Zhu</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm901284w" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55646" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55646" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors wish to thank Mengling Wong, Martin Struble, and Wen Chiu for compound purification and determination of purity by HPLC, mass spectroscopy, and <sup>1</sup>H NMR. We thank Krista K. Bowman, Alberto Estevez, Kyle Mortara, and Jiansheng Wu for technical assistance of protein expression and purification, and Jeremy Murray for depositing structures to the PDB. We thank Emil Plise for plasma protein binding data. We are grateful to Michelle Nannini, Janeko Bower, Alex Vanderbilt, Alfonso Arrazate, Judi-Anne Ramiscal, Vincent Javinal, and Kenton Wong for coordinating and dosing animals for the described efficacy studies.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08778" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08778" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 11 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vivanco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">The phosphatidylinositol 3-kinase AKT pathway in human cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm901284w&amp;key=10.1038%2Fnrc839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=12094235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvFKltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=489-501&author=I.+Vivancoauthor=C.+L.+Sawyers&title=The+phosphatidylinositol+3-kinase+AKT+pathway+in+human+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphatidylinositol 3-Kinase-AKT pathway in human cancer</span></div><div class="casAuthors">Vivanco, Igor; Sawyers, Charles L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">489-501</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  One signal that is overactivated in a wide range of tumor types is the prodn. of a phospholipid, phosphatidylinositol (3,4,5) trisphosphate, by phosphatidylinositol 3-kinase (PI3K).  This lipid and the protein kinase that is activated by it, AKT, trigger a cascade of responses, from cell growth and proliferation to survival and motility, that drive tumor progression.  Small-mol. therapeutics that block PI3K signaling might deal a severe blow to cancer cells by blocking many aspects of the tumor-cell phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzAQ-0qeD7pLVg90H21EOLACvtfcHk0lgiRyj1WNAMuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvFKltLs%253D&md5=c6762d32f9f1281632f4ccdbcd29268c</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fnrc839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc839%26sid%3Dliteratum%253Aachs%26aulast%3DVivanco%26aufirst%3DI.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DThe%2520phosphatidylinositol%25203-kinase%2520AKT%2520pathway%2520in%2520human%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D489%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">The phosphoinositide 3-kinase pathway</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">1655</span><span class="NLM_x">–</span> <span class="NLM_lpage">1657</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm901284w&amp;key=10.1126%2Fscience.296.5573.1655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=12040186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlChu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=1655-1657&author=L.+C.+Cantley&title=The+phosphoinositide+3-kinase+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphoinositide 3-kinase pathway</span></div><div class="casAuthors">Cantley, Lewis C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5573</span>),
    <span class="NLM_cas:pages">1655-1657</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review with 8 refs.  Phosphorylated lipids are produced at cellular membranes during signaling events and contribute to the recruitment and activation of various signaling components.  The role of phosphoinositide 3-kinase (PI3K), which catalyzes the prodn. of phosphatidylinositol 3,4,5-trisphosphate, in cell survival pathways; the regulation of gene expression and cell metab.; and cytoskeletal rearrangements are highlighted.  The PI3K pathway is implicated in human diseases including diabetes and cancer, and understanding the intricacies of this pathway may provide new avenues for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9pxSplxmS1rVg90H21EOLACvtfcHk0lgiRyj1WNAMuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlChu7s%253D&md5=110c8a351448aed6ab938b9ccf90a655</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1126%2Fscience.296.5573.1655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.296.5573.1655%26sid%3Dliteratum%253Aachs%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DThe%2520phosphoinositide%25203-kinase%2520pathway%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D1655%26epage%3D1657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Backer, J. M.</span><span> </span><span class="NLM_article-title">The regulation and function of class III PI3Ks: novel roles for Vps34</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">410</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=2008&pages=1-17&author=J.+M.+Backer&title=The+regulation+and+function+of+class+III+PI3Ks%3A+novel+roles+for+Vps34"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBacker%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520regulation%2520and%2520function%2520of%2520class%2520III%2520PI3Ks%253A%2520novel%2520roles%2520for%2520Vps34%26jtitle%3DBiochem.%2520J.%26date%3D2008%26volume%3D410%26spage%3D1%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Defining the role of mTOR in cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=9-22&author=D.+A.+Guertinauthor=D.+M.+Sabatini&title=Defining+the+role+of+mTOR+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DDefining%2520the%2520role%2520of%2520mTOR%2520in%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D9%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fasolo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sessa, C.</span><span> </span><span class="NLM_article-title">mTOR inhibitors in the treatment of cancer</span> <span class="citation_source-journal">Exp. Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1717</span><span class="NLM_x">–</span> <span class="NLM_lpage">1734</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1717-1734&author=A.+Fasoloauthor=C.+Sessa&title=mTOR+inhibitors+in+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFasolo%26aufirst%3DA.%26aulast%3DSessa%26aufirst%3DC.%26atitle%3DmTOR%2520inhibitors%2520in%2520the%2520treatment%2520of%2520cancer%26jtitle%3DExp.%2520Opin.%2520Investig.%2520Drugs%26date%3D2008%26volume%3D17%26spage%3D1717%26epage%3D1734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Bellacosa, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cristofano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, J. C.</span><span> </span><span class="NLM_article-title">Activation of AKT kinases in cancer: implications for therapeutic targeting</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm901284w&amp;key=10.1016%2FS0065-230X%2805%2994002-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=16095999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1elur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2005&pages=29-86&author=A+Bellacosaauthor=C.+C.+Kumarauthor=A.+Di+Cristofanoauthor=J.+C.+Testa&title=Activation+of+AKT+kinases+in+cancer%3A+implications+for+therapeutic+targeting"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of AKT kinases in cancer: implications for therapeutic targeting</span></div><div class="casAuthors">Bellacosa, Alfonso; Kumar, C. Chandra; Di Cristofano, Antonio; Testa, Joseph Robert</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29-86</span>CODEN:
                <span class="NLM_cas:coden">ACRSAJ</span>;
        ISSN:<span class="NLM_cas:issn">0065-230X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The AKT1, AKT2, and AKT3 kinases have emerged as crit. mediators of signal transduction pathways downstream of activated tyrosine kinases and phosphatidylinositol 3-kinase.  An ever-increasing list of AKT substrates has precisely defined the multiple functions of this kinase family in normal physiol. and disease states.  Cellular processes regulated by AKT include cell proliferation and survival, cell size and response to nutrient availability, intermediary metab., angiogenesis, and tissue invasion.  All these processes represent hallmarks of cancer, and a burgeoning literature has defined the importance of AKT alterations in human cancer and exptl. models of tumorigenesis, continuing the legacy represented by the original identification of v-Akt as the transforming oncogene of a murine retrovirus.  Many oncoproteins and tumor suppressors intersect in the AKT pathway, finely regulating cellular functions at the interface of signal transduction and classical metabolic regulation.  This careful balance is altered in human cancer by a variety of activating and inactivating mechanisms that target both AKT and interrelated proteins.  Reprogramming of this altered circuitry by pharmacol. modulation of the AKT pathway represents a powerful strategy for rational cancer therapy.  In this review, we summarize a large body of data, from many types of cancer, indicating that AKT activation is one of the most common mol. alterations in human malignancy.  We also review mechanisms of activation of AKT kinases, examples of therapeutic modulation of the AKT pathway in animal models, and the current status of efforts to target mol. components of the AKT pathway for cancer therapy and, possibly, cancer prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbtUdzglK927Vg90H21EOLACvtfcHk0li7Dgzcnp2aYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1elur4%253D&md5=556e3c5787e0179786db3cb2e2f1dcf6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0065-230X%2805%2994002-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-230X%252805%252994002-5%26sid%3Dliteratum%253Aachs%26aulast%3DBellacosa%26aufirst%3DA%26aulast%3DKumar%26aufirst%3DC.%2BC.%26aulast%3DDi%2BCristofano%26aufirst%3DA.%26aulast%3DTesta%26aufirst%3DJ.%2BC.%26atitle%3DActivation%2520of%2520AKT%2520kinases%2520in%2520cancer%253A%2520implications%2520for%2520therapeutic%2520targeting%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2005%26volume%3D94%26spage%3D29%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shayesteh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldocchi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godfrey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. W.</span><span> </span><span class="NLM_article-title">PIK3CA is implicated as an oncogene in ovarian cancer</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm901284w&amp;key=10.1038%2F5042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=9916799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADyaK1MXltlWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1999&pages=99-102&author=L.+Shayestehauthor=W.+L.+Kuoauthor=R.+Baldocchiauthor=T.+Godfreyauthor=C.+Collinsauthor=D.+Pinkelauthor=B.+Powellauthor=G.+B.+Millsauthor=J.+W.+Gray&title=PIK3CA+is+implicated+as+an+oncogene+in+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">PIK3CA is implicated as an oncogene in ovarian cancer</span></div><div class="casAuthors">Shayesteh, Laleh; Lu, Yiling; Kuo, Wen-Lin; Baldocchi, Russell; Godfrey, Tony; Collins, Colin; Pinkel, Daniel; Powell, Bethan; Mills, Gordon B.; Gray, Joe W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-102</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Ovarian cancer is the leading cause of death from gynecol. malignancy and the 4th leading cause of cancer death among American women, yet little is known about its mol. etiol.  Studies using comparative genomic hybridization (CGH) have revealed several regions of recurrent, abnormal, DNA sequence copy no. that may encode genes involved in the genesis or progression of the disease.  A region at 3q26 was increased in copy no. in 40% of ovarian and other cancers contains PIK3CA, which encodes the p110α catalytic subunit of phosphatidylinositol 3-kinase (PI3-kinase).  The assocn. between PIK3CA copy no. and PI3-kinase activity makes PIK3CA a candidate oncogene because a broad range of cancer-related functions were assocd. with PI3-kinase mediated signalling.  These include proliferation, glucose transport and catabolism, cell adhesion, apoptosis, RAS signalling6 and oncogenic transformation.  Downstream effectors of PI3-kinase, AKT1 and AKT2, were amplified or activated in human tumors, including ovarian cancer.  We show that PIK3CA is frequently increased in copy no. in ovarian cancers, that the increased copy no. is assocd. with increased PIK3CA transcription, p110α protein expression, and PI3-kinase activity and that treatment with the PI3-kinase inhibitor LY294002 decreases proliferation and increases apoptosis.  These observations suggest PIK3CA is an oncogene that has an important role in ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYnLbYYzMTtrVg90H21EOLACvtfcHk0li7Dgzcnp2aYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltlWjtw%253D%253D&md5=e46ad55fb14c5465bf7ce86fb5a9cca0</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1038%2F5042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F5042%26sid%3Dliteratum%253Aachs%26aulast%3DShayesteh%26aufirst%3DL.%26aulast%3DKuo%26aufirst%3DW.%2BL.%26aulast%3DBaldocchi%26aufirst%3DR.%26aulast%3DGodfrey%26aufirst%3DT.%26aulast%3DCollins%26aufirst%3DC.%26aulast%3DPinkel%26aufirst%3DD.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DGray%26aufirst%3DJ.%2BW.%26atitle%3DPIK3CA%2520is%2520implicated%2520as%2520an%2520oncogene%2520in%2520ovarian%2520cancer%26jtitle%3DNat.%2520Genet.%26date%3D1999%26volume%3D21%26spage%3D99%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silliman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggins, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span> </span><span class="NLM_article-title">High frequency of mutations of the PIK3CA gene in human cancers</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2004&pages=554&author=Y.+Samuelsauthor=Z.+Wangauthor=A.+Bardelliauthor=N.+Sillimanauthor=J.+Ptakauthor=S.+Szaboauthor=H.+Yanauthor=A.+Gazdarauthor=S.+M.+Powellauthor=G.+J.+Rigginsauthor=J.+K.+Willsonauthor=S.+Markowitzauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=V.+E.+Velculescu&title=High+frequency+of+mutations+of+the+PIK3CA+gene+in+human+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DSilliman%26aufirst%3DN.%26aulast%3DPtak%26aufirst%3DJ.%26aulast%3DSzabo%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DGazdar%26aufirst%3DA.%26aulast%3DPowell%26aufirst%3DS.%2BM.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DWillson%26aufirst%3DJ.%2BK.%26aulast%3DMarkowitz%26aufirst%3DS.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26atitle%3DHigh%2520frequency%2520of%2520mutations%2520of%2520the%2520PIK3CA%2520gene%2520in%2520human%2520cancers%26jtitle%3DScience%26date%3D2004%26volume%3D30%26spage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Parsons, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silliman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span> </span><span class="NLM_article-title">Colorectal cancer: mutations in a signalling pathway</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">792</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=792&author=D.+W.+Parsonsauthor=T.+L.+Wangauthor=Y.+Samuelsauthor=A.+Bardelliauthor=J.+M.+Cumminsauthor=L.+DeLongauthor=N.+Sillimanauthor=J.+Ptakauthor=S.+Szaboauthor=J.+K.+Willsonauthor=S.+Markowitzauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=C.+Lengauerauthor=V.+E.+Velculescu&title=Colorectal+cancer%3A+mutations+in+a+signalling+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DD.%2BW.%26aulast%3DWang%26aufirst%3DT.%2BL.%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DCummins%26aufirst%3DJ.%2BM.%26aulast%3DDeLong%26aufirst%3DL.%26aulast%3DSilliman%26aufirst%3DN.%26aulast%3DPtak%26aufirst%3DJ.%26aulast%3DSzabo%26aufirst%3DS.%26aulast%3DWillson%26aufirst%3DJ.%2BK.%26aulast%3DMarkowitz%26aufirst%3DS.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26atitle%3DColorectal%2520cancer%253A%2520mutations%2520in%2520a%2520signalling%2520pathway%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sulis, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span> </span><span class="NLM_article-title">PTEN: from pathology to biology</span> <span class="citation_source-journal">Trends Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">478</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm901284w&amp;key=10.1016%2FS0962-8924%2803%2900175-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=12946627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1ygs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=478-483&author=M.+L.+Sulisauthor=R.+Parsons&title=PTEN%3A+from+pathology+to+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN: from pathology to biology</span></div><div class="casAuthors">Sulis, Maria Luisa; Parsons, Ramon</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">478-483</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The PTEN tumor suppressor gene is mutated frequently in many malignancies and its importance in the development of cancer is probably underestimated.  As the primary phosphatase of phosphatidylinositol (3,4,5)-trisphosphate, PTEN has a central role in reigning in the phosphoinositide 3-kinase (PI 3-kinase) network to control cellular homeostasis.  Cells that lack PTEN are unable to regulate the PtdIns 3-kinase program, which stimulates a variety of cellular phenotypes that favor oncogenesis.  As well as the well-known role as tumor suppressor, recent studies show that PTEN is involved in the regulation of several basic cellular functions, such as cell migration, cell size, contractility of cardiac myocytes and chemotaxis.  Here, we review the roles of PTEN in normal cellular functions and disease development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1ltxp33aXP7Vg90H21EOLACvtfcHk0lje2Hxd5zVrWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1ygs7w%253D&md5=cd18115b50b3c634cb451c5090acda21</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2803%2900175-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252803%252900175-2%26sid%3Dliteratum%253Aachs%26aulast%3DSulis%26aufirst%3DM.%2BL.%26aulast%3DParsons%26aufirst%3DR.%26atitle%3DPTEN%253A%2520from%2520pathology%2520to%2520biology%26jtitle%3DTrends%2520Cell.%2520Biol.%26date%3D2003%26volume%3D13%26spage%3D478%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liaw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podsypanina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puc, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miliaresis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCombie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovanella, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tycko, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibshoosh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigler, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span> </span><span class="NLM_article-title">PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">1943</span><span class="NLM_x">–</span> <span class="NLM_lpage">1947</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=16&amp;doi=10.1021%2Fjm901284w&amp;key=10.1126%2Fscience.275.5308.1943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=9072974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADyaK2sXit1Wgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=1997&pages=1943-1947&author=J.+Liauthor=C.+Yenauthor=D.+Liawauthor=K.+Podsypaninaauthor=S.+Boseauthor=S.+I.+Wangauthor=J.+Pucauthor=C.+Miliaresisauthor=L.+Rodgersauthor=R.+McCombieauthor=S.+H.+Bignerauthor=B.+C.+Giovanellaauthor=M.+Ittmannauthor=B.+Tyckoauthor=H.+Hibshooshauthor=M.+H.+Wiglerauthor=R.+Parsons&title=PTEN%2C+a+putative+protein+tyrosine+phosphatase+gene+mutated+in+human+brain%2C+breast%2C+and+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5eR"><div class="casContent"><span class="casTitleNuber">5e</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer</span></div><div class="casAuthors">Li, Jing; Yen, Clifford; Liaw, Danny; Podsypanina, Katrina; Bose, Shikha; Wang, Steven I.; Puc, Janusz; Miliaresis, Christa; Rodgers, Linda; McCombie, Richard; Bigner, Sandra H.; Giovanella, Beppino C.; Ittmann, Michael; Tycko, Ben; Hibshoosh, Hanina; Wigler, Michael H.; Parsons, Ramon</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">5308</span>),
    <span class="NLM_cas:pages">1943-1947</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mapping of homozygous deletions on human chromosome 10q23 has led to the isolation of a candidate tumor suppressor gene, PTEN, that appears to be mutated at considerable frequency in human cancers.  In preliminary screens, mutations of PTEN were detected in 31% (13/42) of glioblastoma cell lines and xenografts, 100% (4/4) of prostate cancer cell lines, 6% (4/65) of breast cancer cell lines and xenografts, and 17% (3/18) of primary glioblastomas.  The predicted PTEN product has a protein tyrosine phosphatase domain and extensive homol. to tensin, a protein that interacts with actin filaments at focal adhesions.  These homologies suggest that PTEN may suppress tumor cell growth by antagonizing protein tyrosine kinases and may regulate tumor cell invasion and metastasis through interactions at focal adhesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPNCE1bqsPNLVg90H21EOLACvtfcHk0lje2Hxd5zVrWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXit1Wgtbk%253D&md5=9b3810f68cbd7cbb882ff75e98a2f1bf</span></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=10.1126%2Fscience.275.5308.1943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.275.5308.1943%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYen%26aufirst%3DC.%26aulast%3DLiaw%26aufirst%3DD.%26aulast%3DPodsypanina%26aufirst%3DK.%26aulast%3DBose%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DS.%2BI.%26aulast%3DPuc%26aufirst%3DJ.%26aulast%3DMiliaresis%26aufirst%3DC.%26aulast%3DRodgers%26aufirst%3DL.%26aulast%3DMcCombie%26aufirst%3DR.%26aulast%3DBigner%26aufirst%3DS.%2BH.%26aulast%3DGiovanella%26aufirst%3DB.%2BC.%26aulast%3DIttmann%26aufirst%3DM.%26aulast%3DTycko%26aufirst%3DB.%26aulast%3DHibshoosh%26aufirst%3DH.%26aulast%3DWigler%26aufirst%3DM.%2BH.%26aulast%3DParsons%26aufirst%3DR.%26atitle%3DPTEN%252C%2520a%2520putative%2520protein%2520tyrosine%2520phosphatase%2520gene%2520mutated%2520in%2520human%2520brain%252C%2520breast%252C%2520and%2520prostate%2520cancer%26jtitle%3DScience%26date%3D1997%26volume%3D275%26spage%3D1943%26epage%3D1947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Ihle, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powis, G.</span><span> </span><span class="NLM_article-title">Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy</span> <span class="citation_source-journal">Mol. Cancer. Ther</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm901284w&amp;key=10.1158%2F1535-7163.MCT-08-0801" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=19139107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFSntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1-9&issue=1&author=N.+T.+Ihleauthor=G.+Powis&title=Take+your+PIK%3A+phosphatidylinositol+3-kinase+inhibitors+race+through+the+clinic+and+toward+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy</span></div><div class="casAuthors">Ihle, Nathan T.; Powis, Garth</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway is currently one of the most exciting drug targets in oncol.  However, only a short time ago, the paradigm existed that drugs targeted to the four PI3K class I isoforms would be too toxic for use in cancer therapy due to effects on physiol. signaling.  Since that time, studies have delineated the roles of these four isoforms in nonpathol. signaling as well as their roles in cancer.  An extensive effort has gone into developing agents that inhibit one or more PI3K isoforms, as well as closely related proteins implicated in cancer.  These agents have proved to be tolerable and therapeutically beneficial in animal studies, and a no. are in clin. testing.  The agents, their properties, and their mol. targets are discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtwozBC-h437Vg90H21EOLACvtfcHk0lje2Hxd5zVrWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFSntA%253D%253D&md5=4bc339da7fdd1dc74e13eadf76ae53ce</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0801%26sid%3Dliteratum%253Aachs%26aulast%3DIhle%26aufirst%3DN.%2BT.%26aulast%3DPowis%26aufirst%3DG.%26atitle%3DTake%2520your%2520PIK%253A%2520phosphatidylinositol%25203-kinase%2520inhibitors%2520race%2520through%2520the%2520clinic%2520and%2520toward%2520cancer%2520therapy%26jtitle%3DMol.%2520Cancer.%2520Ther%26date%3D2009%26volume%3D8%26issue%3D1%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alix, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandon, A. D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefano, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henley, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergl-Wilson, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhyvoloup, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheldrake, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinase: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1725</span><span class="NLM_x">–</span> <span class="NLM_lpage">1738</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm901284w&amp;key=10.1158%2F1535-7163.MCT-08-1200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=19584227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVynuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1725-1738&issue=7&author=F.+I.+Raynaudauthor=S.+A.+Ecclesauthor=S.+Patelauthor=S.+Alixauthor=G.+Boxauthor=I.+S.+Chuckowreeauthor=A.+J.+Folkesauthor=S.+Gowanauthor=A.+D.+H.+Brandonauthor=F.+D.+Stefanoauthor=A.+Hayesauthor=A.+T.+Henleyauthor=L.+Lensunauthor=G.+H.+Pergl-Wilsonauthor=A.+Robsonauthor=N.+Saghirauthor=P.+Zhyvoloupauthor=E.+McDonaldauthor=P.+Sheldrakeauthor=S.+Shuttleworthauthor=M.+Valentiauthor=N.+C.+Wanauthor=P.+A.+Clarkeauthor=P.+Workman&title=Biological+properties+of+potent+inhibitors+of+class+I+phosphatidylinositide+3-kinase%3A+from+PI-103+through+PI-540%2C+PI-620+to+the+oral+agent+GDC-0941"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941</span></div><div class="casAuthors">Raynaud, Florence I.; Eccles, Suzanne A.; Patel, Sonal; Alix, Sonia; Box, Gary; Chuckowree, Irina; Folkes, Adrian; Gowan, Sharon; De Haven Brandon, Alexis; Di Stefano, Francesca; Hayes, Angela; Henley, Alan T.; Lensun, Letitia; Pergl-Wilson, Giles; Robson, Anthony; Saghir, Nahid; Zhyvoloup, Alexander; McDonald, Edward; Sheldrake, Peter; Shuttleworth, Stephen; Valenti, Melanie; Wan, Nan Chi; Clarke, Paul A.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1725-1738</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphatidylinositide 3-kinase pathway is frequently deregulated in human cancers and inhibitors offer considerable therapeutic potential.  We previously described the promising tricyclic pyridofuropyrimidine lead and chem. tool compd. PI-103.  We now report the properties of the pharmaceutically optimized bicyclic thienopyrimidine derivs. PI-540 and PI-620 and the resulting clin. development candidate GDC-0941.  All four compds. inhibited phosphatidylinositide 3-kinase p110α with IC50 ≤ 10 nmol/L.  Despite some differences in isoform selectivity, these agents exhibited similar in vitro antiproliferative properties to PI-103 in a panel of human cancer cell lines, with submicromolar potency in PTEN-neg. U87MG human glioblastoma cells and comparable phosphatidylinositide 3-kinase pathway modulation.  PI-540 and PI-620 exhibited improvements in soly. and metab. with high tissue distribution in mice.  Both compds. gave improved antitumor efficacy over PI-103, following i.p. dosing in U87MG glioblastoma tumor xenografts in athymic mice, with treated/control values of 34% (66% inhibition) and 27% (73% inhibition) for PI-540 (50 mg/kg b.i.d.) and PI-620 (25 mg/kg b.i.d.), resp.  GDC-0941 showed comparable in vitro antitumor activity to PI-103, PI-540, and PI-620 and exhibited 78% oral bioavailability in mice, with tumor exposure above 50% antiproliferative concns. for >8 h following 150 mg/kg p.o. and sustained phosphatidylinositide 3-kinase pathway inhibition.  These properties led to excellent dose-dependent oral antitumor activity, with daily p.o. dosing at 150 mg/kg achieving 98% and 80% growth inhibition of U87MG glioblastoma and IGROV-1 ovarian cancer xenografts, resp.  Together, these data support the development of GDC-0941 as a potent, orally bioavailable inhibitor of phosphatidylinositide 3-kinase.  GDC-0941 has recently entered phase I clin. trials. [Mol Cancer Ther 2009;8(7):1725-38] [Mol Cancer Ther 2009;8(7):1725-38].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-PRUGO7W3C7Vg90H21EOLACvtfcHk0liwpurwd-jCDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVynuro%253D&md5=2c963517ef112c677fb19ec2f0040e14</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-1200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-1200%26sid%3Dliteratum%253Aachs%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DAlix%26aufirst%3DS.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%2BS.%26aulast%3DFolkes%26aufirst%3DA.%2BJ.%26aulast%3DGowan%26aufirst%3DS.%26aulast%3DBrandon%26aufirst%3DA.%2BD.%2BH.%26aulast%3DStefano%26aufirst%3DF.%2BD.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHenley%26aufirst%3DA.%2BT.%26aulast%3DLensun%26aufirst%3DL.%26aulast%3DPergl-Wilson%26aufirst%3DG.%2BH.%26aulast%3DRobson%26aufirst%3DA.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DZhyvoloup%26aufirst%3DP.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DSheldrake%26aufirst%3DP.%26aulast%3DShuttleworth%26aufirst%3DS.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DBiological%2520properties%2520of%2520potent%2520inhibitors%2520of%2520class%2520I%2520phosphatidylinositide%25203-kinase%253A%2520from%2520PI-103%2520through%2520PI-540%252C%2520PI-620%2520to%2520the%2520oral%2520agent%2520GDC-0941%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26issue%3D7%26spage%3D1725%26epage%3D1738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Maria, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brachmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoemaker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Identification and chanraterization of NVP-BEZ235 a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1851</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm901284w&amp;key=10.1158%2F1535-7163.MCT-08-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=18606717" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1851-1863&issue=7&author=S.-M.+Mariaauthor=F.+Staufferauthor=J.+Brueggenauthor=P.+Furetauthor=C.+Schnellauthor=C.+Fritschauthor=S.+Brachmannauthor=P.+Cheneauthor=A.+De+Poverauthor=K.+Schoemakerauthor=D.+Fabbroauthor=D.+Gabrielauthor=M.+Simonenauthor=L.+Murphyauthor=P.+Finanauthor=W.+Sellersauthor=C.+Garcia-Echeverria&title=Identification+and+chanraterization+of+NVP-BEZ235+a+new+orally+available+dual+phosphatidylinositol+3-kinase%2Fmammalian+target+of+rapamycin+inhibitor+with+potent+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0017%26sid%3Dliteratum%253Aachs%26aulast%3DMaria%26aufirst%3DS.-M.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DBrachmann%26aufirst%3DS.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DDe%2BPover%26aufirst%3DA.%26aulast%3DSchoemaker%26aufirst%3DK.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DD.%26aulast%3DSimonen%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DIdentification%2520and%2520chanraterization%2520of%2520NVP-BEZ235%2520a%2520new%2520orally%2520available%2520dual%2520phosphatidylinositol%25203-kinase%252Fmammalian%2520target%2520of%2520rapamycin%2520inhibitor%2520with%2520potent%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26issue%3D7%26spage%3D1851%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Folkes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alderton, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alix, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depledge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancox, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugendradas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergl-Wilson, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhyvoloup, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvelebil, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span> </span><span class="NLM_article-title">The identification of 2-(1<i>H</i>-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-<i>d</i>]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5532</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800295d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5522-5532&author=A.+J.+Folkesauthor=K.+Ahmadiauthor=W.+K.+Aldertonauthor=S.+Alixauthor=S.+J.+Bakerauthor=G.+Boxauthor=I.+S.+Chuckowreeauthor=P.+A.+Clarkeauthor=P.+Depledgeauthor=S.+A.+Ecclesauthor=L.+S.+Friedmanauthor=A.+Hayesauthor=T.+C.+Hancoxauthor=A.+Kugendradasauthor=L.+Lensunauthor=P.+Mooreauthor=A.+G.+Oliveroauthor=J.+Pangauthor=S.+Patelauthor=G.+H.+Pergl-Wilsonauthor=F.+I.+Raynaudauthor=A.+Robsonauthor=N.+Saghirauthor=L.+Salphatiauthor=S.+Sohalauthor=M.+H.+Ultschauthor=M.+Valentiauthor=H.+J.+A.+Wallweberauthor=N.+C.+Wanauthor=C.+Wiesmannauthor=P.+Workmanauthor=P.+Zhyvoloupauthor=M.+J.+Zvelebilauthor=S.+J.+Shuttleworth&title=The+identification+of+2-%281H-Indazol-4-yl%29-6-%284-methanesulfonyl-piperazin-1-ylmethyl%29-4-morpholin-4-yl-thieno%5B3%2C2-d%5Dpyrimidine+%28GDC-0941%29+as+a+potent%2C+selective%2C+orally+bioavailable+inhibitor+of+class+I+PI3+kinase+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span></div><div class="casAuthors">Folkes, Adrian J.; Ahmadi, Khatereh; Alderton, Wendy K.; Alix, Sonia; Baker, Stewart J.; Box, Gary; Chuckowree, Irina S.; Clarke, Paul A.; Depledge, Paul; Eccles, Suzanne A.; Friedman, Lori S.; Hayes, Angela; Hancox, Timothy C.; Kugendradas, Arumugam; Lensun, Letitia; Moore, Pauline; Olivero, Alan G.; Pang, Jodie; Patel, Sonal; Pergl-Wilson, Giles H.; Raynaud, Florence I.; Robson, Anthony; Saghir, Nahid; Salphati, Laurent; Sohal, Sukhjit; Ultsch, Mark H.; Valenti, Melanie; Wallweber, Heidi J. A.; Wan, Nan Chi; Wiesmann, Christian; Workman, Paul; Zhyvoloup, Alexander; Zvelebil, Marketa J.; Shuttleworth, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5522-5532</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-kinase (PI3K) is an important target in cancer due to the deregulation of the PI3K/Akt signaling pathway in a wide variety of tumors.  A series of thieno[3,2-d]pyrimidine derivs. were prepd. and evaluated as inhibitors of PI3 kinase p110α.  The synthesis, biol. activity, and further profiling of these compds. are described.  This work resulted in the discovery of GDC-0941 (I) which is a potent, selective, orally bioavailable inhibitor of PI3K and is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojkFv29FXqO7Vg90H21EOLACvtfcHk0lhs1QUTmYea8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E&md5=742084954685353ceaf18660ab3a0703</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm800295d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800295d%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%2BJ.%26aulast%3DAhmadi%26aufirst%3DK.%26aulast%3DAlderton%26aufirst%3DW.%2BK.%26aulast%3DAlix%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%2BS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DDepledge%26aufirst%3DP.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHancox%26aufirst%3DT.%2BC.%26aulast%3DKugendradas%26aufirst%3DA.%26aulast%3DLensun%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DP.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPergl-Wilson%26aufirst%3DG.%2BH.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobson%26aufirst%3DA.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DZhyvoloup%26aufirst%3DP.%26aulast%3DZvelebil%26aufirst%3DM.%2BJ.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520identification%2520of%25202-%25281H-Indazol-4-yl%2529-6-%25284-methanesulfonyl-piperazin-1-ylmethyl%2529-4-morpholin-4-yl-thieno%255B3%252C2-d%255Dpyrimidine%2520%2528GDC-0941%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520orally%2520bioavailable%2520inhibitor%2520of%2520class%2520I%2520PI3%2520kinase%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5522%26epage%3D5532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="note"><p class="first last">This critical interaction with the enzyme was noted for molecules in 2 other series: </p></div><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vlahos, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matter, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. F.</span><span> </span><span class="NLM_article-title">A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4<i>H</i>-1-benzopyran-4-one (LY294002)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">5241</span><span class="NLM_x">–</span> <span class="NLM_lpage">5248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=8106507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADyaK2cXjtFGit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=5241-5248&author=C.+J.+Vlahosauthor=W.+F.+Matterauthor=K.+Y.+Huiauthor=R.+F.+Brown&title=A+specific+inhibitor+of+phosphatidylinositol+3-kinase%2C+2-%284-morpholinyl%29-8-phenyl-4H-1-benzopyran-4-one+%28LY294002%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)</span></div><div class="casAuthors">Vlahos, Chris J.; Matter, William F.; Hui, Kwan Y.; Brown, Raymond F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">5241-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Phosphatidylinositol (PtIns) 3-kinase is an enzyme implicated in growth factor signal transduction by assocg. with receptor and nonreceptor tyrosine kinases, including the platelet-derived growth factor receptor.  Inhibitors of PtdIns 3-kinase could potentially give a better understanding of the function and regulatory mechanisms of the enzyme.  Quercetin, a naturally occurring bioflavonoid, was previously shown to inhibit PtdIns 3-kinase with an IC50 of 1.3 μg/mL (3.8 μM); inhibition appeared to be directed at the ATP-binding site of the kinase.  Analogs of quercetin were investigated as PtdIns 3-kinase inhibitors, with the most potent ones exhibiting IC50 values in the range of 1.7-8.4 μg/mL.  In contrast, genistein, a potent tyrosine kinase inhibitor of the isoflavone class, did not inhibit PtdIns 3-kinase significantly (IC50 > 30 μg/mL).  Since quercetin has also been shown to inhibit other PtdIns and protein kinases, other chromones were evaluated as inhibitors of PtdIns 3-kinase without affecting PtdIns 4-kinase or selected protein kinases.  One such compd., 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (also known as 2-(4-morpholinyl)-8-phenylchromone, LY294002), completely and specifically abolished PtdIns 3-kinase activity (IC50 = 0.43 μg/mL; 1.40 μM) but did not inhibit PtdIns 4-kinase or tested protein and lipid kinases.  Analogs of LY294002 demonstrated a very selective structure-activity relationship, with slight changes in structure causing marked decreases in inhibition.  LY294002 was shown to completely abolish PtdIns 3-kinase activity in fMet-Leu-Phe-stimulated human neutrophils, as well as inhibit proliferation of smooth muscle cells in cultured rabbit aortic segments.  Since PtdIns 3-kinase appears to be centrally involved with growth factor signal transduction, the development of specific inhibitors against the kinase may be beneficial in the treatment of proliferative diseases as well as in elucidating the biol. role of the kinase in cellular proliferation and growth factor response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Ii0f457BC7Vg90H21EOLACvtfcHk0lhs1QUTmYea8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXjtFGit78%253D&md5=2635c03af206ce35d55b899f92921477</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVlahos%26aufirst%3DC.%2BJ.%26aulast%3DMatter%26aufirst%3DW.%2BF.%26aulast%3DHui%26aufirst%3DK.%2BY.%26aulast%3DBrown%26aufirst%3DR.%2BF.%26atitle%3DA%2520specific%2520inhibitor%2520of%2520phosphatidylinositol%25203-kinase%252C%25202-%25284-morpholinyl%2529-8-phenyl-4H-1-benzopyran-4-one%2520%2528LY294002%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D5241%26epage%3D5248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hayakawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritomo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterfield, M.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase PI3KR inhibitors</span> <span class="citation_source-journal">Biorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6847</span><span class="NLM_x">–</span> <span class="NLM_lpage">6858</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm901284w&amp;key=10.1016%2Fj.bmc.2006.06.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=16837202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADC%252BD28XptFSks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=6847-6858&author=M.+Hayakawaauthor=H.+Kaizawaauthor=H.+Moritomoauthor=T.+Koizumiauthor=T.+Ohishiauthor=M.+Okadaauthor=M.+Ohtaauthor=S.+Tsukamotoauthor=P.+Parkerauthor=P.+Workmanauthor=M.+Waterfield&title=Synthesis+and+biological+evaluation+of+4-morpholino-2-phenylquinazolines+and+related+derivatives+as+novel+PI3+kinase+PI3KR+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110α inhibitors</span></div><div class="casAuthors">Hayakawa, Masahiko; Kaizawa, Hiroyuki; Moritomo, Hiroyuki; Koizumi, Tomonobu; Ohishi, Takahide; Okada, Minoru; Ohta, Mitsuaki; Tsukamoto, Shin-ichi; Parker, Peter; Workman, Paul; Waterfield, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6847-6858</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of 4-morpholino-2-phenylquinazolines and related derivs. were prepd. and evaluated as inhibitors of PI3 kinase p110α.  In this series, the thieno[3,2-d]pyrimidine deriv. 15e (I) showed the strongest inhibitory activity against p110α, with an IC50 value of 2.0 nM, and inhibited proliferation of A375 melanoma cells with an IC50 value of 0.58 μM.  Moreover, 15e was found to be selective for p110α over other PI3K isoforms and protein kinases, making it the first example of a selective PI3K p110α inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp57O4VuB9kN7Vg90H21EOLACvtfcHk0lhs1QUTmYea8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptFSks7g%253D&md5=b75abfe42f5698d1179c90a9c33777cf</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.06.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.06.046%26sid%3Dliteratum%253Aachs%26aulast%3DHayakawa%26aufirst%3DM.%26aulast%3DKaizawa%26aufirst%3DH.%26aulast%3DMoritomo%26aufirst%3DH.%26aulast%3DKoizumi%26aufirst%3DT.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DTsukamoto%26aufirst%3DS.%26aulast%3DParker%26aufirst%3DP.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWaterfield%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25204-morpholino-2-phenylquinazolines%2520and%2520related%2520derivatives%2520as%2520novel%2520PI3%2520kinase%2520PI3KR%2520inhibitors%26jtitle%3DBiorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D6847%26epage%3D6858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Borwell, F. G.</span><span> </span><span class="NLM_article-title">Equilibrium acidities in dimethyl sulfoxide solution</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">456</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1988&pages=456-463&author=F.+G.+Borwell&title=Equilibrium+acidities+in+dimethyl+sulfoxide+solution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorwell%26aufirst%3DF.%2BG.%26atitle%3DEquilibrium%2520acidities%2520in%2520dimethyl%2520sulfoxide%2520solution%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D1988%26volume%3D21%26spage%3D456%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silber, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rance, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wastall, P.</span><span> </span><span class="NLM_article-title">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=9336307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=46-58&author=R.+S.+Obachauthor=J.+G.+Baxterauthor=T.+E.+Listonauthor=B.+M.+Silberauthor=B.+C.+Jonesauthor=F.+MacIntyreauthor=D.+J.+Ranceauthor=P.+Wastall&title=The+prediction+of+human+pharmacokinetic+parameters+from+preclinical+and+in+vitro+metabolism+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span></div><div class="casAuthors">Obach, R. Scott; Baxter, James G.; Liston, Theodore E.; Silber, B. Michael; Jones, Barry C.; Macintyre, Flona; Rance, David J.; Wastall, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-58</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 35 refs.  We describe a comprehensive retrospective anal. in which the abilities of several methods by which human pharmacokinetic parameters are predicted from preclin. pharmacokinetic data and/or in vitro metab. data were assessed.  The prediction methods examd. included both methods from the scientific literature as well as some described in this report for the first time.  Four methods were examd. for their ability to predict human vol. of distribution.  Three were highly predictive, yielding, on av., predictions that were within 60% to 90% of actual values.  Twelve methods were assessed for their utility in predicting clearance.  The most successful allometric scaling method yielded clearance predictions that were, on av., within 80% of actual values.  The best methods in which in vitro metab. data from human liver microsomes were scaled to in vivo clearance values yielded predicted clearance values that were, on av., within 70% to 80% of actual values.  Human t1/2 was predicted by combining predictions of human vol. of distribution and clearance.  The best t1/2 prediction methods successfully assigned compds. to appropriate dosing regimen categories (e.g., once daily, twice daily and so forth) 70% to 80% of the time.  In addn., correlations between human t1/2 and t1/2 values from preclin. species were also generally successful (72-87%) when used to predict human dosing regimens.  In summary, this retrospective anal. has identified several approaches by which human pharmacokinetic data can be predicted from preclin. data.  Such approaches should find utility in the drug discovery and development processes in the identification and selection of compds. that will possess appropriate pharmacokinetic characteristics in humans for progression to clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAngniZ4izLVg90H21EOLACvtfcHk0lizk7X5QIokmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D&md5=68d1910d925e26ec4a8ef23043ffb1ed</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DBaxter%26aufirst%3DJ.%2BG.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DJones%26aufirst%3DB.%2BC.%26aulast%3DMacIntyre%26aufirst%3DF.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26aulast%3DWastall%26aufirst%3DP.%26atitle%3DThe%2520prediction%2520of%2520human%2520pharmacokinetic%2520parameters%2520from%2520preclinical%2520and%2520in%2520vitro%2520metabolism%2520data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D46%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4'],'ref5':['cit5a','cit5b','cit5c','cit5d','cit5e'],'ref6':['cit6'],'ref7':['cit7a','cit7b'],'ref8':['cit8'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 90 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miao  Zhan</span>, <span class="hlFld-ContribAuthor ">Yufang  Deng</span>, <span class="hlFld-ContribAuthor ">Lifeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Guoyi  Yan</span>, <span class="hlFld-ContribAuthor ">Fangying  Wang</span>, <span class="hlFld-ContribAuthor ">Ye  Tian</span>, <span class="hlFld-ContribAuthor ">Lanxi  Zhang</span>, <span class="hlFld-ContribAuthor ">Hongxia  Jiang</span>, and <span class="hlFld-ContribAuthor ">Yuanwei  Chen</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Dimorpholine Substituted Thienopyrimidines as Potential Class I PI3K/mTOR Dual Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 4023-4035. <a href="https://doi.org/10.1021/acs.jmedchem.7b00357" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00357</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00357%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BDimorpholine%252BSubstituted%252BThienopyrimidines%252Bas%252BPotential%252BClass%252BI%252BPI3K%25252FmTOR%252BDual%252BInhibitors%26aulast%3DZhan%26aufirst%3DMiao%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D08032017%26date%3D24042017%26date%3D11052017%26date%3D14042017%26volume%3D60%26issue%3D9%26spage%3D4023%26epage%3D4035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>  . </span><span class="cited-content_cbyCitation_article-title">Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (22)
                                     , 10030-10066. <a href="https://doi.org/10.1021/acs.jmedchem.6b00618" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00618%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BBrain%252BCancer%26aulast%3DHeffron%26aufirst%3DTimothy%2BP.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21042016%26date%3D03082016%26date%3D23112016%26date%3D14072016%26volume%3D59%26issue%3D22%26spage%3D10030%26epage%3D10066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>, <span class="hlFld-ContribAuthor ">Chudi O.  Ndubaku</span>, <span class="hlFld-ContribAuthor ">Laurent  Salphati</span>, <span class="hlFld-ContribAuthor ">Bruno  Alicke</span>, <span class="hlFld-ContribAuthor ">Jonathan  Cheong</span>, <span class="hlFld-ContribAuthor ">Joy  Drobnick</span>, <span class="hlFld-ContribAuthor ">Kyle  Edgar</span>, <span class="hlFld-ContribAuthor ">Stephen E.  Gould</span>, <span class="hlFld-ContribAuthor ">Leslie B.  Lee</span>, <span class="hlFld-ContribAuthor ">John D.  Lesnick</span>, <span class="hlFld-ContribAuthor ">Cristina  Lewis</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Jodie  Pang</span>, <span class="hlFld-ContribAuthor ">Emile G.  Plise</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Wallin</span>, <span class="hlFld-ContribAuthor ">Lan  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Zhang</span>, and <span class="hlFld-ContribAuthor ">Alan G.  Olivero</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Clinical Development Candidate GDC-0084, a Brain Penetrant Inhibitor of PI3K and mTOR. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (4)
                                     , 351-356. <a href="https://doi.org/10.1021/acsmedchemlett.6b00005" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00005%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BClinical%252BDevelopment%252BCandidate%252BGDC-0084%25252C%252Ba%252BBrain%252BPenetrant%252BInhibitor%252Bof%252BPI3K%252Band%252BmTOR%26aulast%3DHeffron%26aufirst%3DTimothy%2BP.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D06012016%26date%3D16022016%26date%3D17022016%26date%3D14042016%26date%3D16022016%26volume%3D7%26issue%3D4%26spage%3D351%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Timothy P.    Heffron </span><span class="hlFld-ContribAuthor "> Andrew    McClory </span><span class="hlFld-ContribAuthor "> Andreas    Stumpf </span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery and Process Chemistry Development of GDC-0084, a Brain Penetrating Inhibitor of PI3K and mTOR. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 147-173. <a href="https://doi.org/10.1021/bk-2016-1239.ch006" title="DOI URL">https://doi.org/10.1021/bk-2016-1239.ch006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2016-1239.ch006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2016-1239.ch006%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDiscovery%252Band%252BProcess%252BChemistry%252BDevelopment%252Bof%252BGDC-0084%25252C%252Ba%252BBrain%252BPenetrating%252BInhibitor%252Bof%252BPI3K%252Band%252BmTOR%26aulast%3DHeffron%26aufirst%3DTimothy%2BP.%26date%3D2016%26date%3D2016%26spage%3D147%26epage%3D173%26atitle%3DComprehensive%252BAccounts%252Bof%252BPharmaceutical%252BResearch%252Band%252BDevelopment%25253A%252BFrom%252BDiscovery%252Bto%252BLate-Stage%252BProcess%252BDevelopment%252BVolume%252B1%26aulast%3DAbdel-Magid%26aufirst%3DAhmed%2BF.%26date%3D2016%26date%3D2016%26volume%3D1239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Srinivasan    Babu </span><span class="hlFld-ContribAuthor "> Francis    Gosselin </span><span class="hlFld-ContribAuthor "> Theresa    Humphries </span><span class="hlFld-ContribAuthor "> Alan    Olivero </span><span class="hlFld-ContribAuthor "> Daniel    Sutherlin </span><span class="hlFld-ContribAuthor "> Qingping    Tian </span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Process Development of Class I PI3K and Class I PI3K/mTOR Inhibitors GDC-0941 and GDC-0980. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 237-270. <a href="https://doi.org/10.1021/bk-2016-1240.ch008" title="DOI URL">https://doi.org/10.1021/bk-2016-1240.ch008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2016-1240.ch008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2016-1240.ch008%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Band%252BProcess%252BDevelopment%252Bof%252BClass%252BI%252BPI3K%252Band%252BClass%252BI%252BPI3K%25252FmTOR%252BInhibitors%252BGDC-0941%252Band%252BGDC-0980%26aulast%3DBabu%26aufirst%3DSrinivasan%26date%3D2016%26date%3D2016%26spage%3D237%26epage%3D270%26atitle%3DComprehensive%252BAccounts%252Bof%252BPharmaceutical%252BResearch%252Band%252BDevelopment%25253A%252BFrom%252BDiscovery%252Bto%252BLate-Stage%252BProcess%252BDevelopment%252BVolume%252B2%26aulast%3DAbdel-Magid%26aufirst%3DAhmed%2BF.%26date%3D2016%26date%3D2016%26volume%3D1240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Andrs</span>, <span class="hlFld-ContribAuthor ">Jan  Korabecny</span>, <span class="hlFld-ContribAuthor ">Daniel  Jun</span>, <span class="hlFld-ContribAuthor ">Zdenek  Hodny</span>, <span class="hlFld-ContribAuthor ">Jiri  Bartek</span>, and <span class="hlFld-ContribAuthor ">Kamil  Kuca</span>  . </span><span class="cited-content_cbyCitation_article-title">Phosphatidylinositol 3-Kinase (PI3K) and Phosphatidylinositol 3-Kinase-Related Kinase (PIKK) Inhibitors: Importance of the Morpholine Ring. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 41-71. <a href="https://doi.org/10.1021/jm501026z" title="DOI URL">https://doi.org/10.1021/jm501026z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501026z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501026z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPhosphatidylinositol%252B3-Kinase%252B%252528PI3K%252529%252Band%252BPhosphatidylinositol%252B3-Kinase-Related%252BKinase%252B%252528PIKK%252529%252BInhibitors%25253A%252BImportance%252Bof%252Bthe%252BMorpholine%252BRing%26aulast%3DAndrs%26aufirst%3DMartin%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D08072014%26date%3D05122014%26date%3D08012015%26date%3D11112014%26volume%3D58%26issue%3D1%26spage%3D41%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anders  Poulsen</span>, <span class="hlFld-ContribAuthor ">Harish  Nagaraj</span>, <span class="hlFld-ContribAuthor ">Angeline  Lee</span>, <span class="hlFld-ContribAuthor ">Stéphanie  Blanchard</span>, <span class="hlFld-ContribAuthor ">Chang Kai  Soh</span>, <span class="hlFld-ContribAuthor ">Dizhong  Chen</span>, <span class="hlFld-ContribAuthor ">Haishan  Wang</span>, <span class="hlFld-ContribAuthor ">Stefan  Hart</span>, <span class="hlFld-ContribAuthor ">Kee Chuan  Goh</span>, <span class="hlFld-ContribAuthor ">Brian  Dymock</span>, and <span class="hlFld-ContribAuthor ">Meredith  Williams</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure and Ligand-Based Design of mTOR and PI3-Kinase Inhibitors Leading to the Clinical Candidates VS-5584 (SB2343) and SB2602. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (11)
                                     , 3238-3250. <a href="https://doi.org/10.1021/ci500493m" title="DOI URL">https://doi.org/10.1021/ci500493m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci500493m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci500493m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DStructure%252Band%252BLigand-Based%252BDesign%252Bof%252BmTOR%252Band%252BPI3-Kinase%252BInhibitors%252BLeading%252Bto%252Bthe%252BClinical%252BCandidates%252BVS-5584%252B%252528SB2343%252529%252Band%252BSB2602%26aulast%3DPoulsen%26aufirst%3DAnders%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D10082014%26date%3D23102014%26date%3D24112014%26date%3D15102014%26volume%3D54%26issue%3D11%26spage%3D3238%26epage%3D3250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thibault  Saurat</span>, <span class="hlFld-ContribAuthor ">Frédéric  Buron</span>, <span class="hlFld-ContribAuthor ">Nuno  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Marie-Ludivine  de Tauzia</span>, <span class="hlFld-ContribAuthor ">Lionel  Colliandre</span>, <span class="hlFld-ContribAuthor ">Stéphane  Bourg</span>, <span class="hlFld-ContribAuthor ">Pascal  Bonnet</span>, <span class="hlFld-ContribAuthor ">Gérald  Guillaumet</span>, <span class="hlFld-ContribAuthor ">Mohamed  Akssira</span>, <span class="hlFld-ContribAuthor ">Anne  Corlu</span>, <span class="hlFld-ContribAuthor ">Christiane  Guillouzo</span>, <span class="hlFld-ContribAuthor ">Pauline  Berthier</span>, <span class="hlFld-ContribAuthor ">Pascale  Rio</span>, <span class="hlFld-ContribAuthor ">Marie-Lise  Jourdan</span>, <span class="hlFld-ContribAuthor ">Hélène  Bénédetti</span>, and <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Activity of Pyridopyrimidine Scaffolds as Novel PI3K/mTOR Dual Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (3)
                                     , 613-631. <a href="https://doi.org/10.1021/jm401138v" title="DOI URL">https://doi.org/10.1021/jm401138v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401138v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401138v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BActivity%252Bof%252BPyridopyrimidine%252BScaffolds%252Bas%252BNovel%252BPI3K%25252FmTOR%252BDual%252BInhibitors%26aulast%3DSaurat%26aufirst%3DThibault%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D26072013%26date%3D21012014%26date%3D13022014%26date%3D17122013%26volume%3D57%26issue%3D3%26spage%3D613%26epage%3D631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony A.  Estrada</span>, <span class="hlFld-ContribAuthor ">Daniel G.  Shore</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Blackwood</span>, <span class="hlFld-ContribAuthor ">Yung-Hsiang  Chen</span>, <span class="hlFld-ContribAuthor ">Gauri  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Antonio G.  DiPasquale</span>, <span class="hlFld-ContribAuthor ">Jennifer A.  Epler</span>, <span class="hlFld-ContribAuthor ">Lori S.  Friedman</span>, <span class="hlFld-ContribAuthor ">Michael F. T.  Koehler</span>, <span class="hlFld-ContribAuthor ">Lichuan  Liu</span>, <span class="hlFld-ContribAuthor ">Shiva  Malek</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Pei</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Frederic  St-Jean</span>, <span class="hlFld-ContribAuthor ">Lan  Trinh</span>, <span class="hlFld-ContribAuthor ">Tom  Truong</span>, and <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>  . </span><span class="cited-content_cbyCitation_article-title">Pyrimidoaminotropanes as Potent, Selective, and Efficacious Small Molecule Kinase Inhibitors of the Mammalian Target of Rapamycin (mTOR). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (7)
                                     , 3090-3101. <a href="https://doi.org/10.1021/jm400194n" title="DOI URL">https://doi.org/10.1021/jm400194n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400194n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400194n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrimidoaminotropanes%252Bas%252BPotent%25252C%252BSelective%25252C%252Band%252BEfficacious%252BSmall%252BMolecule%252BKinase%252BInhibitors%252Bof%252Bthe%252BMammalian%252BTarget%252Bof%252BRapamycin%252B%252528mTOR%252529%26aulast%3DEstrada%26aufirst%3DAnthony%2BA.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D06022013%26date%3D29032013%26date%3D11042013%26date%3D08032013%26volume%3D56%26issue%3D7%26spage%3D3090%26epage%3D3101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariana  Nacht</span>, <span class="hlFld-ContribAuthor ">Lixin  Qiao</span>, <span class="hlFld-ContribAuthor ">Michael P.  Sheets</span>, <span class="hlFld-ContribAuthor ">Thia  St. Martin</span>, <span class="hlFld-ContribAuthor ">Matthew  Labenski</span>, <span class="hlFld-ContribAuthor ">Hormoz  Mazdiyasni</span>, <span class="hlFld-ContribAuthor ">Russell  Karp</span>, <span class="hlFld-ContribAuthor ">Zhendong  Zhu</span>, <span class="hlFld-ContribAuthor ">Prasoon  Chaturvedi</span>, <span class="hlFld-ContribAuthor ">Deepa  Bhavsar</span>, <span class="hlFld-ContribAuthor ">Deqiang  Niu</span>, <span class="hlFld-ContribAuthor ">William  Westlin</span>, <span class="hlFld-ContribAuthor ">Russell C.  Petter</span>, <span class="hlFld-ContribAuthor ">Aravind Prasad  Medikonda</span>, and <span class="hlFld-ContribAuthor ">Juswinder  Singh</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent and Isoform-Selective Targeted Covalent Inhibitor of the Lipid Kinase PI3Kα. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (3)
                                     , 712-721. <a href="https://doi.org/10.1021/jm3008745" title="DOI URL">https://doi.org/10.1021/jm3008745</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3008745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3008745%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252Band%252BIsoform-Selective%252BTargeted%252BCovalent%252BInhibitor%252Bof%252Bthe%252BLipid%252BKinase%252BPI3K%2525CE%2525B1%26aulast%3DNacht%26aufirst%3DMariana%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D21062012%26date%3D05022013%26date%3D14022013%26date%3D29012013%26volume%3D56%26issue%3D3%26spage%3D712%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael F. T.  Koehler</span>, <span class="hlFld-ContribAuthor ">Philippe  Bergeron</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Blackwood</span>, <span class="hlFld-ContribAuthor ">Krista K.  Bowman</span>, <span class="hlFld-ContribAuthor ">Yung-Hsiang  Chen</span>, <span class="hlFld-ContribAuthor ">Gauri  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Jennifer  Epler</span>, <span class="hlFld-ContribAuthor ">Kevin  Lau</span>, <span class="hlFld-ContribAuthor ">Leslie  Lee</span>, <span class="hlFld-ContribAuthor ">Lichuan  Liu</span>, <span class="hlFld-ContribAuthor ">Cuong  Ly</span>, <span class="hlFld-ContribAuthor ">Shiva  Malek</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Jason  Oeh</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Lan  Trinh</span>, <span class="hlFld-ContribAuthor ">Tom  Truong</span>, <span class="hlFld-ContribAuthor ">Jiansheng  Wu</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Pei</span>, and <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>  . </span><span class="cited-content_cbyCitation_article-title">Potent, Selective, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin Kinase Domain Exhibiting Single Agent Antiproliferative Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (24)
                                     , 10958-10971. <a href="https://doi.org/10.1021/jm301389h" title="DOI URL">https://doi.org/10.1021/jm301389h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301389h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301389h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BInhibitors%252Bof%252Bthe%252BMammalian%252BTarget%252Bof%252BRapamycin%252BKinase%252BDomain%252BExhibiting%252BSingle%252BAgent%252BAntiproliferative%252BActivity%26aulast%3DKoehler%26aufirst%3DMichael%2BF.%2BT.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D24092012%26date%3D12122012%26date%3D27122012%26date%3D30112012%26volume%3D55%26issue%3D24%26spage%3D10958%26epage%3D10971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>, <span class="hlFld-ContribAuthor ">Laurent  Salphati</span>, <span class="hlFld-ContribAuthor ">Bruno  Alicke</span>, <span class="hlFld-ContribAuthor ">Jonathan  Cheong</span>, <span class="hlFld-ContribAuthor ">Jennafer  Dotson</span>, <span class="hlFld-ContribAuthor ">Kyle  Edgar</span>, <span class="hlFld-ContribAuthor ">Richard  Goldsmith</span>, <span class="hlFld-ContribAuthor ">Stephen E.  Gould</span>, <span class="hlFld-ContribAuthor ">Leslie B.  Lee</span>, <span class="hlFld-ContribAuthor ">John D.  Lesnick</span>, <span class="hlFld-ContribAuthor ">Cristina  Lewis</span>, <span class="hlFld-ContribAuthor ">Chudi  Ndubaku</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Alan G.  Olivero</span>, <span class="hlFld-ContribAuthor ">Jodie  Pang</span>, <span class="hlFld-ContribAuthor ">Emile G.  Plise</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Sean  Trapp</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Wallin</span>, <span class="hlFld-ContribAuthor ">Lan  Wang</span>, and <span class="hlFld-ContribAuthor ">Xiaolin  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">The Design and Identification of Brain Penetrant Inhibitors of Phosphoinositide 3-Kinase α. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (18)
                                     , 8007-8020. <a href="https://doi.org/10.1021/jm300867c" title="DOI URL">https://doi.org/10.1021/jm300867c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300867c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300867c%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDesign%252Band%252BIdentification%252Bof%252BBrain%252BPenetrant%252BInhibitors%252Bof%252BPhosphoinositide%252B3-Kinase%252B%2525CE%2525B1%26aulast%3DHeffron%26aufirst%3DTimothy%2BP.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D20062012%26date%3D11092012%26date%3D27092012%26date%3D04092012%26volume%3D55%26issue%3D18%26spage%3D8007%26epage%3D8020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeremy M.  Murray</span>, <span class="hlFld-ContribAuthor ">Zachary K.  Sweeney</span>, <span class="hlFld-ContribAuthor ">Bryan K.  Chan</span>, <span class="hlFld-ContribAuthor ">Mercedesz  Balazs</span>, <span class="hlFld-ContribAuthor ">Erin  Bradley</span>, <span class="hlFld-ContribAuthor ">Georgette  Castanedo</span>, <span class="hlFld-ContribAuthor ">Christine  Chabot</span>, <span class="hlFld-ContribAuthor ">David  Chantry</span>, <span class="hlFld-ContribAuthor ">Michael  Flagella</span>, <span class="hlFld-ContribAuthor ">David M.  Goldstein</span>, <span class="hlFld-ContribAuthor ">Rama  Kondru</span>, <span class="hlFld-ContribAuthor ">John  Lesnick</span>, <span class="hlFld-ContribAuthor ">Jun  Li</span>, <span class="hlFld-ContribAuthor ">Matthew C.  Lucas</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Jodie  Pang</span>, <span class="hlFld-ContribAuthor ">Stephen  Price</span>, <span class="hlFld-ContribAuthor ">Laurent  Salphati</span>, <span class="hlFld-ContribAuthor ">Brian  Safina</span>, <span class="hlFld-ContribAuthor ">Pascal P. A.  Savy</span>, <span class="hlFld-ContribAuthor ">Eileen M.  Seward</span>, <span class="hlFld-ContribAuthor ">Mark  Ultsch</span>, and <span class="hlFld-ContribAuthor ">Daniel P.  Sutherlin</span>  . </span><span class="cited-content_cbyCitation_article-title">Potent and Highly Selective Benzimidazole Inhibitors of PI3-Kinase Delta. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (17)
                                     , 7686-7695. <a href="https://doi.org/10.1021/jm300717c" title="DOI URL">https://doi.org/10.1021/jm300717c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300717c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300717c%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%252Band%252BHighly%252BSelective%252BBenzimidazole%252BInhibitors%252Bof%252BPI3-Kinase%252BDelta%26aulast%3DMurray%26aufirst%3DJeremy%2BM.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D22052012%26date%3D21082012%26date%3D13092012%26date%3D09082012%26volume%3D55%26issue%3D17%26spage%3D7686%26epage%3D7695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian S.  Safina</span>, <span class="hlFld-ContribAuthor ">Stewart  Baker</span>, <span class="hlFld-ContribAuthor ">Matt  Baumgardner</span>, <span class="hlFld-ContribAuthor ">Paul M.  Blaney</span>, <span class="hlFld-ContribAuthor ">Bryan K.  Chan</span>, <span class="hlFld-ContribAuthor ">Yung-Hsiang  Chen</span>, <span class="hlFld-ContribAuthor ">Matthew W.  Cartwright</span>, <span class="hlFld-ContribAuthor ">Georgette  Castanedo</span>, <span class="hlFld-ContribAuthor ">Christine  Chabot</span>, <span class="hlFld-ContribAuthor ">Arnaud J.  Cheguillaume</span>, <span class="hlFld-ContribAuthor ">Paul  Goldsmith</span>, <span class="hlFld-ContribAuthor ">David M.  Goldstein</span>, <span class="hlFld-ContribAuthor ">Bindu  Goyal</span>, <span class="hlFld-ContribAuthor ">Timothy  Hancox</span>, <span class="hlFld-ContribAuthor ">Raj K.  Handa</span>, <span class="hlFld-ContribAuthor ">Pravin S  Iyer</span>, <span class="hlFld-ContribAuthor ">Jasmit  Kaur</span>, <span class="hlFld-ContribAuthor ">Rama  Kondru</span>, <span class="hlFld-ContribAuthor ">Jane R.  Kenny</span>, <span class="hlFld-ContribAuthor ">Sussie L.  Krintel</span>, <span class="hlFld-ContribAuthor ">Jun  Li</span>, <span class="hlFld-ContribAuthor ">John  Lesnick</span>, <span class="hlFld-ContribAuthor ">Matthew C.  Lucas</span>, <span class="hlFld-ContribAuthor ">Cristina  Lewis</span>, <span class="hlFld-ContribAuthor ">Sophie  Mukadam</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, <span class="hlFld-ContribAuthor ">Alan J.  Nadin</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Fernando  Padilla</span>, <span class="hlFld-ContribAuthor ">Wylie S.  Palmer</span>, <span class="hlFld-ContribAuthor ">Jodie  Pang</span>, <span class="hlFld-ContribAuthor ">Neil  Pegg</span>, <span class="hlFld-ContribAuthor ">Steve  Price</span>, <span class="hlFld-ContribAuthor ">Karin  Reif</span>, <span class="hlFld-ContribAuthor ">Laurent  Salphati</span>, <span class="hlFld-ContribAuthor ">Pascal A.  Savy</span>, <span class="hlFld-ContribAuthor ">Eileen M.  Seward</span>, <span class="hlFld-ContribAuthor ">Stephen  Shuttleworth</span>, <span class="hlFld-ContribAuthor ">Sukhjit  Sohal</span>, <span class="hlFld-ContribAuthor ">Zachary K.  Sweeney</span>, <span class="hlFld-ContribAuthor ">Suzanne  Tay</span>, <span class="hlFld-ContribAuthor ">Parcharee  Tivitmahaisoon</span>, <span class="hlFld-ContribAuthor ">Bohdan  Waszkowycz</span>, <span class="hlFld-ContribAuthor ">Binqing  Wei</span>, <span class="hlFld-ContribAuthor ">Qin  Yue</span>, <span class="hlFld-ContribAuthor ">Chenghong  Zhang</span>, and <span class="hlFld-ContribAuthor ">Daniel P.  Sutherlin</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel PI3-Kinase δ Specific Inhibitors for the Treatment of Rheumatoid Arthritis: Taming CYP3A4 Time-Dependent Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (12)
                                     , 5887-5900. <a href="https://doi.org/10.1021/jm3003747" title="DOI URL">https://doi.org/10.1021/jm3003747</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3003747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3003747%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BPI3-Kinase%252B%2525CE%2525B4%252BSpecific%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BRheumatoid%252BArthritis%25253A%252BTaming%252BCYP3A4%252BTime-Dependent%252BInhibition%26aulast%3DSafina%26aufirst%3DBrian%2BS.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D18032012%26date%3D11062012%26date%3D28062012%26date%3D24052012%26volume%3D55%26issue%3D12%26spage%3D5887%26epage%3D5900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>, <span class="hlFld-ContribAuthor ">BinQing  Wei</span>, <span class="hlFld-ContribAuthor ">Alan  Olivero</span>, <span class="hlFld-ContribAuthor ">Steven T.  Staben</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Steven  Do</span>, <span class="hlFld-ContribAuthor ">Jennafer  Dotson</span>, <span class="hlFld-ContribAuthor ">Adrian J.  Folkes</span>, <span class="hlFld-ContribAuthor ">Paul  Goldsmith</span>, <span class="hlFld-ContribAuthor ">Richard  Goldsmith</span>, <span class="hlFld-ContribAuthor ">Janet  Gunzner</span>, <span class="hlFld-ContribAuthor ">John  Lesnick</span>, <span class="hlFld-ContribAuthor ">Cristina  Lewis</span>, <span class="hlFld-ContribAuthor ">Simon  Mathieu</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Stephen  Shuttleworth</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Sutherlin</span>, <span class="hlFld-ContribAuthor ">Nan Chi  Wan</span>, <span class="hlFld-ContribAuthor ">Shumei  Wang</span>, <span class="hlFld-ContribAuthor ">Christian  Wiesmann</span>, and <span class="hlFld-ContribAuthor ">Bing-Yan  Zhu</span>  . </span><span class="cited-content_cbyCitation_article-title">Rational Design of Phosphoinositide 3-Kinase α Inhibitors That Exhibit Selectivity over the Phosphoinositide 3-Kinase β Isoform. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (22)
                                     , 7815-7833. <a href="https://doi.org/10.1021/jm2007084" title="DOI URL">https://doi.org/10.1021/jm2007084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm2007084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm2007084%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252BDesign%252Bof%252BPhosphoinositide%252B3-Kinase%252B%2525CE%2525B1%252BInhibitors%252BThat%252BExhibit%252BSelectivity%252Bover%252Bthe%252BPhosphoinositide%252B3-Kinase%252B%2525CE%2525B2%252BIsoform%26aulast%3DHeffron%26aufirst%3DTimothy%2BP.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D02062011%26date%3D21102011%26date%3D24112011%26date%3D10102011%26volume%3D54%26issue%3D22%26spage%3D7815%26epage%3D7833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel P.  Sutherlin</span>, <span class="hlFld-ContribAuthor ">Linda  Bao</span>, <span class="hlFld-ContribAuthor ">Megan  Berry</span>, <span class="hlFld-ContribAuthor ">Georgette  Castanedo</span>, <span class="hlFld-ContribAuthor ">Irina  Chuckowree</span>, <span class="hlFld-ContribAuthor ">Jenna  Dotson</span>, <span class="hlFld-ContribAuthor ">Adrian  Folks</span>, <span class="hlFld-ContribAuthor ">Lori  Friedman</span>, <span class="hlFld-ContribAuthor ">Richard  Goldsmith</span>, <span class="hlFld-ContribAuthor ">Janet  Gunzner</span>, <span class="hlFld-ContribAuthor ">Timothy  Heffron</span>, <span class="hlFld-ContribAuthor ">John  Lesnick</span>, <span class="hlFld-ContribAuthor ">Cristina  Lewis</span>, <span class="hlFld-ContribAuthor ">Simon  Mathieu</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Jodie  Pang</span>, <span class="hlFld-ContribAuthor ">Niel  Pegg</span>, <span class="hlFld-ContribAuthor ">Wei Wei  Prior</span>, <span class="hlFld-ContribAuthor ">Lionel  Rouge</span>, <span class="hlFld-ContribAuthor ">Laurent  Salphati</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Qingping  Tian</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Nan Chi  Wan</span>, <span class="hlFld-ContribAuthor ">Shumei  Wang</span>, <span class="hlFld-ContribAuthor ">BinQing  Wei</span>, <span class="hlFld-ContribAuthor ">Christian  Wiesmann</span>, <span class="hlFld-ContribAuthor ">Ping  Wu</span>, <span class="hlFld-ContribAuthor ">Bing-Yan  Zhu</span>, and <span class="hlFld-ContribAuthor ">Alan  Olivero</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (21)
                                     , 7579-7587. <a href="https://doi.org/10.1021/jm2009327" title="DOI URL">https://doi.org/10.1021/jm2009327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm2009327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm2009327%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BAvailable%252BClass%252BI%252BPhosphatidylinositol%252B3-Kinase%252B%252528PI3K%252529%25252FMammalian%252BTarget%252Bof%252BRapamycin%252B%252528mTOR%252529%252BKinase%252BInhibitor%252B%252528GDC-0980%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BCancer%26aulast%3DSutherlin%26aufirst%3DDaniel%2BP.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D13072011%26date%3D07102011%26date%3D10112011%26volume%3D54%26issue%3D21%26spage%3D7579%26epage%3D7587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederick  Cohen</span>, <span class="hlFld-ContribAuthor ">Philippe  Bergeron</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Blackwood</span>, <span class="hlFld-ContribAuthor ">Krista K.  Bowman</span>, <span class="hlFld-ContribAuthor ">Huifen  Chen</span>, <span class="hlFld-ContribAuthor ">Antonio G.  DiPasquale</span>, <span class="hlFld-ContribAuthor ">Jennifer A.  Epler</span>, <span class="hlFld-ContribAuthor ">Michael F. T.  Koehler</span>, <span class="hlFld-ContribAuthor ">Kevin  Lau</span>, <span class="hlFld-ContribAuthor ">Cristina  Lewis</span>, <span class="hlFld-ContribAuthor ">Lichuan  Liu</span>, <span class="hlFld-ContribAuthor ">Cuong Q.  Ly</span>, <span class="hlFld-ContribAuthor ">Shiva  Malek</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Pei</span>, <span class="hlFld-ContribAuthor ">Kirk D.  Robarge</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Lan  Trinh</span>, <span class="hlFld-ContribAuthor ">Tom  Truong</span>, <span class="hlFld-ContribAuthor ">Jiansheng  Wu</span>, <span class="hlFld-ContribAuthor ">Xianrui  Zhao</span>, and <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>  . </span><span class="cited-content_cbyCitation_article-title">Potent, Selective, and Orally Bioavailable Inhibitors of Mammalian Target of Rapamycin (mTOR) Kinase Based on a Quaternary Substituted Dihydrofuropyrimidine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (9)
                                     , 3426-3435. <a href="https://doi.org/10.1021/jm200215y" title="DOI URL">https://doi.org/10.1021/jm200215y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200215y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200215y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BInhibitors%252Bof%252BMammalian%252BTarget%252Bof%252BRapamycin%252B%252528mTOR%252529%252BKinase%252BBased%252Bon%252Ba%252BQuaternary%252BSubstituted%252BDihydrofuropyrimidine%26aulast%3DCohen%26aufirst%3DFrederick%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D24022011%26date%3D15042011%26date%3D12052011%26volume%3D54%26issue%3D9%26spage%3D3426%26epage%3D3435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingsong  Liu</span>, <span class="hlFld-ContribAuthor ">Jae Won  Chang</span>, <span class="hlFld-ContribAuthor ">Jinhua  Wang</span>, <span class="hlFld-ContribAuthor ">Seong A.  Kang</span>, <span class="hlFld-ContribAuthor ">Carson C.  Thoreen</span>, <span class="hlFld-ContribAuthor ">Andrew  Markhard</span>, <span class="hlFld-ContribAuthor ">Wooyoung  Hur</span>, <span class="hlFld-ContribAuthor ">Jianming  Zhang</span>, <span class="hlFld-ContribAuthor ">Taebo  Sim</span>, <span class="hlFld-ContribAuthor ">David M.  Sabatini</span>, and <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 1-(4-(4-Propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a Highly Potent, Selective Mammalian Target of Rapamycin (mTOR) Inhibitor for the Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (19)
                                     , 7146-7155. <a href="https://doi.org/10.1021/jm101144f" title="DOI URL">https://doi.org/10.1021/jm101144f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm101144f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm101144f%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B1-%2525284-%2525284-Propionylpiperazin-1-yl%252529-3-%252528trifluoromethyl%252529phenyl%252529-9-%252528quinolin-3-yl%252529benzo%25255Bh%25255D%25255B1%25252C6%25255Dnaphthyridin-2%2525281H%252529-one%252Bas%252Ba%252BHighly%252BPotent%25252C%252BSelective%252BMammalian%252BTarget%252Bof%252BRapamycin%252B%252528mTOR%252529%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BCancer%26aulast%3DLiu%26aufirst%3DQingsong%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D27062010%26date%3D22092010%26date%3D14102010%26volume%3D53%26issue%3D19%26spage%3D7146%26epage%3D7155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chiara  Borsari</span>, <span class="hlFld-ContribAuthor ">Martina  De Pascale</span>, <span class="hlFld-ContribAuthor ">Matthias P.  Wymann</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical and Structural Strategies to Selectively Target mTOR Kinase. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.1002/cmdc.202100332" title="DOI URL">https://doi.org/10.1002/cmdc.202100332</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100332%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DChemical%252Band%252BStructural%252BStrategies%252Bto%252BSelectively%252BTarget%252BmTOR%252BKinase%26aulast%3DBorsari%26aufirst%3DChiara%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahmoud A. E.  Hawass</span>, <span class="hlFld-ContribAuthor ">Sherif M. H.  Sanad</span>, <span class="hlFld-ContribAuthor ">Ahmed H. M.  Elwahy</span>, <span class="hlFld-ContribAuthor ">Ismail A.  Abdelhamid</span>. </span><span class="cited-content_cbyCitation_article-title">Hantzsch synthesis of
              bis
              (pyrido[2,3-
              d
              :6,5-
              d
              ']dipyrimidines),
              bis
              (pyrimido[4,5-
              b
              ]quinolines), and
              bis
              (benzo[4,5]imidazo[2,1-
              b
              ]quinazolines) linked to pyrazole units as novel hybrid molecules. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2021,</strong> <em>51 </em>
                                    (12)
                                     , 1899-1912. <a href="https://doi.org/10.1080/00397911.2021.1913604" title="DOI URL">https://doi.org/10.1080/00397911.2021.1913604</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2021.1913604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2021.1913604%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DHantzsch%252Bsynthesis%252Bof%252Bbis%252B%252528pyrido%25255B2%25252C3-%252Bd%252B%25253A6%25252C5-%252Bd%252B%252527%25255Ddipyrimidines%252529%25252C%252Bbis%252B%252528pyrimido%25255B4%25252C5-%252Bb%252B%25255Dquinolines%252529%25252C%252Band%252Bbis%252B%252528benzo%25255B4%25252C5%25255Dimidazo%25255B2%25252C1-%252Bb%252B%25255Dquinazolines%252529%252Blinked%252Bto%252Bpyrazole%252Bunits%252Bas%252Bnovel%252Bhybrid%252Bmolecules%26aulast%3DHawass%26aufirst%3DMahmoud%2BA.%2BE.%26date%3D2021%26date%3D2021%26volume%3D51%26issue%3D12%26spage%3D1899%26epage%3D1912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed F.  Saber</span>, <span class="hlFld-ContribAuthor ">Mostafa  Sayed</span>, <span class="hlFld-ContribAuthor ">Mahmoud S.  Tolba</span>, <span class="hlFld-ContribAuthor ">Adel M.  Kamal El-Dean</span>, <span class="hlFld-ContribAuthor ">Reda  Hassanien</span>, <span class="hlFld-ContribAuthor ">Mostafa  Ahmed</span>. </span><span class="cited-content_cbyCitation_article-title">A facile method for preparation and evaluation of the antimicrobial efficiency of various heterocycles containing thieno[2,3-
              d
              ]pyrimidine. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2021,</strong> <em>51 </em>
                                    (3)
                                     , 398-409. <a href="https://doi.org/10.1080/00397911.2020.1829645" title="DOI URL">https://doi.org/10.1080/00397911.2020.1829645</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2020.1829645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2020.1829645%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DA%252Bfacile%252Bmethod%252Bfor%252Bpreparation%252Band%252Bevaluation%252Bof%252Bthe%252Bantimicrobial%252Befficiency%252Bof%252Bvarious%252Bheterocycles%252Bcontaining%252Bthieno%25255B2%25252C3-%252Bd%252B%25255Dpyrimidine%26aulast%3DSaber%26aufirst%3DAhmed%2BF.%26date%3D2021%26date%3D2020%26volume%3D51%26issue%3D3%26spage%3D398%26epage%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin E.  Blass</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro ADME and in vivo pharmacokinetics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 305-369. <a href="https://doi.org/10.1016/B978-0-12-817214-8.00006-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-817214-8.00006-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-817214-8.00006-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-817214-8.00006-3%26sid%3Dliteratum%253Aachs%26atitle%3DIn%252Bvitro%252BADME%252Band%252Bin%252Bvivo%252Bpharmacokinetics%26aulast%3DBlass%26aufirst%3DBenjamin%2BE.%26date%3D2021%26spage%3D305%26epage%3D369%26pub%3DElsevier%26atitle%3DBasic%252BPrinciples%252Bof%252BDrug%252BDiscovery%252Band%252BDevelopment%26date%3D2021%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yifan  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Research progress of mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>208 </em>, 112820. <a href="https://doi.org/10.1016/j.ejmech.2020.112820" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112820</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112820%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DResearch%252Bprogress%252Bof%252BmTOR%252Binhibitors%26aulast%3DChen%26aufirst%3DYifan%26date%3D2020%26volume%3D208%26spage%3D112820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wan‐Chen  Pan</span>, <span class="hlFld-ContribAuthor ">Yi‐Chun  Wang</span>, <span class="hlFld-ContribAuthor ">Tuan‐Jie  Li</span>, <span class="hlFld-ContribAuthor ">Jian‐Quan  Liu</span>, <span class="hlFld-ContribAuthor ">Xiang‐Shan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient synthesis of 6‐benzyl‐2‐arylthieno[2,3‐
              d
              ]pyrimidin‐4(
              
                3
                H
              
              )‐ones catalyzed by
              HCl
              involving a
              Friedel‐Crafts
              alkylation reaction. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2020,</strong> <em>57 </em>
                                    (11)
                                     , 3970-3979. <a href="https://doi.org/10.1002/jhet.4107" title="DOI URL">https://doi.org/10.1002/jhet.4107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.4107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.4107%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DAn%252Befficient%252Bsynthesis%252Bof%252B6%2525E2%252580%252590benzyl%2525E2%252580%2525902%2525E2%252580%252590arylthieno%25255B2%25252C3%2525E2%252580%252590%252Bd%252B%25255Dpyrimidin%2525E2%252580%2525904%252528%252B3%252BH%252B%252529%2525E2%252580%252590ones%252Bcatalyzed%252Bby%252BHCl%252Binvolving%252Ba%252BFriedel%2525E2%252580%252590Crafts%252Balkylation%252Breaction%26aulast%3DPan%26aufirst%3DWan%25E2%2580%2590Chen%26date%3D2020%26date%3D2020%26volume%3D57%26issue%3D11%26spage%3D3970%26epage%3D3979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pei  Huang</span>, <span class="hlFld-ContribAuthor ">Juan  Zhao</span>, <span class="hlFld-ContribAuthor ">Yan-Hong  Gao</span>, <span class="hlFld-ContribAuthor ">Ling-Xia  Jin</span>, <span class="hlFld-ContribAuthor ">Qin  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-Hu  Yu</span>, <span class="hlFld-ContribAuthor ">Xiao-Hui  Ji</span>, <span class="hlFld-ContribAuthor ">Jiu-Fu  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">N-{2-[(2-chlorothieno[3,2-d]pyrimidin-4-yl)amino]ethyl}-3-methoxybenzamide: design, synthesis, crystal structure, antiproliferative activity, DFT, Hirshfeld surface analysis and molecular docking study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>69 </em>, 1-9. <a href="https://doi.org/10.1080/07391102.2020.1819424" title="DOI URL">https://doi.org/10.1080/07391102.2020.1819424</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1819424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1819424%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DN-%25257B2-%25255B%2525282-chlorothieno%25255B3%25252C2-d%25255Dpyrimidin-4-yl%252529amino%25255Dethyl%25257D-3-methoxybenzamide%25253A%252Bdesign%25252C%252Bsynthesis%25252C%252Bcrystal%252Bstructure%25252C%252Bantiproliferative%252Bactivity%25252C%252BDFT%25252C%252BHirshfeld%252Bsurface%252Banalysis%252Band%252Bmolecular%252Bdocking%252Bstudy%26aulast%3DHuang%26aufirst%3DPei%26date%3D2020%26date%3D2020%26volume%3D69%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tianyu  Ye</span>, <span class="hlFld-ContribAuthor ">Yufei  Han</span>, <span class="hlFld-ContribAuthor ">Ruxin  Wang</span>, <span class="hlFld-ContribAuthor ">Pingzhen  Yan</span>, <span class="hlFld-ContribAuthor ">Shaowei  Chen</span>, <span class="hlFld-ContribAuthor ">Yunlei  Hou</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 2,4-bismorpholinothieno[3,2-d]pyrimidine and 2-morpholinothieno[3,2-d]pyrimidinone derivatives as potent antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>99 </em>, 103796. <a href="https://doi.org/10.1016/j.bioorg.2020.103796" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103796</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103796%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B2%25252C4-bismorpholinothieno%25255B3%25252C2-d%25255Dpyrimidine%252Band%252B2-morpholinothieno%25255B3%25252C2-d%25255Dpyrimidinone%252Bderivatives%252Bas%252Bpotent%252Bantitumor%252Bagents%26aulast%3DYe%26aufirst%3DTianyu%26date%3D2020%26volume%3D99%26spage%3D103796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaorong  Liang</span>, <span class="hlFld-ContribAuthor ">Jenninfer  LeCouter</span>, <span class="hlFld-ContribAuthor ">Savita  Ubhayakar</span>, <span class="hlFld-ContribAuthor ">Jacob  Chen</span>, <span class="hlFld-ContribAuthor ">Jay  Cheng</span>, <span class="hlFld-ContribAuthor ">Tom  Lee</span>, <span class="hlFld-ContribAuthor ">Joe  Lubach</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Sheerin  Shahidi-Latham</span>, <span class="hlFld-ContribAuthor ">Cristine  Quiason</span>, <span class="hlFld-ContribAuthor ">Eric  Solon</span>, <span class="hlFld-ContribAuthor ">Matthew  Wright</span>, <span class="hlFld-ContribAuthor ">Cornelis E.C.A.  Hop</span>, <span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of Antineovascularization Activity and Ocular Pharmacokinetics of Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor GNE-947. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2020,</strong> <em>48 </em>
                                    (5)
                                     , 408-419. <a href="https://doi.org/10.1124/dmd.119.089763" title="DOI URL">https://doi.org/10.1124/dmd.119.089763</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.119.089763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.119.089763%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DCharacterization%252Bof%252BAntineovascularization%252BActivity%252Band%252BOcular%252BPharmacokinetics%252Bof%252BPhosphoinositide%252B3-Kinase%25252FMammalian%252BTarget%252Bof%252BRapamycin%252BInhibitor%252BGNE-947%26aulast%3DLiu%26aufirst%3DXingrong%26date%3D2020%26date%3D2020%26volume%3D48%26issue%3D5%26spage%3D408%26epage%3D419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Walaa I. El-Sofany</span>, <span class="hlFld-ContribAuthor ">Dalia Ahmed A.  Othman</span>, <span class="hlFld-ContribAuthor ">Asma M.  Mahran</span>, <span class="hlFld-ContribAuthor ">El-Manawaty A.  May</span>, <span class="hlFld-ContribAuthor ">Wael A.  El-Sayed</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Anticancer Activity of Functionalized Thieno[2,3-d]pyrimidine Compounds and Their Triazinyl and Tetrazinyl Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>46 </em>
                                    (3)
                                     , 393-402. <a href="https://doi.org/10.1134/S106816202003005X" title="DOI URL">https://doi.org/10.1134/S106816202003005X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S106816202003005X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS106816202003005X%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Bioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252BAnticancer%252BActivity%252Bof%252BFunctionalized%252BThieno%25255B2%25252C3-d%25255Dpyrimidine%252BCompounds%252Band%252BTheir%252BTriazinyl%252Band%252BTetrazinyl%252BDerivatives%26aulast%3DWalaa%2BI.%2BEl-Sofany%26date%3D2020%26date%3D2020%26volume%3D46%26issue%3D3%26spage%3D393%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fiona  Scott</span>, <span class="hlFld-ContribAuthor ">Angela M.  Fala</span>, <span class="hlFld-ContribAuthor ">Lewis E.  Pennicott</span>, <span class="hlFld-ContribAuthor ">Tristan D.  Reuillon</span>, <span class="hlFld-ContribAuthor ">Katlin B.  Massirer</span>, <span class="hlFld-ContribAuthor ">Jonathan M.  Elkins</span>, <span class="hlFld-ContribAuthor ">Simon E.  Ward</span>. </span><span class="cited-content_cbyCitation_article-title">Development of 2-(4-pyridyl)-benzimidazoles as PKN2 chemical tools to probe cancer. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (8)
                                     , 127040. <a href="https://doi.org/10.1016/j.bmcl.2020.127040" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127040%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252B2-%2525284-pyridyl%252529-benzimidazoles%252Bas%252BPKN2%252Bchemical%252Btools%252Bto%252Bprobe%252Bcancer%26aulast%3DScott%26aufirst%3DFiona%26date%3D2020%26volume%3D30%26issue%3D8%26spage%3D127040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gautham  Gampa</span>, <span class="hlFld-ContribAuthor ">Surabhi  Talele</span>, <span class="hlFld-ContribAuthor ">Minjee  Kim</span>, <span class="hlFld-ContribAuthor ">Afroz  Mohammad</span>, <span class="hlFld-ContribAuthor ">Jessica  Griffith</span>, <span class="hlFld-ContribAuthor ">William F.  Elmquist</span>. </span><span class="cited-content_cbyCitation_article-title">Influence of transporters in treating cancers in the CNS. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 277-301. <a href="https://doi.org/10.1016/B978-0-12-816434-1.00009-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-816434-1.00009-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816434-1.00009-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816434-1.00009-7%26sid%3Dliteratum%253Aachs%26atitle%3DInfluence%252Bof%252Btransporters%252Bin%252Btreating%252Bcancers%252Bin%252Bthe%252BCNS%26aulast%3DGampa%26aufirst%3DGautham%26date%3D2020%26spage%3D277%26epage%3D301%26pub%3DElsevier%26atitle%3DDrug%252BEfflux%252BPumps%252Bin%252BCancer%252BResistance%252BPathways%25253A%252BFrom%252BMolecular%252BRecognition%252Band%252BCharacterization%252Bto%252BPossible%252BInhibition%252BStrategies%252Bin%252BChemotherapy%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Souad A.  El-Metwally</span>, <span class="hlFld-ContribAuthor ">Ali K.  Khalil</span>, <span class="hlFld-ContribAuthor ">Wael M.  El-Sayed</span>. </span><span class="cited-content_cbyCitation_article-title">Design, molecular modeling and anticancer evaluation of thieno[2,3-d]pyrimidine derivatives as inhibitors of topoisomerase II. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>94 </em>, 103492. <a href="https://doi.org/10.1016/j.bioorg.2019.103492" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103492</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103492%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bmolecular%252Bmodeling%252Band%252Banticancer%252Bevaluation%252Bof%252Bthieno%25255B2%25252C3-d%25255Dpyrimidine%252Bderivatives%252Bas%252Binhibitors%252Bof%252Btopoisomerase%252BII%26aulast%3DEl-Metwally%26aufirst%3DSouad%2BA.%26date%3D2020%26volume%3D94%26spage%3D103492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stanley  Jin</span>, <span class="hlFld-ContribAuthor ">Satoshi  Mikami</span>, <span class="hlFld-ContribAuthor ">Nick  Scorah</span>, <span class="hlFld-ContribAuthor ">Young  Chen</span>, <span class="hlFld-ContribAuthor ">Petro  Halkowycz</span>, <span class="hlFld-ContribAuthor ">Lihong  Shi</span>, <span class="hlFld-ContribAuthor ">Jason  Kahana</span>, <span class="hlFld-ContribAuthor ">Patrick  Vincent</span>, <span class="hlFld-ContribAuthor ">Ron  de Jong</span>, <span class="hlFld-ContribAuthor ">Joy  Atienza</span>, <span class="hlFld-ContribAuthor ">Robyn  Fabrey</span>, <span class="hlFld-ContribAuthor ">Lilly  Zhang</span>, <span class="hlFld-ContribAuthor ">Matthew  Lardy</span>. </span><span class="cited-content_cbyCitation_article-title">Rational discovery of a highly novel and selective mTOR inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (21)
                                     , 126659. <a href="https://doi.org/10.1016/j.bmcl.2019.126659" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126659</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126659%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRational%252Bdiscovery%252Bof%252Ba%252Bhighly%252Bnovel%252Band%252Bselective%252BmTOR%252Binhibitor%26aulast%3DJin%26aufirst%3DStanley%26date%3D2019%26volume%3D29%26issue%3D21%26spage%3D126659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ishan I.  Panchal</span>, <span class="hlFld-ContribAuthor ">Sandip N.  Badeliya</span>, <span class="hlFld-ContribAuthor ">Rakesh  Patel</span>, <span class="hlFld-ContribAuthor ">Ashish  Patel</span>, <span class="hlFld-ContribAuthor ">Animesh  Devaligar</span>. </span><span class="cited-content_cbyCitation_article-title">In silico Analysis and Molecular Docking Studies of Novel 4-Amino-3- (Isoquinolin-4-yl)-1H-Pyrazolo[3,4-d]Pyrimidine Derivatives as Dual PI3-K/mTOR Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Current Drug Discovery Technologies</span><span> <strong>2019,</strong> <em>16 </em>
                                    (3)
                                     , 297-306. <a href="https://doi.org/10.2174/1568009618666181102144934" title="DOI URL">https://doi.org/10.2174/1568009618666181102144934</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568009618666181102144934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568009618666181102144934%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Drug%2520Discovery%2520Technologies%26atitle%3DIn%252Bsilico%252BAnalysis%252Band%252BMolecular%252BDocking%252BStudies%252Bof%252BNovel%252B4-Amino-3-%252B%252528Isoquinolin-4-yl%252529-1H-Pyrazolo%25255B3%25252C4-d%25255DPyrimidine%252BDerivatives%252Bas%252BDual%252BPI3-K%25252FmTOR%252BInhibitors%26aulast%3DPanchal%26aufirst%3DIshan%2BI.%26date%3D2019%26volume%3D16%26issue%3D3%26spage%3D297%26epage%3D306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Hu</span>, <span class="hlFld-ContribAuthor ">Yuhong  Dong</span>, <span class="hlFld-ContribAuthor ">Ming  Li</span>, <span class="hlFld-ContribAuthor ">Ruxin  Wang</span>, <span class="hlFld-ContribAuthor ">Xian  Zhang</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine and quinazoline derivatives as potent antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>90 </em>, 103086. <a href="https://doi.org/10.1016/j.bioorg.2019.103086" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103086%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bthieno%25255B3%25252C2-d%25255Dpyrimidine%252Band%252Bquinazoline%252Bderivatives%252Bas%252Bpotent%252Bantitumor%252Bagents%26aulast%3DHu%26aufirst%3DHao%26date%3D2019%26volume%3D90%26spage%3D103086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eslam M.H.  Ali</span>, <span class="hlFld-ContribAuthor ">Mohammed S.  Abdel-Maksoud</span>, <span class="hlFld-ContribAuthor ">Chang-Hyun  Oh</span>. </span><span class="cited-content_cbyCitation_article-title">Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (7)
                                     , 1159-1194. <a href="https://doi.org/10.1016/j.bmc.2019.02.044" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.02.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.02.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.02.044%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DThieno%25255B2%25252C3-d%25255Dpyrimidine%252Bas%252Ba%252Bpromising%252Bscaffold%252Bin%252Bmedicinal%252Bchemistry%25253A%252BRecent%252Badvances%26aulast%3DAli%26aufirst%3DEslam%2BM.H.%26date%3D2019%26volume%3D27%26issue%3D7%26spage%3D1159%26epage%3D1194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Posa Venkata Sri  Ramya</span>, <span class="hlFld-ContribAuthor ">Sowjanya  Thatikonda</span>, <span class="hlFld-ContribAuthor ">Srinivas  Angapelly</span>, <span class="hlFld-ContribAuthor ">Bathini Nagendra  Babu</span>, <span class="hlFld-ContribAuthor ">Vegi Ganga Modi  Naidu</span>, <span class="hlFld-ContribAuthor ">Ahmed  Kamal</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Thieno[2, 3-
              d
              ]pyrimidine-amides as Potential Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (11)
                                     , 3101-3106. <a href="https://doi.org/10.1002/slct.201703061" title="DOI URL">https://doi.org/10.1002/slct.201703061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201703061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201703061%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BThieno%25255B2%25252C%2525E2%252580%2525893-%252Bd%252B%25255Dpyrimidine-amides%252Bas%252BPotential%252BAnticancer%252BAgents%26aulast%3DRamya%26aufirst%3DPosa%2BVenkata%2BSri%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D11%26spage%3D3101%26epage%3D3106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Costantino</span>, <span class="hlFld-ContribAuthor ">Daniela  Barlocco</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Approaches to Multitarget Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 161-205. <a href="https://doi.org/10.1002/9783527674381.ch7" title="DOI URL">https://doi.org/10.1002/9783527674381.ch7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527674381.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527674381.ch7%26sid%3Dliteratum%253Aachs%26atitle%3DDesigning%252BApproaches%252Bto%252BMultitarget%252BDrugs%26aulast%3DCostantino%26aufirst%3DLuca%26date%3D2017%26date%3D2017%26spage%3D161%26epage%3D205%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DDrug%252BSelectivity%26aulast%3DHandler%26aufirst%3DNorbert%26date%3D2017%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ioannis K.  Zervantonakis</span>, <span class="hlFld-ContribAuthor ">Claudia  Iavarone</span>, <span class="hlFld-ContribAuthor ">Hsing-Yu  Chen</span>, <span class="hlFld-ContribAuthor ">Laura M.  Selfors</span>, <span class="hlFld-ContribAuthor ">Sangeetha  Palakurthi</span>, <span class="hlFld-ContribAuthor ">Joyce F.  Liu</span>, <span class="hlFld-ContribAuthor ">Ronny  Drapkin</span>, <span class="hlFld-ContribAuthor ">Ursula  Matulonis</span>, <span class="hlFld-ContribAuthor ">Joel D.  Leverson</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Gordon B.  Mills</span>, <span class="hlFld-ContribAuthor ">Joan S.  Brugge</span>. </span><span class="cited-content_cbyCitation_article-title">Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2017,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-017-00263-7" title="DOI URL">https://doi.org/10.1038/s41467-017-00263-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-017-00263-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-017-00263-7%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DSystems%252Banalysis%252Bof%252Bapoptotic%252Bpriming%252Bin%252Bovarian%252Bcancer%252Bidentifies%252Bvulnerabilities%252Band%252Bpredictors%252Bof%252Bdrug%252Bresponse%26aulast%3DZervantonakis%26aufirst%3DIoannis%2BK.%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaoru  Ishida</span>, <span class="hlFld-ContribAuthor ">Chie  Ito</span>, <span class="hlFld-ContribAuthor ">Yukimi  Ohmori</span>, <span class="hlFld-ContribAuthor ">Kohei  Kume</span>, <span class="hlFld-ContribAuthor ">Kei A.  Sato</span>, <span class="hlFld-ContribAuthor ">Yuka  Koizumi</span>, <span class="hlFld-ContribAuthor ">Akari  Konta</span>, <span class="hlFld-ContribAuthor ">Takeshi  Iwaya</span>, <span class="hlFld-ContribAuthor ">Mamoru  Nukatsuka</span>, <span class="hlFld-ContribAuthor ">Takashi  Kobunai</span>, <span class="hlFld-ContribAuthor ">Teiji  Takechi</span>, <span class="hlFld-ContribAuthor ">Satoshi S.  Nishizuka</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of PI3K suppresses propagation of drug-tolerant cancer cell subpopulations enriched by 5-fluorouracil. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-02548-9" title="DOI URL">https://doi.org/10.1038/s41598-017-02548-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-02548-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-02548-9%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DInhibition%252Bof%252BPI3K%252Bsuppresses%252Bpropagation%252Bof%252Bdrug-tolerant%252Bcancer%252Bcell%252Bsubpopulations%252Benriched%252Bby%252B5-fluorouracil%26aulast%3DIshida%26aufirst%3DKaoru%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qinqin  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaojing  Li</span>, <span class="hlFld-ContribAuthor ">Chengyu  Sun</span>, <span class="hlFld-ContribAuthor ">Binliang  Zhang</span>, <span class="hlFld-ContribAuthor ">Pengwu  Zheng</span>, <span class="hlFld-ContribAuthor ">Wufu  Zhu</span>, <span class="hlFld-ContribAuthor ">Shan  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Structure–Activity Relationships of 4-Morpholino-7,8-Dihydro-5H-Thiopyrano[4,3-d]pyrimidine Derivatives Bearing Pyrazoline Scaffold. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (11)
                                     , 1870. <a href="https://doi.org/10.3390/molecules22111870" title="DOI URL">https://doi.org/10.3390/molecules22111870</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22111870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22111870%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252B4-Morpholino-7%25252C8-Dihydro-5H-Thiopyrano%25255B4%25252C3-d%25255Dpyrimidine%252BDerivatives%252BBearing%252BPyrazoline%252BScaffold%26aulast%3DWang%26aufirst%3DQinqin%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D11%26spage%3D1870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.  Sangeetha</span>, <span class="hlFld-ContribAuthor ">R.P.  Sasikala</span>, <span class="hlFld-ContribAuthor ">K.S.  Meena</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore modeling, virtual screening and molecular docking of ATPase inhibitors of HSP70. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2017,</strong> <em>70 </em>, 164-174. <a href="https://doi.org/10.1016/j.compbiolchem.2017.05.011" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2017.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2017.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2017.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DPharmacophore%252Bmodeling%25252C%252Bvirtual%252Bscreening%252Band%252Bmolecular%252Bdocking%252Bof%252BATPase%252Binhibitors%252Bof%252BHSP70%26aulast%3DSangeetha%26aufirst%3DK.%26date%3D2017%26volume%3D70%26spage%3D164%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Wen-zhu  Wan</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Guan-lian  Zhou</span>, <span class="hlFld-ContribAuthor ">Xin-guang  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent development of ATP-competitive small molecule phosphatidylinostitol-3-kinase inhibitors as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (4)
                                     , 7181-7200. <a href="https://doi.org/10.18632/oncotarget.12742" title="DOI URL">https://doi.org/10.18632/oncotarget.12742</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.12742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.12742%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DRecent%252Bdevelopment%252Bof%252BATP-competitive%252Bsmall%252Bmolecule%252Bphosphatidylinostitol-3-kinase%252Binhibitors%252Bas%252Banticancer%252Bagents%26aulast%3DLiu%26aufirst%3DYu%26date%3D2017%26date%3D2016%26volume%3D8%26issue%3D4%26spage%3D7181%26epage%3D7200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiumeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Luyao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jie  Yu</span>, <span class="hlFld-ContribAuthor ">Heng  Li</span>, <span class="hlFld-ContribAuthor ">Shijun  He</span>, <span class="hlFld-ContribAuthor ">Wei  Tang</span>, <span class="hlFld-ContribAuthor ">Jianping  Zuo</span>, <span class="hlFld-ContribAuthor ">Wei  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new BTK inhibitors with B cell suppression activity bearing a 4,6-substituted thieno[3,2-d]pyrimidine scaffold. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (42)
                                     , 26060-26069. <a href="https://doi.org/10.1039/C7RA04261B" title="DOI URL">https://doi.org/10.1039/C7RA04261B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7RA04261B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7RA04261B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDiscovery%252Bof%252Bnew%252BBTK%252Binhibitors%252Bwith%252BB%252Bcell%252Bsuppression%252Bactivity%252Bbearing%252Ba%252B4%25252C6-substituted%252Bthieno%25255B3%25252C2-d%25255Dpyrimidine%252Bscaffold%26aulast%3DZhang%26aufirst%3DQiumeng%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D42%26spage%3D26060%26epage%3D26069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taru  Muranen</span>, <span class="hlFld-ContribAuthor ">Laura M.  Selfors</span>, <span class="hlFld-ContribAuthor ">Julie  Hwang</span>, <span class="hlFld-ContribAuthor ">Lisa L.  Gallegos</span>, <span class="hlFld-ContribAuthor ">Jonathan L.  Coloff</span>, <span class="hlFld-ContribAuthor ">Carson C.  Thoreen</span>, <span class="hlFld-ContribAuthor ">Seong A.  Kang</span>, <span class="hlFld-ContribAuthor ">David M.  Sabatini</span>, <span class="hlFld-ContribAuthor ">Gordon B.  Mills</span>, <span class="hlFld-ContribAuthor ">Joan S.  Brugge</span>. </span><span class="cited-content_cbyCitation_article-title">ERK and p38 MAPK Activities Determine Sensitivity to PI3K/mTOR Inhibition via Regulation of MYC and YAP. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2016,</strong> <em>76 </em>
                                    (24)
                                     , 7168-7180. <a href="https://doi.org/10.1158/0008-5472.CAN-16-0155" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-16-0155</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-16-0155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-16-0155%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DERK%252Band%252Bp38%252BMAPK%252BActivities%252BDetermine%252BSensitivity%252Bto%252BPI3K%25252FmTOR%252BInhibition%252Bvia%252BRegulation%252Bof%252BMYC%252Band%252BYAP%26aulast%3DMuranen%26aufirst%3DTaru%26date%3D2016%26date%3D2016%26volume%3D76%26issue%3D24%26spage%3D7168%26epage%3D7180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon J.F.  Macdonald</span>, <span class="hlFld-ContribAuthor ">M. Jonathan  Fray</span>, <span class="hlFld-ContribAuthor ">Thomas  McInally</span>. </span><span class="cited-content_cbyCitation_article-title">Passing on the medicinal chemistry baton: training undergraduates to be industry-ready through research projects between the University of Nottingham and GlaxoSmithKline. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2016,</strong> <em>21 </em>
                                    (6)
                                     , 880-887. <a href="https://doi.org/10.1016/j.drudis.2016.01.015" title="DOI URL">https://doi.org/10.1016/j.drudis.2016.01.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2016.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2016.01.015%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DPassing%252Bon%252Bthe%252Bmedicinal%252Bchemistry%252Bbaton%25253A%252Btraining%252Bundergraduates%252Bto%252Bbe%252Bindustry-ready%252Bthrough%252Bresearch%252Bprojects%252Bbetween%252Bthe%252BUniversity%252Bof%252BNottingham%252Band%252BGlaxoSmithKline%26aulast%3DMacdonald%26aufirst%3DSimon%2BJ.F.%26date%3D2016%26volume%3D21%26issue%3D6%26spage%3D880%26epage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rupak  Banik</span>, <span class="hlFld-ContribAuthor ">Subhadip  Roy</span>, <span class="hlFld-ContribAuthor ">Alexander M.  Kirillov</span>, <span class="hlFld-ContribAuthor ">Antonio  Bauza</span>, <span class="hlFld-ContribAuthor ">Antonio  Frontera</span>, <span class="hlFld-ContribAuthor ">Antonio  Rodríguez-Diéguez</span>, <span class="hlFld-ContribAuthor ">Juan M.  Salas</span>, <span class="hlFld-ContribAuthor ">Waldemar  Maniukiewicz</span>, <span class="hlFld-ContribAuthor ">Saroj Kr.  Das</span>, <span class="hlFld-ContribAuthor ">Subrata  Das</span>. </span><span class="cited-content_cbyCitation_article-title">Two mixed-ligand cadmium(
              ii
              ) compounds bearing 5-nitrosopyrimidine and N-donor aromatic blocks: self-assembly generation, structural and topological features, DFT studies, and Hirshfeld surface analysis. </span><span class="cited-content_cbyCitation_journal-name">CrystEngComm</span><span> <strong>2016,</strong> <em>18 </em>
                                    (30)
                                     , 5647-5657. <a href="https://doi.org/10.1039/C6CE00989A" title="DOI URL">https://doi.org/10.1039/C6CE00989A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6CE00989A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6CE00989A%26sid%3Dliteratum%253Aachs%26jtitle%3DCrystEngComm%26atitle%3DTwo%252Bmixed-ligand%252Bcadmium%252528%252Bii%252B%252529%252Bcompounds%252Bbearing%252B5-nitrosopyrimidine%252Band%252BN-donor%252Baromatic%252Bblocks%25253A%252Bself-assembly%252Bgeneration%25252C%252Bstructural%252Band%252Btopological%252Bfeatures%25252C%252BDFT%252Bstudies%25252C%252Band%252BHirshfeld%252Bsurface%252Banalysis%26aulast%3DBanik%26aufirst%3DRupak%26date%3D2016%26date%3D2016%26volume%3D18%26issue%3D30%26spage%3D5647%26epage%3D5657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaopeng  Xu</span>, <span class="hlFld-ContribAuthor ">Si  Chen</span>, <span class="hlFld-ContribAuthor ">Yanqin  Shi</span>, <span class="hlFld-ContribAuthor ">Bozhen  Wu</span>, <span class="hlFld-ContribAuthor ">Meng  Ma</span>, <span class="hlFld-ContribAuthor ">Xu  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Novel organic antibacterial thermal stabilizers for transparent poly(vinyl chloride). </span><span class="cited-content_cbyCitation_journal-name">Journal of Thermal Analysis and Calorimetry</span><span> <strong>2015,</strong> <em>122 </em>
                                    (3)
                                     , 1435-1444. <a href="https://doi.org/10.1007/s10973-015-4869-5" title="DOI URL">https://doi.org/10.1007/s10973-015-4869-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10973-015-4869-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10973-015-4869-5%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Thermal%2520Analysis%2520and%2520Calorimetry%26atitle%3DNovel%252Borganic%252Bantibacterial%252Bthermal%252Bstabilizers%252Bfor%252Btransparent%252Bpoly%252528vinyl%252Bchloride%252529%26aulast%3DXu%26aufirst%3DXiaopeng%26date%3D2015%26date%3D2015%26volume%3D122%26issue%3D3%26spage%3D1435%26epage%3D1444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vunnam  Venkateswarlu</span>, <span class="hlFld-ContribAuthor ">Anup Singh  Pathania</span>, <span class="hlFld-ContribAuthor ">K.A.  Aravinda Kumar</span>, <span class="hlFld-ContribAuthor ">Priya  Mahajan</span>, <span class="hlFld-ContribAuthor ">Amit  Nargotra</span>, <span class="hlFld-ContribAuthor ">Ram A.  Vishwakarma</span>, <span class="hlFld-ContribAuthor ">Fayaz A.  Malik</span>, <span class="hlFld-ContribAuthor ">Sanghapal D.  Sawant</span>. </span><span class="cited-content_cbyCitation_article-title">4-(N-Phenyl-N′-substituted benzenesulfonyl)-6-(4-hydroxyphenyl)quinolines as inhibitors of mammalian target of rapamycin. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (15)
                                     , 4237-4247. <a href="https://doi.org/10.1016/j.bmc.2015.06.046" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.06.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.06.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.06.046%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3D4-%252528N-Phenyl-N%2525E2%252580%2525B2-substituted%252Bbenzenesulfonyl%252529-6-%2525284-hydroxyphenyl%252529quinolines%252Bas%252Binhibitors%252Bof%252Bmammalian%252Btarget%252Bof%252Brapamycin%26aulast%3DVenkateswarlu%26aufirst%3DVunnam%26date%3D2015%26volume%3D23%26issue%3D15%26spage%3D4237%26epage%3D4247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manman  Wei</span>, <span class="hlFld-ContribAuthor ">Xiang  Wang</span>, <span class="hlFld-ContribAuthor ">Zilan  Song</span>, <span class="hlFld-ContribAuthor ">Mingkun  Jiao</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Ling-Hua  Meng</span>, <span class="hlFld-ContribAuthor ">Ao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting PI3Kδ: Emerging Therapy for Chronic Lymphocytic Leukemia and Beyond. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2015,</strong> <em>35 </em>
                                    (4)
                                     , 720-752. <a href="https://doi.org/10.1002/med.21341" title="DOI URL">https://doi.org/10.1002/med.21341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21341%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DTargeting%252BPI3K%2525CE%2525B4%25253A%252BEmerging%252BTherapy%252Bfor%252BChronic%252BLymphocytic%252BLeukemia%252Band%252BBeyond%26aulast%3DWei%26aufirst%3DManman%26date%3D2015%26date%3D2015%26volume%3D35%26issue%3D4%26spage%3D720%26epage%3D752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wufu  Zhu</span>, <span class="hlFld-ContribAuthor ">Chen  Chen</span>, <span class="hlFld-ContribAuthor ">Chengyu  Sun</span>, <span class="hlFld-ContribAuthor ">Shan  Xu</span>, <span class="hlFld-ContribAuthor ">Chunjiang  Wu</span>, <span class="hlFld-ContribAuthor ">Fei  Lei</span>, <span class="hlFld-ContribAuthor ">Hui  Xia</span>, <span class="hlFld-ContribAuthor ">Qidong  Tu</span>, <span class="hlFld-ContribAuthor ">Pengwu  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and docking studies of novel thienopyrimidine derivatives bearing chromone moiety as mTOR/PI3Kα inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>93 </em>, 64-73. <a href="https://doi.org/10.1016/j.ejmech.2015.01.061" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.01.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.01.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.01.061%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bdocking%252Bstudies%252Bof%252Bnovel%252Bthienopyrimidine%252Bderivatives%252Bbearing%252Bchromone%252Bmoiety%252Bas%252BmTOR%25252FPI3K%2525CE%2525B1%252Binhibitors%26aulast%3DZhu%26aufirst%3DWufu%26date%3D2015%26volume%3D93%26spage%3D64%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagy M.  Khalifa</span>, <span class="hlFld-ContribAuthor ">Mohamed A.  Al-Omar</span>, <span class="hlFld-ContribAuthor ">Abd El-Galil E.  Amr</span>, <span class="hlFld-ContribAuthor ">Ayman R.  Baiuomy</span>, <span class="hlFld-ContribAuthor ">Rehab F.  Abdel-Rahman</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of some novel fused thiazolo[3,2-a]pyrimidines as potential analgesic and anti-inflammatory agents. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Bioorganic Chemistry</span><span> <strong>2015,</strong> <em>41 </em>
                                    (2)
                                     , 192-200. <a href="https://doi.org/10.1134/S1068162015020090" title="DOI URL">https://doi.org/10.1134/S1068162015020090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1068162015020090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1068162015020090%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Bioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bsome%252Bnovel%252Bfused%252Bthiazolo%25255B3%25252C2-a%25255Dpyrimidines%252Bas%252Bpotential%252Banalgesic%252Band%252Banti-inflammatory%252Bagents%26aulast%3DKhalifa%26aufirst%3DNagy%2BM.%26date%3D2015%26date%3D2015%26volume%3D41%26issue%3D2%26spage%3D192%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael W.  He</span>, <span class="hlFld-ContribAuthor ">Patrick S.  Lee</span>, <span class="hlFld-ContribAuthor ">Zachary K.  Sweeney</span>. </span><span class="cited-content_cbyCitation_article-title">Promiscuity and the Conformational Rearrangement of Drug-Like Molecules: Insight from the Protein Data Bank. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2015,</strong> <em>10 </em>
                                    (2)
                                     , 238-244. <a href="https://doi.org/10.1002/cmdc.201402389" title="DOI URL">https://doi.org/10.1002/cmdc.201402389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201402389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201402389%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DPromiscuity%252Band%252Bthe%252BConformational%252BRearrangement%252Bof%252BDrug-Like%252BMolecules%25253A%252BInsight%252Bfrom%252Bthe%252BProtein%252BData%252BBank%26aulast%3DHe%26aufirst%3DMichael%2BW.%26date%3D2015%26date%3D2014%26volume%3D10%26issue%3D2%26spage%3D238%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin E.  Blass</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro ADME and In vivo Pharmacokinetics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 245-306. <a href="https://doi.org/10.1016/B978-0-12-411508-8.00006-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-411508-8.00006-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-411508-8.00006-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-411508-8.00006-2%26sid%3Dliteratum%253Aachs%26atitle%3DIn%2525C2%2525A0vitro%252BADME%252Band%252BIn%2525C2%2525A0vivo%252BPharmacokinetics%26aulast%3DBlass%26aufirst%3DBenjamin%2BE.%26date%3D2015%26spage%3D245%26epage%3D306%26pub%3DElsevier%26atitle%3DBasic%252BPrinciples%252Bof%252BDrug%252BDiscovery%252Band%252BDevelopment%26date%3D2015%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zijian  Liu</span>, <span class="hlFld-ContribAuthor ">Shasha  Wu</span>, <span class="hlFld-ContribAuthor ">Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Ruijuan  Li</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Lihui  Wang</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine derivatives possessing diaryl semicarbazone scaffolds as potent antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>87 </em>, 782-793. <a href="https://doi.org/10.1016/j.ejmech.2014.10.022" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.10.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.10.022%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bthieno%25255B3%25252C2-d%25255Dpyrimidine%252Bderivatives%252Bpossessing%252Bdiaryl%252Bsemicarbazone%252Bscaffolds%252Bas%252Bpotent%252Bantitumor%252Bagents%26aulast%3DLiu%26aufirst%3DZijian%26date%3D2014%26volume%3D87%26spage%3D782%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zijian  Liu</span>, <span class="hlFld-ContribAuthor ">Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Huafang  Lin</span>, <span class="hlFld-ContribAuthor ">Dazhuang  Zuo</span>, <span class="hlFld-ContribAuthor ">Lihui  Wang</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine derivatives containing diaryl urea moiety as potent antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>85 </em>, 215-227. <a href="https://doi.org/10.1016/j.ejmech.2014.07.099" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.07.099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.07.099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.07.099%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bthieno%25255B3%25252C2-d%25255Dpyrimidine%252Bderivatives%252Bcontaining%252Bdiaryl%252Burea%252Bmoiety%252Bas%252Bpotent%252Bantitumor%252Bagents%26aulast%3DLiu%26aufirst%3DZijian%26date%3D2014%26volume%3D85%26spage%3D215%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yujeong  Jeong</span>, <span class="hlFld-ContribAuthor ">Daeil  Kwon</span>, <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Selective and potent small-molecule inhibitors of PI3Ks. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (7)
                                     , 737-756. <a href="https://doi.org/10.4155/fmc.14.28" title="DOI URL">https://doi.org/10.4155/fmc.14.28</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.28%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSelective%252Band%252Bpotent%252Bsmall-molecule%252Binhibitors%252Bof%252BPI3Ks%26aulast%3DJeong%26aufirst%3DYujeong%26date%3D2014%26volume%3D6%26issue%3D7%26spage%3D737%26epage%3D756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kartik W.  Temburnikar</span>, <span class="hlFld-ContribAuthor ">Sarah C.  Zimmermann</span>, <span class="hlFld-ContribAuthor ">Nathaniel T.  Kim</span>, <span class="hlFld-ContribAuthor ">Christina R.  Ross</span>, <span class="hlFld-ContribAuthor ">Christopher  Gelbmann</span>, <span class="hlFld-ContribAuthor ">Christine E.  Salomon</span>, <span class="hlFld-ContribAuthor ">Gerald M.  Wilson</span>, <span class="hlFld-ContribAuthor ">Jan  Balzarini</span>, <span class="hlFld-ContribAuthor ">Katherine L.  Seley-Radtke</span>. </span><span class="cited-content_cbyCitation_article-title">Antiproliferative activities of halogenated thieno[3,2-d]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (7)
                                     , 2113-2122. <a href="https://doi.org/10.1016/j.bmc.2014.02.033" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.02.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.02.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.02.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DAntiproliferative%252Bactivities%252Bof%252Bhalogenated%252Bthieno%25255B3%25252C2-d%25255Dpyrimidines%26aulast%3DTemburnikar%26aufirst%3DKartik%2BW.%26date%3D2014%26volume%3D22%26issue%3D7%26spage%3D2113%26epage%3D2122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaizhen  Song</span>, <span class="hlFld-ContribAuthor ">Junjie  Ma</span>, <span class="hlFld-ContribAuthor ">Xiao  Wang</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antitumor activities of novel 4-morpholinothieno[3,2-d]pyrimidine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Chinese Universities</span><span> <strong>2014,</strong> <em>30 </em>
                                    (1)
                                     , 75-81. <a href="https://doi.org/10.1007/s40242-013-3281-6" title="DOI URL">https://doi.org/10.1007/s40242-013-3281-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40242-013-3281-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40242-013-3281-6%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Chinese%2520Universities%26atitle%3DSynthesis%252Band%252Bantitumor%252Bactivities%252Bof%252Bnovel%252B4-morpholinothieno%25255B3%25252C2-d%25255Dpyrimidine%252Bderivatives%26aulast%3DSong%26aufirst%3DKaizhen%26date%3D2014%26date%3D2013%26volume%3D30%26issue%3D1%26spage%3D75%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William A.  Denny</span>, <span class="hlFld-ContribAuthor ">Gordon W.  Rewcastle</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of the Phosphatidylinositol 3-Kinase Pathway. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 449-478. <a href="https://doi.org/10.1016/B978-0-12-396521-9.00015-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-396521-9.00015-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-396521-9.00015-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-396521-9.00015-2%26sid%3Dliteratum%253Aachs%26atitle%3DInhibitors%252Bof%252Bthe%252BPhosphatidylinositol%252B3-Kinase%252BPathway%26aulast%3DDenny%26aufirst%3DWilliam%2BA.%26date%3D2014%26spage%3D449%26epage%3D478%26pub%3DElsevier%26atitle%3DCancer%252BDrug%252BDesign%252Band%252BDiscovery%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Baljinder  Singh</span>, <span class="hlFld-ContribAuthor ">Santosh K.  Guru</span>, <span class="hlFld-ContribAuthor ">Smit  Kour</span>, <span class="hlFld-ContribAuthor ">Shreyans K.  Jain</span>, <span class="hlFld-ContribAuthor ">Rajni  Sharma</span>, <span class="hlFld-ContribAuthor ">Parduman R.  Sharma</span>, <span class="hlFld-ContribAuthor ">Shashank K.  Singh</span>, <span class="hlFld-ContribAuthor ">Shashi  Bhushan</span>, <span class="hlFld-ContribAuthor ">Sandip B.  Bharate</span>, <span class="hlFld-ContribAuthor ">Ram A.  Vishwakarma</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, antiproliferative and apoptosis-inducing activity of thiazolo[5,4-d]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>70 </em>, 864-874. <a href="https://doi.org/10.1016/j.ejmech.2013.10.039" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.10.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.10.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.10.039%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bantiproliferative%252Band%252Bapoptosis-inducing%252Bactivity%252Bof%252Bthiazolo%25255B5%25252C4-d%25255Dpyrimidines%26aulast%3DSingh%26aufirst%3DBaljinder%26date%3D2013%26volume%3D70%26spage%3D864%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L-Y  Huw</span>, <span class="hlFld-ContribAuthor ">C  O'Brien</span>, <span class="hlFld-ContribAuthor ">A  Pandita</span>, <span class="hlFld-ContribAuthor ">S  Mohan</span>, <span class="hlFld-ContribAuthor ">J M  Spoerke</span>, <span class="hlFld-ContribAuthor ">S  Lu</span>, <span class="hlFld-ContribAuthor ">Y  Wang</span>, <span class="hlFld-ContribAuthor ">G M  Hampton</span>, <span class="hlFld-ContribAuthor ">T R  Wilson</span>, <span class="hlFld-ContribAuthor ">M R  Lackner</span>. </span><span class="cited-content_cbyCitation_article-title">Acquired PIK3CA amplification causes resistance to selective phosphoinositide 3-kinase inhibitors in breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Oncogenesis</span><span> <strong>2013,</strong> <em>2 </em>
                                    (12)
                                     , e83-e83. <a href="https://doi.org/10.1038/oncsis.2013.46" title="DOI URL">https://doi.org/10.1038/oncsis.2013.46</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/oncsis.2013.46&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Foncsis.2013.46%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogenesis%26atitle%3DAcquired%252BPIK3CA%252Bamplification%252Bcauses%252Bresistance%252Bto%252Bselective%252Bphosphoinositide%252B3-kinase%252Binhibitors%252Bin%252Bbreast%252Bcancer%26aulast%3DHuw%26aufirst%3DL-Y%26date%3D2013%26date%3D2013%26volume%3D2%26issue%3D12%26spage%3De83%26epage%3De83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wendy  Lee</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Philippe  Bergeron</span>, <span class="hlFld-ContribAuthor ">Kevin  Lau</span>, <span class="hlFld-ContribAuthor ">Lichuan  Lin</span>, <span class="hlFld-ContribAuthor ">Shiva  Malek</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Pei</span>, <span class="hlFld-ContribAuthor ">Kirk D.  Robarge</span>, <span class="hlFld-ContribAuthor ">Stephen  Schmidt</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>. </span><span class="cited-content_cbyCitation_article-title">A hit to lead discovery of novel N-methylated imidazolo-, pyrrolo-, and pyrazolo-pyrimidines as potent and selective mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (18)
                                     , 5097-5104. <a href="https://doi.org/10.1016/j.bmcl.2013.07.027" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.07.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.07.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.07.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bhit%252Bto%252Blead%252Bdiscovery%252Bof%252Bnovel%252BN-methylated%252Bimidazolo-%25252C%252Bpyrrolo-%25252C%252Band%252Bpyrazolo-pyrimidines%252Bas%252Bpotent%252Band%252Bselective%252BmTOR%252Binhibitors%26aulast%3DLee%26aufirst%3DWendy%26date%3D2013%26volume%3D23%26issue%3D18%26spage%3D5097%26epage%3D5104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Jason  Oeh</span>, <span class="hlFld-ContribAuthor ">Shelby K.  Wyatt</span>, <span class="hlFld-ContribAuthor ">Tim C.  Cao</span>, <span class="hlFld-ContribAuthor ">Hartmut  Koeppen</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Eastham-Anderson</span>, <span class="hlFld-ContribAuthor ">Liliane  Robillard</span>, <span class="hlFld-ContribAuthor ">Calvin C.K.  Ho</span>, <span class="hlFld-ContribAuthor ">Jed  Ross</span>, <span class="hlFld-ContribAuthor ">Guanglei  Zhuang</span>, <span class="hlFld-ContribAuthor ">Hani Bou  Reslan</span>, <span class="hlFld-ContribAuthor ">Philip  Vitorino</span>, <span class="hlFld-ContribAuthor ">Kai H.  Barck</span>, <span class="hlFld-ContribAuthor ">Sharon E.  Ungersma</span>, <span class="hlFld-ContribAuthor ">Jean Michel  Vernes</span>, <span class="hlFld-ContribAuthor ">Maresa  Caunt</span>, <span class="hlFld-ContribAuthor ">Nick  Van Bruggen</span>, <span class="hlFld-ContribAuthor ">Weilan  Ye</span>, <span class="hlFld-ContribAuthor ">Ulka  Vijapurkar</span>, <span class="hlFld-ContribAuthor ">Yu-Ju Gloria  Meng</span>, <span class="hlFld-ContribAuthor ">Napoleone  Ferrara</span>, <span class="hlFld-ContribAuthor ">Lori S.  Friedman</span>, <span class="hlFld-ContribAuthor ">Richard A.D.  Carano</span>. </span><span class="cited-content_cbyCitation_article-title">Multimodal Microvascular Imaging Reveals that Selective Inhibition of Class I PI3K Is Sufficient to Induce an Antivascular Response. </span><span class="cited-content_cbyCitation_journal-name">Neoplasia</span><span> <strong>2013,</strong> <em>15 </em>
                                    (7)
                                     , 694-IN4. <a href="https://doi.org/10.1593/neo.13470" title="DOI URL">https://doi.org/10.1593/neo.13470</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1593/neo.13470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1593%2Fneo.13470%26sid%3Dliteratum%253Aachs%26jtitle%3DNeoplasia%26atitle%3DMultimodal%252BMicrovascular%252BImaging%252BReveals%252Bthat%252BSelective%252BInhibition%252Bof%252BClass%252BI%252BPI3K%252BIs%252BSufficient%252Bto%252BInduce%252Ban%252BAntivascular%252BResponse%26aulast%3DSampath%26aufirst%3DDeepak%26date%3D2013%26volume%3D15%26issue%3D7%26spage%3D694%26epage%3DIN4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vijay K.  Das</span>, <span class="hlFld-ContribAuthor ">Ashim J.  Thakur</span>. </span><span class="cited-content_cbyCitation_article-title">Nanorod-Shaped Basic
              
                
                  
                    Al
                  
                  
                    2
                  
                
                
                  
                    O
                  
                  
                    3
                  
                
              
              Catalyzed
              N,N
              -Diformylation of Bisuracil Derivatives: A Greener “NOSE” Approach. </span><span class="cited-content_cbyCitation_journal-name">ISRN Organic Chemistry</span><span> <strong>2013,</strong> <em>2013 </em>, 1-6. <a href="https://doi.org/10.1155/2013/793159" title="DOI URL">https://doi.org/10.1155/2013/793159</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2013/793159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2013%2F793159%26sid%3Dliteratum%253Aachs%26jtitle%3DISRN%2520Organic%2520Chemistry%26atitle%3DNanorod-Shaped%252BBasic%252BAl%252B2%252BO%252B3%252BCatalyzed%252BN%25252CN%252B-Diformylation%252Bof%252BBisuracil%252BDerivatives%25253A%252BA%252BGreener%252B%2525E2%252580%25259CNOSE%2525E2%252580%25259D%252BApproach%26aulast%3DDas%26aufirst%3DVijay%2BK.%26date%3D2013%26volume%3D2013%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fauzia Anjum  Chattha</span>, <span class="hlFld-ContribAuthor ">Munawar Ali  Munawar</span>, <span class="hlFld-ContribAuthor ">Saeed Ahmad  Nagra</span>, <span class="hlFld-ContribAuthor ">Mohammad  Ashraf</span>, <span class="hlFld-ContribAuthor ">Misbahul Ain  Khan</span>, <span class="hlFld-ContribAuthor ">Samina  Kosur</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 3-Aryl-1H-Indazoles and Their Effects on Plant Growth. </span><span class="cited-content_cbyCitation_journal-name">Journal of Plant Growth Regulation</span><span> <strong>2013,</strong> <em>32 </em>
                                    (2)
                                     , 291-297. <a href="https://doi.org/10.1007/s00344-012-9297-1" title="DOI URL">https://doi.org/10.1007/s00344-012-9297-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00344-012-9297-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00344-012-9297-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Plant%2520Growth%2520Regulation%26atitle%3DSynthesis%252Bof%252B3-Aryl-1H-Indazoles%252Band%252BTheir%252BEffects%252Bon%252BPlant%252BGrowth%26aulast%3DChattha%26aufirst%3DFauzia%2BAnjum%26date%3D2013%26date%3D2012%26volume%3D32%26issue%3D2%26spage%3D291%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wufu  Zhu</span>, <span class="hlFld-ContribAuthor ">Yajing  Liu</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>, <span class="hlFld-ContribAuthor ">Xiao  Wang</span>, <span class="hlFld-ContribAuthor ">Yan  Zhu</span>, <span class="hlFld-ContribAuthor ">Di  Wu</span>, <span class="hlFld-ContribAuthor ">Hongyu  Zhou</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and 3D-QSAR analysis of novel 2-hydrazinyl-4-morpholinothieno[3,2-d]pyrimidine derivatives as potential antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>57 </em>, 162-175. <a href="https://doi.org/10.1016/j.ejmech.2012.09.002" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.09.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.09.002%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252B3D-QSAR%252Banalysis%252Bof%252Bnovel%252B2-hydrazinyl-4-morpholinothieno%25255B3%25252C2-d%25255Dpyrimidine%252Bderivatives%252Bas%252Bpotential%252Bantitumor%252Bagents%26aulast%3DZhu%26aufirst%3DWufu%26date%3D2012%26volume%3D57%26spage%3D162%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steffen  Bugge</span>, <span class="hlFld-ContribAuthor ">Svein Jacob  Kaspersen</span>, <span class="hlFld-ContribAuthor ">Eirik  Sundby</span>, <span class="hlFld-ContribAuthor ">Bård Helge  Hoff</span>. </span><span class="cited-content_cbyCitation_article-title">Route selection in the synthesis of C-4 and C-6 substituted thienopyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2012,</strong> <em>68 </em>
                                    (45)
                                     , 9226-9233. <a href="https://doi.org/10.1016/j.tet.2012.08.090" title="DOI URL">https://doi.org/10.1016/j.tet.2012.08.090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2012.08.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2012.08.090%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DRoute%252Bselection%252Bin%252Bthe%252Bsynthesis%252Bof%252BC-4%252Band%252BC-6%252Bsubstituted%252Bthienopyrimidines%26aulast%3DBugge%26aufirst%3DSteffen%26date%3D2012%26volume%3D68%26issue%3D45%26spage%3D9226%26epage%3D9233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan P.  Wurz</span>, <span class="hlFld-ContribAuthor ">Longbin  Liu</span>, <span class="hlFld-ContribAuthor ">Kevin  Yang</span>, <span class="hlFld-ContribAuthor ">Nobuko  Nishimura</span>, <span class="hlFld-ContribAuthor ">Yunxin  Bo</span>, <span class="hlFld-ContribAuthor ">Liping H.  Pettus</span>, <span class="hlFld-ContribAuthor ">Sean  Caenepeel</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Freeman</span>, <span class="hlFld-ContribAuthor ">John D.  McCarter</span>, <span class="hlFld-ContribAuthor ">Erin L.  Mullady</span>, <span class="hlFld-ContribAuthor ">Tisha San  Miguel</span>, <span class="hlFld-ContribAuthor ">Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Nancy  Zhang</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Jian  Jiang</span>, <span class="hlFld-ContribAuthor ">Raju  Subramanian</span>, <span class="hlFld-ContribAuthor ">Paul E.  Hughes</span>, <span class="hlFld-ContribAuthor ">Mark H.  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure–activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1,3,5-triazine sulfonamide scaffold. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (17)
                                     , 5714-5720. <a href="https://doi.org/10.1016/j.bmcl.2012.06.078" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.06.078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.06.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.06.078%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bdual%252BPI3K%25252FmTOR%252Binhibitors%252Bbased%252Bon%252Ba%252B4-amino-6-methyl-1%25252C3%25252C5-triazine%252Bsulfonamide%252Bscaffold%26aulast%3DWurz%26aufirst%3DRyan%2BP.%26date%3D2012%26volume%3D22%26issue%3D17%26spage%3D5714%26epage%3D5720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chia-Chun  Yu</span>, <span class="hlFld-ContribAuthor ">Po-Cheng  Chiang</span>, <span class="hlFld-ContribAuthor ">Pin-Hsuan  Lu</span>, <span class="hlFld-ContribAuthor ">Mao-Tien  Kuo</span>, <span class="hlFld-ContribAuthor ">Wu-Che  Wen</span>, <span class="hlFld-ContribAuthor ">Peini  Chen</span>, <span class="hlFld-ContribAuthor ">Jih-Hwa  Guh</span>. </span><span class="cited-content_cbyCitation_article-title">Antroquinonol, a natural ubiquinone derivative, induces a cross talk between apoptosis, autophagy and senescence in human pancreatic carcinoma cells. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Nutritional Biochemistry</span><span> <strong>2012,</strong> <em>23 </em>
                                    (8)
                                     , 900-907. <a href="https://doi.org/10.1016/j.jnutbio.2011.04.015" title="DOI URL">https://doi.org/10.1016/j.jnutbio.2011.04.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jnutbio.2011.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jnutbio.2011.04.015%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Nutritional%2520Biochemistry%26atitle%3DAntroquinonol%25252C%252Ba%252Bnatural%252Bubiquinone%252Bderivative%25252C%252Binduces%252Ba%252Bcross%252Btalk%252Bbetween%252Bapoptosis%25252C%252Bautophagy%252Band%252Bsenescence%252Bin%252Bhuman%252Bpancreatic%252Bcarcinoma%252Bcells%26aulast%3DYu%26aufirst%3DChia-Chun%26date%3D2012%26volume%3D23%26issue%3D8%26spage%3D900%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel P.  Sutherlin</span>, <span class="hlFld-ContribAuthor ">Stewart  Baker</span>, <span class="hlFld-ContribAuthor ">Angelina  Bisconte</span>, <span class="hlFld-ContribAuthor ">Paul M.  Blaney</span>, <span class="hlFld-ContribAuthor ">Anthony  Brown</span>, <span class="hlFld-ContribAuthor ">Bryan K.  Chan</span>, <span class="hlFld-ContribAuthor ">David  Chantry</span>, <span class="hlFld-ContribAuthor ">Georgette  Castanedo</span>, <span class="hlFld-ContribAuthor ">Paul  DePledge</span>, <span class="hlFld-ContribAuthor ">Paul  Goldsmith</span>, <span class="hlFld-ContribAuthor ">David M.  Goldstein</span>, <span class="hlFld-ContribAuthor ">Timothy  Hancox</span>, <span class="hlFld-ContribAuthor ">Jasmit  Kaur</span>, <span class="hlFld-ContribAuthor ">David  Knowles</span>, <span class="hlFld-ContribAuthor ">Rama  Kondru</span>, <span class="hlFld-ContribAuthor ">John  Lesnick</span>, <span class="hlFld-ContribAuthor ">Matthew C.  Lucas</span>, <span class="hlFld-ContribAuthor ">Cristina  Lewis</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, <span class="hlFld-ContribAuthor ">Alan J.  Nadin</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Jodie  Pang</span>, <span class="hlFld-ContribAuthor ">Neil  Pegg</span>, <span class="hlFld-ContribAuthor ">Steve  Price</span>, <span class="hlFld-ContribAuthor ">Karin  Reif</span>, <span class="hlFld-ContribAuthor ">Brian S.  Safina</span>, <span class="hlFld-ContribAuthor ">Laurent  Salphati</span>, <span class="hlFld-ContribAuthor ">Steven  Staben</span>, <span class="hlFld-ContribAuthor ">Eileen M.  Seward</span>, <span class="hlFld-ContribAuthor ">Stephen  Shuttleworth</span>, <span class="hlFld-ContribAuthor ">Sukhjit  Sohal</span>, <span class="hlFld-ContribAuthor ">Zachary K.  Sweeney</span>, <span class="hlFld-ContribAuthor ">Mark  Ultsch</span>, <span class="hlFld-ContribAuthor ">Bohdan  Waszkowycz</span>, <span class="hlFld-ContribAuthor ">Binqing  Wei</span>. </span><span class="cited-content_cbyCitation_article-title">Potent and selective inhibitors of PI3Kδ: Obtaining isoform selectivity from the affinity pocket and tryptophan shelf. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (13)
                                     , 4296-4302. <a href="https://doi.org/10.1016/j.bmcl.2012.05.027" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.05.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.05.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPotent%252Band%252Bselective%252Binhibitors%252Bof%252BPI3K%2525CE%2525B4%25253A%252BObtaining%252Bisoform%252Bselectivity%252Bfrom%252Bthe%252Baffinity%252Bpocket%252Band%252Btryptophan%252Bshelf%26aulast%3DSutherlin%26aufirst%3DDaniel%2BP.%26date%3D2012%26volume%3D22%26issue%3D13%26spage%3D4296%26epage%3D4302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.  Lin</span>, <span class="hlFld-ContribAuthor ">J.  Lin</span>, <span class="hlFld-ContribAuthor ">W.-I.  Wu</span>, <span class="hlFld-ContribAuthor ">J.  Ballard</span>, <span class="hlFld-ContribAuthor ">B. B.  Lee</span>, <span class="hlFld-ContribAuthor ">S. L.  Gloor</span>, <span class="hlFld-ContribAuthor ">G. P. A.  Vigers</span>, <span class="hlFld-ContribAuthor ">T. H.  Morales</span>, <span class="hlFld-ContribAuthor ">L. S.  Friedman</span>, <span class="hlFld-ContribAuthor ">N.  Skelton</span>, <span class="hlFld-ContribAuthor ">B. J.  Brandhuber</span>. </span><span class="cited-content_cbyCitation_article-title">An ATP-Site On-Off Switch That Restricts Phosphatase Accessibility of Akt. </span><span class="cited-content_cbyCitation_journal-name">Science Signaling</span><span> <strong>2012,</strong> <em>5 </em>
                                    (223)
                                     , ra37-ra37. <a href="https://doi.org/10.1126/scisignal.2002618" title="DOI URL">https://doi.org/10.1126/scisignal.2002618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scisignal.2002618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscisignal.2002618%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Signaling%26atitle%3DAn%252BATP-Site%252BOn-Off%252BSwitch%252BThat%252BRestricts%252BPhosphatase%252BAccessibility%252Bof%252BAkt%26aulast%3DLin%26aufirst%3DK.%26date%3D2012%26date%3D2012%26volume%3D5%26issue%3D223%26spage%3Dra37%26epage%3Dra37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sonia  Martínez González</span>, <span class="hlFld-ContribAuthor ">Ana Isabel  Hernández</span>, <span class="hlFld-ContribAuthor ">Carmen  Varela</span>, <span class="hlFld-ContribAuthor ">Sonsoles  Rodríguez-Arístegui</span>, <span class="hlFld-ContribAuthor ">Milagros  Lorenzo</span>, <span class="hlFld-ContribAuthor ">Antonio  Rodríguez</span>, <span class="hlFld-ContribAuthor ">Virginia  Rivero</span>, <span class="hlFld-ContribAuthor ">José Ignacio  Martín</span>, <span class="hlFld-ContribAuthor ">Carl Gustav  Saluste</span>, <span class="hlFld-ContribAuthor ">Francisco  Ramos-Lima</span>, <span class="hlFld-ContribAuthor ">Elena  Cendón</span>, <span class="hlFld-ContribAuthor ">David  Cebrián</span>, <span class="hlFld-ContribAuthor ">Enara  Aguirre</span>, <span class="hlFld-ContribAuthor ">Elena  Gomez-Casero</span>, <span class="hlFld-ContribAuthor ">Maribel  Albarrán</span>, <span class="hlFld-ContribAuthor ">Patricia  Alfonso</span>, <span class="hlFld-ContribAuthor ">Beatriz  García-Serelde</span>, <span class="hlFld-ContribAuthor ">Julen  Oyarzabal</span>, <span class="hlFld-ContribAuthor ">Obdulia  Rabal</span>, <span class="hlFld-ContribAuthor ">Francisca  Mulero</span>, <span class="hlFld-ContribAuthor ">Teresa  Gonzalez-Granda</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Link</span>, <span class="hlFld-ContribAuthor ">Jesús  Fominaya</span>, <span class="hlFld-ContribAuthor ">Mariano  Barbacid</span>, <span class="hlFld-ContribAuthor ">James R.  Bischoff</span>, <span class="hlFld-ContribAuthor ">Pilar  Pizcueta</span>, <span class="hlFld-ContribAuthor ">Joaquín  Pastor</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of ETP-46321, a potent and orally bioavailable PI3K α, δ inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (10)
                                     , 3460-3466. <a href="https://doi.org/10.1016/j.bmcl.2012.03.090" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.03.090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.03.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.03.090%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252BETP-46321%25252C%252Ba%252Bpotent%252Band%252Borally%252Bbioavailable%252BPI3K%252B%2525CE%2525B1%25252C%252B%2525CE%2525B4%252Binhibitor%26aulast%3DMart%25C3%25ADnez%2BGonz%25C3%25A1lez%26aufirst%3DSonia%26date%3D2012%26volume%3D22%26issue%3D10%26spage%3D3460%26epage%3D3466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Georgia  Hatzivassiliou</span>, <span class="hlFld-ContribAuthor ">Bonnie  Liu</span>, <span class="hlFld-ContribAuthor ">Carol  O'Brien</span>, <span class="hlFld-ContribAuthor ">Jill M.  Spoerke</span>, <span class="hlFld-ContribAuthor ">Klaus P.  Hoeflich</span>, <span class="hlFld-ContribAuthor ">Peter M.  Haverty</span>, <span class="hlFld-ContribAuthor ">Robert  Soriano</span>, <span class="hlFld-ContribAuthor ">William F.  Forrest</span>, <span class="hlFld-ContribAuthor ">Sherry  Heldens</span>, <span class="hlFld-ContribAuthor ">Huifen  Chen</span>, <span class="hlFld-ContribAuthor ">Karen  Toy</span>, <span class="hlFld-ContribAuthor ">Connie  Ha</span>, <span class="hlFld-ContribAuthor ">Wei  Zhou</span>, <span class="hlFld-ContribAuthor ">Kyung  Song</span>, <span class="hlFld-ContribAuthor ">Lori S.  Friedman</span>, <span class="hlFld-ContribAuthor ">Lukas C.  Amler</span>, <span class="hlFld-ContribAuthor ">Garret M.  Hampton</span>, <span class="hlFld-ContribAuthor ">John  Moffat</span>, <span class="hlFld-ContribAuthor ">Marcia  Belvin</span>, <span class="hlFld-ContribAuthor ">Mark R.  Lackner</span>. </span><span class="cited-content_cbyCitation_article-title">ERK Inhibition Overcomes Acquired Resistance to MEK Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2012,</strong> <em>11 </em>
                                    (5)
                                     , 1143-1154. <a href="https://doi.org/10.1158/1535-7163.MCT-11-1010" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-11-1010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-11-1010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-11-1010%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DERK%252BInhibition%252BOvercomes%252BAcquired%252BResistance%252Bto%252BMEK%252BInhibitors%26aulast%3DHatzivassiliou%26aufirst%3DGeorgia%26date%3D2012%26date%3D2012%26volume%3D11%26issue%3D5%26spage%3D1143%26epage%3D1154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liuyu  Dong</span>, <span class="hlFld-ContribAuthor ">Houying  Gui</span>, <span class="hlFld-ContribAuthor ">Qiuming  Zhou</span>, <span class="hlFld-ContribAuthor ">Xinming  Hu</span>, <span class="hlFld-ContribAuthor ">Shaoyong  Gui</span>. </span><span class="cited-content_cbyCitation_article-title">A new technique for synthesis of 2,4-dichloro-thieno[3,2-d]pyrimidine. </span><span class="cited-content_cbyCitation_journal-name">Wuhan University Journal of Natural Sciences</span><span> <strong>2012,</strong> <em>17 </em>
                                    (2)
                                     , 177-184. <a href="https://doi.org/10.1007/s11859-012-0824-5" title="DOI URL">https://doi.org/10.1007/s11859-012-0824-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11859-012-0824-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11859-012-0824-5%26sid%3Dliteratum%253Aachs%26jtitle%3DWuhan%2520University%2520Journal%2520of%2520Natural%2520Sciences%26atitle%3DA%252Bnew%252Btechnique%252Bfor%252Bsynthesis%252Bof%252B2%25252C4-dichloro-thieno%25255B3%25252C2-d%25255Dpyrimidine%26aulast%3DDong%26aufirst%3DLiuyu%26date%3D2012%26date%3D2012%26volume%3D17%26issue%3D2%26spage%3D177%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taru  Muranen</span>, <span class="hlFld-ContribAuthor ">Laura M.  Selfors</span>, <span class="hlFld-ContribAuthor ">Devin T.  Worster</span>, <span class="hlFld-ContribAuthor ">Marcin P.  Iwanicki</span>, <span class="hlFld-ContribAuthor ">Loling  Song</span>, <span class="hlFld-ContribAuthor ">Fabiana C.  Morales</span>, <span class="hlFld-ContribAuthor ">Sizhen  Gao</span>, <span class="hlFld-ContribAuthor ">Gordon B.  Mills</span>, <span class="hlFld-ContribAuthor ">Joan S.  Brugge</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Cancer Cell</span><span> <strong>2012,</strong> <em>21 </em>
                                    (2)
                                     , 227-239. <a href="https://doi.org/10.1016/j.ccr.2011.12.024" title="DOI URL">https://doi.org/10.1016/j.ccr.2011.12.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccr.2011.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccr.2011.12.024%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Cell%26atitle%3DInhibition%252Bof%252BPI3K%25252FmTOR%252BLeads%252Bto%252BAdaptive%252BResistance%252Bin%252BMatrix-Attached%252BCancer%252BCells%26aulast%3DMuranen%26aufirst%3DTaru%26date%3D2012%26volume%3D21%26issue%3D2%26spage%3D227%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sauveur-Michel  Maira</span>, <span class="hlFld-ContribAuthor ">Sabina  Pecchi</span>, <span class="hlFld-ContribAuthor ">Alan  Huang</span>, <span class="hlFld-ContribAuthor ">Matthew  Burger</span>, <span class="hlFld-ContribAuthor ">Mark  Knapp</span>, <span class="hlFld-ContribAuthor ">Dario  Sterker</span>, <span class="hlFld-ContribAuthor ">Christian  Schnell</span>, <span class="hlFld-ContribAuthor ">Daniel  Guthy</span>, <span class="hlFld-ContribAuthor ">Tobi  Nagel</span>, <span class="hlFld-ContribAuthor ">Marion  Wiesmann</span>, <span class="hlFld-ContribAuthor ">Saskia  Brachmann</span>, <span class="hlFld-ContribAuthor ">Christine  Fritsch</span>, <span class="hlFld-ContribAuthor ">Marion  Dorsch</span>, <span class="hlFld-ContribAuthor ">Patrick  Chène</span>, <span class="hlFld-ContribAuthor ">Kevin  Shoemaker</span>, <span class="hlFld-ContribAuthor ">Alain  De Pover</span>, <span class="hlFld-ContribAuthor ">Daniel  Menezes</span>, <span class="hlFld-ContribAuthor ">Georg  Martiny-Baron</span>, <span class="hlFld-ContribAuthor ">Doriano  Fabbro</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Wilson</span>, <span class="hlFld-ContribAuthor ">Robert  Schlegel</span>, <span class="hlFld-ContribAuthor ">Francesco  Hofmann</span>, <span class="hlFld-ContribAuthor ">Carlos  García-Echeverría</span>, <span class="hlFld-ContribAuthor ">William R.  Sellers</span>, <span class="hlFld-ContribAuthor ">Charles F.  Voliva</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class I PI3-Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2012,</strong> <em>11 </em>
                                    (2)
                                     , 317-328. <a href="https://doi.org/10.1158/1535-7163.MCT-11-0474" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-11-0474</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-11-0474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-11-0474%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DIdentification%252Band%252BCharacterization%252Bof%252BNVP-BKM120%25252C%252Ban%252BOrally%252BAvailable%252BPan-Class%252BI%252BPI3-Kinase%252BInhibitor%26aulast%3DMaira%26aufirst%3DSauveur-Michel%26date%3D2012%26date%3D2011%26volume%3D11%26issue%3D2%26spage%3D317%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia  Wang</span>, <span class="hlFld-ContribAuthor ">Xiang  Wang</span>, <span class="hlFld-ContribAuthor ">Yanhong  Chen</span>, <span class="hlFld-ContribAuthor ">Simeng  Chen</span>, <span class="hlFld-ContribAuthor ">Guang  Chen</span>, <span class="hlFld-ContribAuthor ">Linjiang  Tong</span>, <span class="hlFld-ContribAuthor ">Linghua  Meng</span>, <span class="hlFld-ContribAuthor ">Yuyuan  Xie</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Chunhao  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and bioactivity of 4-(2-arylpyrido[3′,2′:3,4]pyrrolo[1,2-f][1,2,4]triazin-4-yl) morpholine derivatives as novel PI3K inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (1)
                                     , 339-342. <a href="https://doi.org/10.1016/j.bmcl.2011.11.003" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.11.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.11.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Bbioactivity%252Bof%252B4-%2525282-arylpyrido%25255B3%2525E2%252580%2525B2%25252C2%2525E2%252580%2525B2%25253A3%25252C4%25255Dpyrrolo%25255B1%25252C2-f%25255D%25255B1%25252C2%25252C4%25255Dtriazin-4-yl%252529%252Bmorpholine%252Bderivatives%252Bas%252Bnovel%252BPI3K%252Binhibitors%26aulast%3DWang%26aufirst%3DJia%26date%3D2012%26volume%3D22%26issue%3D1%26spage%3D339%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wufu  Zhu</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>, <span class="hlFld-ContribAuthor ">Qiangqiang  Fu</span>, <span class="hlFld-ContribAuthor ">Fei  Guo</span>, <span class="hlFld-ContribAuthor ">Mei  Bai</span>, <span class="hlFld-ContribAuthor ">Jianqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Haiyan  Wang</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Anticancer Activity of 4-Morpholinothieno[3,2-d]pyrimidine Derivatives Bearing Arylmethylene Hydrazine Moiety. </span><span class="cited-content_cbyCitation_journal-name">Chemical and Pharmaceutical Bulletin</span><span> <strong>2012,</strong> <em>60 </em>
                                    (8)
                                     , 1037-1045. <a href="https://doi.org/10.1248/cpb.c12-00342" title="DOI URL">https://doi.org/10.1248/cpb.c12-00342</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c12-00342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c12-00342%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BAnticancer%252BActivity%252Bof%252B4-Morpholinothieno%25255B3%25252C2-d%25255Dpyrimidine%252BDerivatives%252BBearing%252BArylmethylene%252BHydrazine%252BMoiety%26aulast%3DZhu%26aufirst%3DWufu%26date%3D2012%26volume%3D60%26issue%3D8%26spage%3D1037%26epage%3D1045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eliška  Procházková</span>, <span class="hlFld-ContribAuthor ">Petr  Jansa</span>, <span class="hlFld-ContribAuthor ">Martin  Dračínský</span>, <span class="hlFld-ContribAuthor ">Antonín  Holý</span>, <span class="hlFld-ContribAuthor ">Helena  Mertlíková-Kaiserová</span>. </span><span class="cited-content_cbyCitation_article-title">Determination of the antioxidative activity of substituted 5-aminopyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Free Radical Research</span><span> <strong>2012,</strong> <em>46 </em>
                                    (1)
                                     , 61-67. <a href="https://doi.org/10.3109/10715762.2011.638292" title="DOI URL">https://doi.org/10.3109/10715762.2011.638292</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/10715762.2011.638292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F10715762.2011.638292%26sid%3Dliteratum%253Aachs%26jtitle%3DFree%2520Radical%2520Research%26atitle%3DDetermination%252Bof%252Bthe%252Bantioxidative%252Bactivity%252Bof%252Bsubstituted%252B5-aminopyrimidines%26aulast%3DProch%25C3%25A1zkov%25C3%25A1%26aufirst%3DEli%25C5%25A1ka%26date%3D2012%26date%3D2011%26volume%3D46%26issue%3D1%26spage%3D61%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Wojtalla</span>, <span class="hlFld-ContribAuthor ">Alexandre  Arcaro</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting phosphoinositide 3-kinase signalling in lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Critical Reviews in Oncology/Hematology</span><span> <strong>2011,</strong> <em>80 </em>
                                    (2)
                                     , 278-290. <a href="https://doi.org/10.1016/j.critrevonc.2011.01.007" title="DOI URL">https://doi.org/10.1016/j.critrevonc.2011.01.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.critrevonc.2011.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.critrevonc.2011.01.007%26sid%3Dliteratum%253Aachs%26jtitle%3DCritical%2520Reviews%2520in%2520Oncology%252FHematology%26atitle%3DTargeting%252Bphosphoinositide%252B3-kinase%252Bsignalling%252Bin%252Blung%252Bcancer%26aulast%3DWojtalla%26aufirst%3DAnna%26date%3D2011%26volume%3D80%26issue%3D2%26spage%3D278%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christoph M.  Dehnhardt</span>, <span class="hlFld-ContribAuthor ">Aranapakam M.  Venkatesan</span>, <span class="hlFld-ContribAuthor ">Zecheng  Chen</span>, <span class="hlFld-ContribAuthor ">Efren  Delos-Santos</span>, <span class="hlFld-ContribAuthor ">Semiramis  Ayral-Kaloustian</span>, <span class="hlFld-ContribAuthor ">Natasja  Brooijmans</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span>, <span class="hlFld-ContribAuthor ">Irwin  Hollander</span>, <span class="hlFld-ContribAuthor ">Larry  Feldberg</span>, <span class="hlFld-ContribAuthor ">Judy  Lucas</span>, <span class="hlFld-ContribAuthor ">Robert  Mallon</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of 2-oxatriazines as highly potent pan-PI3K/mTOR dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (16)
                                     , 4773-4778. <a href="https://doi.org/10.1016/j.bmcl.2011.06.063" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.06.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.06.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.06.063%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252B2-oxatriazines%252Bas%252Bhighly%252Bpotent%252Bpan-PI3K%25252FmTOR%252Bdual%252Binhibitors%26aulast%3DDehnhardt%26aufirst%3DChristoph%2BM.%26date%3D2011%26volume%3D21%26issue%3D16%26spage%3D4773%26epage%3D4778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven T.  Staben</span>, <span class="hlFld-ContribAuthor ">Michael  Siu</span>, <span class="hlFld-ContribAuthor ">Richard  Goldsmith</span>, <span class="hlFld-ContribAuthor ">Alan G.  Olivero</span>, <span class="hlFld-ContribAuthor ">Steven  Do</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Burdick</span>, <span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>, <span class="hlFld-ContribAuthor ">Jenna  Dotson</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Sutherlin</span>, <span class="hlFld-ContribAuthor ">Bing-Yan  Zhu</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Hoa  Le</span>, <span class="hlFld-ContribAuthor ">Leslie  Lee</span>, <span class="hlFld-ContribAuthor ">John  Lesnick</span>, <span class="hlFld-ContribAuthor ">Cristina  Lewis</span>, <span class="hlFld-ContribAuthor ">Jeremy M.  Murray</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Jodie  Pang</span>, <span class="hlFld-ContribAuthor ">Wei Wei  Prior</span>, <span class="hlFld-ContribAuthor ">Laurent  Salphati</span>, <span class="hlFld-ContribAuthor ">Lionel  Rouge</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Christian  Wiesmann</span>, <span class="hlFld-ContribAuthor ">Ping  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design of thienobenzoxepin inhibitors of PI3-kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (13)
                                     , 4054-4058. <a href="https://doi.org/10.1016/j.bmcl.2011.04.124" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.04.124</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.04.124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.04.124%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Bdesign%252Bof%252Bthienobenzoxepin%252Binhibitors%252Bof%252BPI3-kinase%26aulast%3DStaben%26aufirst%3DSteven%2BT.%26date%3D2011%26volume%3D21%26issue%3D13%26spage%3D4054%26epage%3D4058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stéphane  Sengmany</span>, <span class="hlFld-ContribAuthor ">Erwan  Le Gall</span>, <span class="hlFld-ContribAuthor ">Eric  Léonel</span>. </span><span class="cited-content_cbyCitation_article-title">An Electrochemical Synthesis of Functionalized Arylpyrimidines from 4-Amino-6-Chloropyrimidines and Aryl Halides. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2011,</strong> <em>16 </em>
                                    (7)
                                     , 5550-5560. <a href="https://doi.org/10.3390/molecules16075550" title="DOI URL">https://doi.org/10.3390/molecules16075550</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules16075550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules16075550%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAn%252BElectrochemical%252BSynthesis%252Bof%252BFunctionalized%252BArylpyrimidines%252Bfrom%252B4-Amino-6-Chloropyrimidines%252Band%252BAryl%252BHalides%26aulast%3DSengmany%26aufirst%3DSt%25C3%25A9phane%26date%3D2011%26date%3D2011%26volume%3D16%26issue%3D7%26spage%3D5550%26epage%3D5560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Subrata  Das</span>, <span class="hlFld-ContribAuthor ">Ashim Jyoti  Thakur</span>. </span><span class="cited-content_cbyCitation_article-title">A Clean, Highly Efficient and One-Pot Green Synthesis of Aryl/Alkyl/Heteroaryl-Substituted Bis(6-amino-1,3-dimethyluracil-5-yl)methanes in Water. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2011,</strong> <em>2011 </em>
                                    (12)
                                     , 2301-2308. <a href="https://doi.org/10.1002/ejoc.201001581" title="DOI URL">https://doi.org/10.1002/ejoc.201001581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201001581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201001581%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DA%252BClean%25252C%252BHighly%252BEfficient%252Band%252BOne-Pot%252BGreen%252BSynthesis%252Bof%252BAryl%25252FAlkyl%25252FHeteroaryl-Substituted%252BBis%2525286-amino-1%25252C3-dimethyluracil-5-yl%252529methanes%252Bin%252BWater%26aulast%3DDas%26aufirst%3DSubrata%26date%3D2011%26date%3D2011%26volume%3D2011%26issue%3D12%26spage%3D2301%26epage%3D2308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Ohwada</span>, <span class="hlFld-ContribAuthor ">Hirosato  Ebiike</span>, <span class="hlFld-ContribAuthor ">Hatsuo  Kawada</span>, <span class="hlFld-ContribAuthor ">Masao  Tsukazaki</span>, <span class="hlFld-ContribAuthor ">Mitsuaki  Nakamura</span>, <span class="hlFld-ContribAuthor ">Takuya  Miyazaki</span>, <span class="hlFld-ContribAuthor ">Kenji  Morikami</span>, <span class="hlFld-ContribAuthor ">Kiyoshi  Yoshinari</span>, <span class="hlFld-ContribAuthor ">Miyuki  Yoshida</span>, <span class="hlFld-ContribAuthor ">Osamu  Kondoh</span>, <span class="hlFld-ContribAuthor ">Shino  Kuramoto</span>, <span class="hlFld-ContribAuthor ">Kotaro  Ogawa</span>, <span class="hlFld-ContribAuthor ">Yuko  Aoki</span>, <span class="hlFld-ContribAuthor ">Nobuo  Shimma</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and biological activity of a novel class I PI3K inhibitor, CH5132799. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (6)
                                     , 1767-1772. <a href="https://doi.org/10.1016/j.bmcl.2011.01.065" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.01.065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.01.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.01.065%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Bbiological%252Bactivity%252Bof%252Ba%252Bnovel%252Bclass%252BI%252BPI3K%252Binhibitor%25252C%252BCH5132799%26aulast%3DOhwada%26aufirst%3DJun%26date%3D2011%26volume%3D21%26issue%3D6%26spage%3D1767%26epage%3D1772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Johannes  Werzowa</span>, <span class="hlFld-ContribAuthor ">Stefan  Koehrer</span>, <span class="hlFld-ContribAuthor ">Sabine  Strommer</span>, <span class="hlFld-ContribAuthor ">Daniel  Cejka</span>, <span class="hlFld-ContribAuthor ">Thorsten  Fuereder</span>, <span class="hlFld-ContribAuthor ">Eva  Zebedin</span>, <span class="hlFld-ContribAuthor ">Volker  Wacheck</span>. </span><span class="cited-content_cbyCitation_article-title">Vertical Inhibition of the mTORC1/mTORC2/PI3K Pathway Shows Synergistic Effects against Melanoma In Vitro and In Vivo. </span><span class="cited-content_cbyCitation_journal-name">Journal of Investigative Dermatology</span><span> <strong>2011,</strong> <em>131 </em>
                                    (2)
                                     , 495-503. <a href="https://doi.org/10.1038/jid.2010.327" title="DOI URL">https://doi.org/10.1038/jid.2010.327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/jid.2010.327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fjid.2010.327%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Investigative%2520Dermatology%26atitle%3DVertical%252BInhibition%252Bof%252Bthe%252BmTORC1%25252FmTORC2%25252FPI3K%252BPathway%252BShows%252BSynergistic%252BEffects%252Bagainst%252BMelanoma%252BIn%252BVitro%252Band%252BIn%252BVivo%26aulast%3DWerzowa%26aufirst%3DJohannes%26date%3D2011%26volume%3D131%26issue%3D2%26spage%3D495%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seunghee  Hong</span>, <span class="hlFld-ContribAuthor ">Soyoung  Lee</span>, <span class="hlFld-ContribAuthor ">Bomi  Kim</span>, <span class="hlFld-ContribAuthor ">Hyunseung  Lee</span>, <span class="hlFld-ContribAuthor ">Soon-Sun  Hong</span>, <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new azaindole-based PI3Kα inhibitors: Apoptotic and antiangiogenic effect on cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (24)
                                     , 7212-7215. <a href="https://doi.org/10.1016/j.bmcl.2010.10.108" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.10.108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.10.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.10.108%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnew%252Bazaindole-based%252BPI3K%2525CE%2525B1%252Binhibitors%25253A%252BApoptotic%252Band%252Bantiangiogenic%252Beffect%252Bon%252Bcancer%252Bcells%26aulast%3DHong%26aufirst%3DSeunghee%26date%3D2010%26volume%3D20%26issue%3D24%26spage%3D7212%26epage%3D7215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven T.  Staben</span>, <span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Sutherlin</span>, <span class="hlFld-ContribAuthor ">Seema R.  Bhat</span>, <span class="hlFld-ContribAuthor ">Georgette M.  Castanedo</span>, <span class="hlFld-ContribAuthor ">Irina S.  Chuckowree</span>, <span class="hlFld-ContribAuthor ">Jenna  Dotson</span>, <span class="hlFld-ContribAuthor ">Adrian J.  Folkes</span>, <span class="hlFld-ContribAuthor ">Lori S.  Friedman</span>, <span class="hlFld-ContribAuthor ">Leslie  Lee</span>, <span class="hlFld-ContribAuthor ">John  Lesnick</span>, <span class="hlFld-ContribAuthor ">Cristina  Lewis</span>, <span class="hlFld-ContribAuthor ">Jeremy M.  Murray</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Alan G.  Olivero</span>, <span class="hlFld-ContribAuthor ">Emile  Plise</span>, <span class="hlFld-ContribAuthor ">Jodie  Pang</span>, <span class="hlFld-ContribAuthor ">Wei Wei  Prior</span>, <span class="hlFld-ContribAuthor ">Laurent  Salphati</span>, <span class="hlFld-ContribAuthor ">Lionel  Rouge</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Nan Chi  Wan</span>, <span class="hlFld-ContribAuthor ">Shumei  Wang</span>, <span class="hlFld-ContribAuthor ">Christian  Weismann</span>, <span class="hlFld-ContribAuthor ">Ping  Wu</span>, <span class="hlFld-ContribAuthor ">Bing-Yan  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based optimization of pyrazolo-pyrimidine and -pyridine inhibitors of PI3-kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (20)
                                     , 6048-6051. <a href="https://doi.org/10.1016/j.bmcl.2010.08.067" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.08.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.08.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.08.067%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Boptimization%252Bof%252Bpyrazolo-pyrimidine%252Band%252B-pyridine%252Binhibitors%252Bof%252BPI3-kinase%26aulast%3DStaben%26aufirst%3DSteven%2BT.%26date%3D2010%26volume%3D20%26issue%3D20%26spage%3D6048%26epage%3D6051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>, <span class="hlFld-ContribAuthor ">Megan  Berry</span>, <span class="hlFld-ContribAuthor ">Georgette  Castanedo</span>, <span class="hlFld-ContribAuthor ">Christine  Chang</span>, <span class="hlFld-ContribAuthor ">Irina  Chuckowree</span>, <span class="hlFld-ContribAuthor ">Jennafer  Dotson</span>, <span class="hlFld-ContribAuthor ">Adrian  Folkes</span>, <span class="hlFld-ContribAuthor ">Janet  Gunzner</span>, <span class="hlFld-ContribAuthor ">John D.  Lesnick</span>, <span class="hlFld-ContribAuthor ">Cristina  Lewis</span>, <span class="hlFld-ContribAuthor ">Simon  Mathieu</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Alan  Olivero</span>, <span class="hlFld-ContribAuthor ">Jodie  Pang</span>, <span class="hlFld-ContribAuthor ">David  Peterson</span>, <span class="hlFld-ContribAuthor ">Laurent  Salphati</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Sutherlin</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Nan Chi  Wan</span>, <span class="hlFld-ContribAuthor ">Shumei  Wang</span>, <span class="hlFld-ContribAuthor ">Susan  Wong</span>, <span class="hlFld-ContribAuthor ">Bing-yan  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of GNE-477, a potent and efficacious dual PI3K/mTOR inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (8)
                                     , 2408-2411. <a href="https://doi.org/10.1016/j.bmcl.2010.03.046" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.03.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.03.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.03.046%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252BGNE-477%25252C%252Ba%252Bpotent%252Band%252Befficacious%252Bdual%252BPI3K%25252FmTOR%252Binhibitor%26aulast%3DHeffron%26aufirst%3DTimothy%2BP.%26date%3D2010%26volume%3D20%26issue%3D8%26spage%3D2408%26epage%3D2411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Workman</span>, <span class="hlFld-ContribAuthor ">Paul A.  Clarke</span>, <span class="hlFld-ContribAuthor ">Florence I.  Raynaud</span>, <span class="hlFld-ContribAuthor ">Rob L.M.  van Montfort</span>. </span><span class="cited-content_cbyCitation_article-title">Drugging the PI3 Kinome: From Chemical Tools to Drugs in the Clinic. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2010,</strong> <em>70 </em>
                                    (6)
                                     , 2146-2157. <a href="https://doi.org/10.1158/0008-5472.CAN-09-4355" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-09-4355</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-09-4355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-09-4355%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DDrugging%252Bthe%252BPI3%252BKinome%25253A%252BFrom%252BChemical%252BTools%252Bto%252BDrugs%252Bin%252Bthe%252BClinic%26aulast%3DWorkman%26aufirst%3DPaul%26date%3D2010%26date%3D2010%26volume%3D70%26issue%3D6%26spage%3D2146%26epage%3D2157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901284w&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0013.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Discovery of compounds <b>5</b> and <b>21</b>, starting from phenols <b>1</b> and <b>2 </b>(<b>GDC-941</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901284w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0014.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of compounds found in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>−<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901284w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) nBuLi, THF, −78 °C, DMF; (b) <i>N</i>-sulphonylpiperazine, 1,2-DCE, HC(OCH<sub>3</sub>)<sub>3</sub>, Na(OAc)<sub>3</sub>BH; (c) boronic acid/ester, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, NaHCO<sub>3</sub>, H<sub>2</sub>O, CH<sub>3</sub>CN, microwave, 150−140 °C, 15−30 min; (d) NaBH<sub>4</sub>, MeOH; (e) PBr<sub>3</sub>, benzene, 80 °C, 1 h; (f) phthalimide, K<sub>2</sub>CO<sub>3</sub>, DMF, 20 h; (g) N<sub>2</sub>H<sub>4</sub>, MeOH, 65 °C, 1 h; (h) AcCl, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h; (i) nBuLi, THF, −78 °C, acetone; (j) MeMgBr, THF, 0 °C.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal Structure of <b>2</b> in PI3Kγ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901284w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structures of <b>14</b> (panel A) and <b>16</b> (panel B) bound to PI3Kγ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901284w&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0010.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure of <b>20</b> bound to PI3Kγ. Residues labeled in blue are identical in mTOR, while residues in black align to different amino acids in mTOR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901284w&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0015.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo efficacy of <b>5</b> versus PC3 prostate cancer xenografts and compounds <b>5</b> and <b>21</b>, versus MCF7.1 breast cancer xenografts. (A) Nu/nu (nude) female mice bearing PC3 tumors established from human prostate cancer cells implanted subcutaneously were dosed orally either with <b>5</b> at the indicated concentrations as a solution/suspension in vehicle (0.5% methylcellulose/0.2% Tween-80) or with vehicle daily (QD) for 14 days. (B) Nu/nu (nude) female mice bearing tumors established from MCF7.1 breast cancer cells implanted subcutaneously were dosed orally with vehicle, or as a solution/suspension of <b>5</b> or <b>21</b> at the indicated concentrations in the aforementioned vehicle daily (QD) for 21 days. Dunnett <i>t</i> test was used to calculate <i>p</i>-values comparing the drug-treated groups with vehicle control group at the end of dosing either on day 14 or 21.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901284w&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/medium/jm-2009-01284w_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0016.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of <b>5</b> and <b>21</b> on PD markers in the MCF7.1 breast cancer xenograft model after 21 days of continuous dosing. Tumors were excised from animals 1 and 4 h after the last administered dose on day 21 and processed for analysis of PI3K/Akt pathway markers as described in Methods. (A) Levels of pAkt (Ser<sup>473</sup>) and total Akt were measured by electrochemiluminescence using Meso Scale Discovery according to manufacturer’s instructions (Gaithersburg, MD). (B) Levels of pPras40 (Thr<sup>246</sup>) and total Pras40 were measured by ELISA at an absorbance of 450 nm as described in Methods. (C) pS6RP(Ser<sup>235/236</sup>) and total S6RP were assessed using assays measuring electrochemiluminescence from Meso Scale Discovery (Gaithersburg, MD) according to manufacturer’s instructions. (%) = % of phospho-protein suppression compared to vehicle control groups (100%); <i>p</i>-values determined by Student’s <i>t</i> test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-3/jm901284w/production/images/large/jm-2009-01284w_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901284w&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42852" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42852" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 11 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vivanco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">The phosphatidylinositol 3-kinase AKT pathway in human cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm901284w&amp;key=10.1038%2Fnrc839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=12094235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvFKltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=489-501&author=I.+Vivancoauthor=C.+L.+Sawyers&title=The+phosphatidylinositol+3-kinase+AKT+pathway+in+human+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphatidylinositol 3-Kinase-AKT pathway in human cancer</span></div><div class="casAuthors">Vivanco, Igor; Sawyers, Charles L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">489-501</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  One signal that is overactivated in a wide range of tumor types is the prodn. of a phospholipid, phosphatidylinositol (3,4,5) trisphosphate, by phosphatidylinositol 3-kinase (PI3K).  This lipid and the protein kinase that is activated by it, AKT, trigger a cascade of responses, from cell growth and proliferation to survival and motility, that drive tumor progression.  Small-mol. therapeutics that block PI3K signaling might deal a severe blow to cancer cells by blocking many aspects of the tumor-cell phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzAQ-0qeD7pLVg90H21EOLACvtfcHk0lipZoIdWMXIhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvFKltLs%253D&md5=c6762d32f9f1281632f4ccdbcd29268c</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fnrc839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc839%26sid%3Dliteratum%253Aachs%26aulast%3DVivanco%26aufirst%3DI.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DThe%2520phosphatidylinositol%25203-kinase%2520AKT%2520pathway%2520in%2520human%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D489%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">The phosphoinositide 3-kinase pathway</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">1655</span><span class="NLM_x">–</span> <span class="NLM_lpage">1657</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm901284w&amp;key=10.1126%2Fscience.296.5573.1655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=12040186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlChu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=1655-1657&author=L.+C.+Cantley&title=The+phosphoinositide+3-kinase+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphoinositide 3-kinase pathway</span></div><div class="casAuthors">Cantley, Lewis C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5573</span>),
    <span class="NLM_cas:pages">1655-1657</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review with 8 refs.  Phosphorylated lipids are produced at cellular membranes during signaling events and contribute to the recruitment and activation of various signaling components.  The role of phosphoinositide 3-kinase (PI3K), which catalyzes the prodn. of phosphatidylinositol 3,4,5-trisphosphate, in cell survival pathways; the regulation of gene expression and cell metab.; and cytoskeletal rearrangements are highlighted.  The PI3K pathway is implicated in human diseases including diabetes and cancer, and understanding the intricacies of this pathway may provide new avenues for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9pxSplxmS1rVg90H21EOLACvtfcHk0lipZoIdWMXIhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlChu7s%253D&md5=110c8a351448aed6ab938b9ccf90a655</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1126%2Fscience.296.5573.1655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.296.5573.1655%26sid%3Dliteratum%253Aachs%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DThe%2520phosphoinositide%25203-kinase%2520pathway%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D1655%26epage%3D1657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Backer, J. M.</span><span> </span><span class="NLM_article-title">The regulation and function of class III PI3Ks: novel roles for Vps34</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">410</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=2008&pages=1-17&author=J.+M.+Backer&title=The+regulation+and+function+of+class+III+PI3Ks%3A+novel+roles+for+Vps34"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBacker%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520regulation%2520and%2520function%2520of%2520class%2520III%2520PI3Ks%253A%2520novel%2520roles%2520for%2520Vps34%26jtitle%3DBiochem.%2520J.%26date%3D2008%26volume%3D410%26spage%3D1%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Defining the role of mTOR in cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=9-22&author=D.+A.+Guertinauthor=D.+M.+Sabatini&title=Defining+the+role+of+mTOR+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DDefining%2520the%2520role%2520of%2520mTOR%2520in%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D9%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fasolo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sessa, C.</span><span> </span><span class="NLM_article-title">mTOR inhibitors in the treatment of cancer</span> <span class="citation_source-journal">Exp. Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1717</span><span class="NLM_x">–</span> <span class="NLM_lpage">1734</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1717-1734&author=A.+Fasoloauthor=C.+Sessa&title=mTOR+inhibitors+in+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFasolo%26aufirst%3DA.%26aulast%3DSessa%26aufirst%3DC.%26atitle%3DmTOR%2520inhibitors%2520in%2520the%2520treatment%2520of%2520cancer%26jtitle%3DExp.%2520Opin.%2520Investig.%2520Drugs%26date%3D2008%26volume%3D17%26spage%3D1717%26epage%3D1734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Bellacosa, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cristofano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, J. C.</span><span> </span><span class="NLM_article-title">Activation of AKT kinases in cancer: implications for therapeutic targeting</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm901284w&amp;key=10.1016%2FS0065-230X%2805%2994002-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=16095999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1elur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2005&pages=29-86&author=A+Bellacosaauthor=C.+C.+Kumarauthor=A.+Di+Cristofanoauthor=J.+C.+Testa&title=Activation+of+AKT+kinases+in+cancer%3A+implications+for+therapeutic+targeting"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of AKT kinases in cancer: implications for therapeutic targeting</span></div><div class="casAuthors">Bellacosa, Alfonso; Kumar, C. Chandra; Di Cristofano, Antonio; Testa, Joseph Robert</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29-86</span>CODEN:
                <span class="NLM_cas:coden">ACRSAJ</span>;
        ISSN:<span class="NLM_cas:issn">0065-230X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The AKT1, AKT2, and AKT3 kinases have emerged as crit. mediators of signal transduction pathways downstream of activated tyrosine kinases and phosphatidylinositol 3-kinase.  An ever-increasing list of AKT substrates has precisely defined the multiple functions of this kinase family in normal physiol. and disease states.  Cellular processes regulated by AKT include cell proliferation and survival, cell size and response to nutrient availability, intermediary metab., angiogenesis, and tissue invasion.  All these processes represent hallmarks of cancer, and a burgeoning literature has defined the importance of AKT alterations in human cancer and exptl. models of tumorigenesis, continuing the legacy represented by the original identification of v-Akt as the transforming oncogene of a murine retrovirus.  Many oncoproteins and tumor suppressors intersect in the AKT pathway, finely regulating cellular functions at the interface of signal transduction and classical metabolic regulation.  This careful balance is altered in human cancer by a variety of activating and inactivating mechanisms that target both AKT and interrelated proteins.  Reprogramming of this altered circuitry by pharmacol. modulation of the AKT pathway represents a powerful strategy for rational cancer therapy.  In this review, we summarize a large body of data, from many types of cancer, indicating that AKT activation is one of the most common mol. alterations in human malignancy.  We also review mechanisms of activation of AKT kinases, examples of therapeutic modulation of the AKT pathway in animal models, and the current status of efforts to target mol. components of the AKT pathway for cancer therapy and, possibly, cancer prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbtUdzglK927Vg90H21EOLACvtfcHk0ljNkPcFC5oQ3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1elur4%253D&md5=556e3c5787e0179786db3cb2e2f1dcf6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0065-230X%2805%2994002-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-230X%252805%252994002-5%26sid%3Dliteratum%253Aachs%26aulast%3DBellacosa%26aufirst%3DA%26aulast%3DKumar%26aufirst%3DC.%2BC.%26aulast%3DDi%2BCristofano%26aufirst%3DA.%26aulast%3DTesta%26aufirst%3DJ.%2BC.%26atitle%3DActivation%2520of%2520AKT%2520kinases%2520in%2520cancer%253A%2520implications%2520for%2520therapeutic%2520targeting%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2005%26volume%3D94%26spage%3D29%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shayesteh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldocchi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godfrey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. W.</span><span> </span><span class="NLM_article-title">PIK3CA is implicated as an oncogene in ovarian cancer</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm901284w&amp;key=10.1038%2F5042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=9916799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADyaK1MXltlWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1999&pages=99-102&author=L.+Shayestehauthor=W.+L.+Kuoauthor=R.+Baldocchiauthor=T.+Godfreyauthor=C.+Collinsauthor=D.+Pinkelauthor=B.+Powellauthor=G.+B.+Millsauthor=J.+W.+Gray&title=PIK3CA+is+implicated+as+an+oncogene+in+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">PIK3CA is implicated as an oncogene in ovarian cancer</span></div><div class="casAuthors">Shayesteh, Laleh; Lu, Yiling; Kuo, Wen-Lin; Baldocchi, Russell; Godfrey, Tony; Collins, Colin; Pinkel, Daniel; Powell, Bethan; Mills, Gordon B.; Gray, Joe W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-102</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Ovarian cancer is the leading cause of death from gynecol. malignancy and the 4th leading cause of cancer death among American women, yet little is known about its mol. etiol.  Studies using comparative genomic hybridization (CGH) have revealed several regions of recurrent, abnormal, DNA sequence copy no. that may encode genes involved in the genesis or progression of the disease.  A region at 3q26 was increased in copy no. in 40% of ovarian and other cancers contains PIK3CA, which encodes the p110α catalytic subunit of phosphatidylinositol 3-kinase (PI3-kinase).  The assocn. between PIK3CA copy no. and PI3-kinase activity makes PIK3CA a candidate oncogene because a broad range of cancer-related functions were assocd. with PI3-kinase mediated signalling.  These include proliferation, glucose transport and catabolism, cell adhesion, apoptosis, RAS signalling6 and oncogenic transformation.  Downstream effectors of PI3-kinase, AKT1 and AKT2, were amplified or activated in human tumors, including ovarian cancer.  We show that PIK3CA is frequently increased in copy no. in ovarian cancers, that the increased copy no. is assocd. with increased PIK3CA transcription, p110α protein expression, and PI3-kinase activity and that treatment with the PI3-kinase inhibitor LY294002 decreases proliferation and increases apoptosis.  These observations suggest PIK3CA is an oncogene that has an important role in ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYnLbYYzMTtrVg90H21EOLACvtfcHk0ljNkPcFC5oQ3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltlWjtw%253D%253D&md5=e46ad55fb14c5465bf7ce86fb5a9cca0</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1038%2F5042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F5042%26sid%3Dliteratum%253Aachs%26aulast%3DShayesteh%26aufirst%3DL.%26aulast%3DKuo%26aufirst%3DW.%2BL.%26aulast%3DBaldocchi%26aufirst%3DR.%26aulast%3DGodfrey%26aufirst%3DT.%26aulast%3DCollins%26aufirst%3DC.%26aulast%3DPinkel%26aufirst%3DD.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DGray%26aufirst%3DJ.%2BW.%26atitle%3DPIK3CA%2520is%2520implicated%2520as%2520an%2520oncogene%2520in%2520ovarian%2520cancer%26jtitle%3DNat.%2520Genet.%26date%3D1999%26volume%3D21%26spage%3D99%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silliman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggins, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span> </span><span class="NLM_article-title">High frequency of mutations of the PIK3CA gene in human cancers</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2004&pages=554&author=Y.+Samuelsauthor=Z.+Wangauthor=A.+Bardelliauthor=N.+Sillimanauthor=J.+Ptakauthor=S.+Szaboauthor=H.+Yanauthor=A.+Gazdarauthor=S.+M.+Powellauthor=G.+J.+Rigginsauthor=J.+K.+Willsonauthor=S.+Markowitzauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=V.+E.+Velculescu&title=High+frequency+of+mutations+of+the+PIK3CA+gene+in+human+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DSilliman%26aufirst%3DN.%26aulast%3DPtak%26aufirst%3DJ.%26aulast%3DSzabo%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DGazdar%26aufirst%3DA.%26aulast%3DPowell%26aufirst%3DS.%2BM.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DWillson%26aufirst%3DJ.%2BK.%26aulast%3DMarkowitz%26aufirst%3DS.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26atitle%3DHigh%2520frequency%2520of%2520mutations%2520of%2520the%2520PIK3CA%2520gene%2520in%2520human%2520cancers%26jtitle%3DScience%26date%3D2004%26volume%3D30%26spage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Parsons, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silliman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span> </span><span class="NLM_article-title">Colorectal cancer: mutations in a signalling pathway</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">792</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=792&author=D.+W.+Parsonsauthor=T.+L.+Wangauthor=Y.+Samuelsauthor=A.+Bardelliauthor=J.+M.+Cumminsauthor=L.+DeLongauthor=N.+Sillimanauthor=J.+Ptakauthor=S.+Szaboauthor=J.+K.+Willsonauthor=S.+Markowitzauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=C.+Lengauerauthor=V.+E.+Velculescu&title=Colorectal+cancer%3A+mutations+in+a+signalling+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DD.%2BW.%26aulast%3DWang%26aufirst%3DT.%2BL.%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DCummins%26aufirst%3DJ.%2BM.%26aulast%3DDeLong%26aufirst%3DL.%26aulast%3DSilliman%26aufirst%3DN.%26aulast%3DPtak%26aufirst%3DJ.%26aulast%3DSzabo%26aufirst%3DS.%26aulast%3DWillson%26aufirst%3DJ.%2BK.%26aulast%3DMarkowitz%26aufirst%3DS.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26atitle%3DColorectal%2520cancer%253A%2520mutations%2520in%2520a%2520signalling%2520pathway%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sulis, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span> </span><span class="NLM_article-title">PTEN: from pathology to biology</span> <span class="citation_source-journal">Trends Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">478</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm901284w&amp;key=10.1016%2FS0962-8924%2803%2900175-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=12946627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1ygs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=478-483&author=M.+L.+Sulisauthor=R.+Parsons&title=PTEN%3A+from+pathology+to+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN: from pathology to biology</span></div><div class="casAuthors">Sulis, Maria Luisa; Parsons, Ramon</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">478-483</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The PTEN tumor suppressor gene is mutated frequently in many malignancies and its importance in the development of cancer is probably underestimated.  As the primary phosphatase of phosphatidylinositol (3,4,5)-trisphosphate, PTEN has a central role in reigning in the phosphoinositide 3-kinase (PI 3-kinase) network to control cellular homeostasis.  Cells that lack PTEN are unable to regulate the PtdIns 3-kinase program, which stimulates a variety of cellular phenotypes that favor oncogenesis.  As well as the well-known role as tumor suppressor, recent studies show that PTEN is involved in the regulation of several basic cellular functions, such as cell migration, cell size, contractility of cardiac myocytes and chemotaxis.  Here, we review the roles of PTEN in normal cellular functions and disease development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1ltxp33aXP7Vg90H21EOLACvtfcHk0lhqWerv7TyqtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1ygs7w%253D&md5=cd18115b50b3c634cb451c5090acda21</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2803%2900175-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252803%252900175-2%26sid%3Dliteratum%253Aachs%26aulast%3DSulis%26aufirst%3DM.%2BL.%26aulast%3DParsons%26aufirst%3DR.%26atitle%3DPTEN%253A%2520from%2520pathology%2520to%2520biology%26jtitle%3DTrends%2520Cell.%2520Biol.%26date%3D2003%26volume%3D13%26spage%3D478%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liaw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podsypanina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puc, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miliaresis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCombie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovanella, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tycko, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibshoosh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigler, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span> </span><span class="NLM_article-title">PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">1943</span><span class="NLM_x">–</span> <span class="NLM_lpage">1947</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=16&amp;doi=10.1021%2Fjm901284w&amp;key=10.1126%2Fscience.275.5308.1943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=9072974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADyaK2sXit1Wgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=1997&pages=1943-1947&author=J.+Liauthor=C.+Yenauthor=D.+Liawauthor=K.+Podsypaninaauthor=S.+Boseauthor=S.+I.+Wangauthor=J.+Pucauthor=C.+Miliaresisauthor=L.+Rodgersauthor=R.+McCombieauthor=S.+H.+Bignerauthor=B.+C.+Giovanellaauthor=M.+Ittmannauthor=B.+Tyckoauthor=H.+Hibshooshauthor=M.+H.+Wiglerauthor=R.+Parsons&title=PTEN%2C+a+putative+protein+tyrosine+phosphatase+gene+mutated+in+human+brain%2C+breast%2C+and+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5eR"><div class="casContent"><span class="casTitleNuber">5e</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer</span></div><div class="casAuthors">Li, Jing; Yen, Clifford; Liaw, Danny; Podsypanina, Katrina; Bose, Shikha; Wang, Steven I.; Puc, Janusz; Miliaresis, Christa; Rodgers, Linda; McCombie, Richard; Bigner, Sandra H.; Giovanella, Beppino C.; Ittmann, Michael; Tycko, Ben; Hibshoosh, Hanina; Wigler, Michael H.; Parsons, Ramon</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">5308</span>),
    <span class="NLM_cas:pages">1943-1947</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mapping of homozygous deletions on human chromosome 10q23 has led to the isolation of a candidate tumor suppressor gene, PTEN, that appears to be mutated at considerable frequency in human cancers.  In preliminary screens, mutations of PTEN were detected in 31% (13/42) of glioblastoma cell lines and xenografts, 100% (4/4) of prostate cancer cell lines, 6% (4/65) of breast cancer cell lines and xenografts, and 17% (3/18) of primary glioblastomas.  The predicted PTEN product has a protein tyrosine phosphatase domain and extensive homol. to tensin, a protein that interacts with actin filaments at focal adhesions.  These homologies suggest that PTEN may suppress tumor cell growth by antagonizing protein tyrosine kinases and may regulate tumor cell invasion and metastasis through interactions at focal adhesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPNCE1bqsPNLVg90H21EOLACvtfcHk0lhqWerv7TyqtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXit1Wgtbk%253D&md5=9b3810f68cbd7cbb882ff75e98a2f1bf</span></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=10.1126%2Fscience.275.5308.1943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.275.5308.1943%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYen%26aufirst%3DC.%26aulast%3DLiaw%26aufirst%3DD.%26aulast%3DPodsypanina%26aufirst%3DK.%26aulast%3DBose%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DS.%2BI.%26aulast%3DPuc%26aufirst%3DJ.%26aulast%3DMiliaresis%26aufirst%3DC.%26aulast%3DRodgers%26aufirst%3DL.%26aulast%3DMcCombie%26aufirst%3DR.%26aulast%3DBigner%26aufirst%3DS.%2BH.%26aulast%3DGiovanella%26aufirst%3DB.%2BC.%26aulast%3DIttmann%26aufirst%3DM.%26aulast%3DTycko%26aufirst%3DB.%26aulast%3DHibshoosh%26aufirst%3DH.%26aulast%3DWigler%26aufirst%3DM.%2BH.%26aulast%3DParsons%26aufirst%3DR.%26atitle%3DPTEN%252C%2520a%2520putative%2520protein%2520tyrosine%2520phosphatase%2520gene%2520mutated%2520in%2520human%2520brain%252C%2520breast%252C%2520and%2520prostate%2520cancer%26jtitle%3DScience%26date%3D1997%26volume%3D275%26spage%3D1943%26epage%3D1947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Ihle, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powis, G.</span><span> </span><span class="NLM_article-title">Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy</span> <span class="citation_source-journal">Mol. Cancer. Ther</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm901284w&amp;key=10.1158%2F1535-7163.MCT-08-0801" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=19139107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFSntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1-9&issue=1&author=N.+T.+Ihleauthor=G.+Powis&title=Take+your+PIK%3A+phosphatidylinositol+3-kinase+inhibitors+race+through+the+clinic+and+toward+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy</span></div><div class="casAuthors">Ihle, Nathan T.; Powis, Garth</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway is currently one of the most exciting drug targets in oncol.  However, only a short time ago, the paradigm existed that drugs targeted to the four PI3K class I isoforms would be too toxic for use in cancer therapy due to effects on physiol. signaling.  Since that time, studies have delineated the roles of these four isoforms in nonpathol. signaling as well as their roles in cancer.  An extensive effort has gone into developing agents that inhibit one or more PI3K isoforms, as well as closely related proteins implicated in cancer.  These agents have proved to be tolerable and therapeutically beneficial in animal studies, and a no. are in clin. testing.  The agents, their properties, and their mol. targets are discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtwozBC-h437Vg90H21EOLACvtfcHk0lhqWerv7TyqtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFSntA%253D%253D&md5=4bc339da7fdd1dc74e13eadf76ae53ce</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0801%26sid%3Dliteratum%253Aachs%26aulast%3DIhle%26aufirst%3DN.%2BT.%26aulast%3DPowis%26aufirst%3DG.%26atitle%3DTake%2520your%2520PIK%253A%2520phosphatidylinositol%25203-kinase%2520inhibitors%2520race%2520through%2520the%2520clinic%2520and%2520toward%2520cancer%2520therapy%26jtitle%3DMol.%2520Cancer.%2520Ther%26date%3D2009%26volume%3D8%26issue%3D1%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alix, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandon, A. D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefano, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henley, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergl-Wilson, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhyvoloup, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheldrake, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinase: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1725</span><span class="NLM_x">–</span> <span class="NLM_lpage">1738</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm901284w&amp;key=10.1158%2F1535-7163.MCT-08-1200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=19584227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVynuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1725-1738&issue=7&author=F.+I.+Raynaudauthor=S.+A.+Ecclesauthor=S.+Patelauthor=S.+Alixauthor=G.+Boxauthor=I.+S.+Chuckowreeauthor=A.+J.+Folkesauthor=S.+Gowanauthor=A.+D.+H.+Brandonauthor=F.+D.+Stefanoauthor=A.+Hayesauthor=A.+T.+Henleyauthor=L.+Lensunauthor=G.+H.+Pergl-Wilsonauthor=A.+Robsonauthor=N.+Saghirauthor=P.+Zhyvoloupauthor=E.+McDonaldauthor=P.+Sheldrakeauthor=S.+Shuttleworthauthor=M.+Valentiauthor=N.+C.+Wanauthor=P.+A.+Clarkeauthor=P.+Workman&title=Biological+properties+of+potent+inhibitors+of+class+I+phosphatidylinositide+3-kinase%3A+from+PI-103+through+PI-540%2C+PI-620+to+the+oral+agent+GDC-0941"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941</span></div><div class="casAuthors">Raynaud, Florence I.; Eccles, Suzanne A.; Patel, Sonal; Alix, Sonia; Box, Gary; Chuckowree, Irina; Folkes, Adrian; Gowan, Sharon; De Haven Brandon, Alexis; Di Stefano, Francesca; Hayes, Angela; Henley, Alan T.; Lensun, Letitia; Pergl-Wilson, Giles; Robson, Anthony; Saghir, Nahid; Zhyvoloup, Alexander; McDonald, Edward; Sheldrake, Peter; Shuttleworth, Stephen; Valenti, Melanie; Wan, Nan Chi; Clarke, Paul A.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1725-1738</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphatidylinositide 3-kinase pathway is frequently deregulated in human cancers and inhibitors offer considerable therapeutic potential.  We previously described the promising tricyclic pyridofuropyrimidine lead and chem. tool compd. PI-103.  We now report the properties of the pharmaceutically optimized bicyclic thienopyrimidine derivs. PI-540 and PI-620 and the resulting clin. development candidate GDC-0941.  All four compds. inhibited phosphatidylinositide 3-kinase p110α with IC50 ≤ 10 nmol/L.  Despite some differences in isoform selectivity, these agents exhibited similar in vitro antiproliferative properties to PI-103 in a panel of human cancer cell lines, with submicromolar potency in PTEN-neg. U87MG human glioblastoma cells and comparable phosphatidylinositide 3-kinase pathway modulation.  PI-540 and PI-620 exhibited improvements in soly. and metab. with high tissue distribution in mice.  Both compds. gave improved antitumor efficacy over PI-103, following i.p. dosing in U87MG glioblastoma tumor xenografts in athymic mice, with treated/control values of 34% (66% inhibition) and 27% (73% inhibition) for PI-540 (50 mg/kg b.i.d.) and PI-620 (25 mg/kg b.i.d.), resp.  GDC-0941 showed comparable in vitro antitumor activity to PI-103, PI-540, and PI-620 and exhibited 78% oral bioavailability in mice, with tumor exposure above 50% antiproliferative concns. for >8 h following 150 mg/kg p.o. and sustained phosphatidylinositide 3-kinase pathway inhibition.  These properties led to excellent dose-dependent oral antitumor activity, with daily p.o. dosing at 150 mg/kg achieving 98% and 80% growth inhibition of U87MG glioblastoma and IGROV-1 ovarian cancer xenografts, resp.  Together, these data support the development of GDC-0941 as a potent, orally bioavailable inhibitor of phosphatidylinositide 3-kinase.  GDC-0941 has recently entered phase I clin. trials. [Mol Cancer Ther 2009;8(7):1725-38] [Mol Cancer Ther 2009;8(7):1725-38].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-PRUGO7W3C7Vg90H21EOLACvtfcHk0ljfV7ob1uG79Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVynuro%253D&md5=2c963517ef112c677fb19ec2f0040e14</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-1200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-1200%26sid%3Dliteratum%253Aachs%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DAlix%26aufirst%3DS.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%2BS.%26aulast%3DFolkes%26aufirst%3DA.%2BJ.%26aulast%3DGowan%26aufirst%3DS.%26aulast%3DBrandon%26aufirst%3DA.%2BD.%2BH.%26aulast%3DStefano%26aufirst%3DF.%2BD.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHenley%26aufirst%3DA.%2BT.%26aulast%3DLensun%26aufirst%3DL.%26aulast%3DPergl-Wilson%26aufirst%3DG.%2BH.%26aulast%3DRobson%26aufirst%3DA.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DZhyvoloup%26aufirst%3DP.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DSheldrake%26aufirst%3DP.%26aulast%3DShuttleworth%26aufirst%3DS.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DBiological%2520properties%2520of%2520potent%2520inhibitors%2520of%2520class%2520I%2520phosphatidylinositide%25203-kinase%253A%2520from%2520PI-103%2520through%2520PI-540%252C%2520PI-620%2520to%2520the%2520oral%2520agent%2520GDC-0941%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26issue%3D7%26spage%3D1725%26epage%3D1738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Maria, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brachmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoemaker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Identification and chanraterization of NVP-BEZ235 a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1851</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm901284w&amp;key=10.1158%2F1535-7163.MCT-08-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=18606717" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1851-1863&issue=7&author=S.-M.+Mariaauthor=F.+Staufferauthor=J.+Brueggenauthor=P.+Furetauthor=C.+Schnellauthor=C.+Fritschauthor=S.+Brachmannauthor=P.+Cheneauthor=A.+De+Poverauthor=K.+Schoemakerauthor=D.+Fabbroauthor=D.+Gabrielauthor=M.+Simonenauthor=L.+Murphyauthor=P.+Finanauthor=W.+Sellersauthor=C.+Garcia-Echeverria&title=Identification+and+chanraterization+of+NVP-BEZ235+a+new+orally+available+dual+phosphatidylinositol+3-kinase%2Fmammalian+target+of+rapamycin+inhibitor+with+potent+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0017%26sid%3Dliteratum%253Aachs%26aulast%3DMaria%26aufirst%3DS.-M.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DBrachmann%26aufirst%3DS.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DDe%2BPover%26aufirst%3DA.%26aulast%3DSchoemaker%26aufirst%3DK.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DD.%26aulast%3DSimonen%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DIdentification%2520and%2520chanraterization%2520of%2520NVP-BEZ235%2520a%2520new%2520orally%2520available%2520dual%2520phosphatidylinositol%25203-kinase%252Fmammalian%2520target%2520of%2520rapamycin%2520inhibitor%2520with%2520potent%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26issue%3D7%26spage%3D1851%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Folkes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alderton, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alix, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depledge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancox, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugendradas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergl-Wilson, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhyvoloup, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvelebil, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span> </span><span class="NLM_article-title">The identification of 2-(1<i>H</i>-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-<i>d</i>]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5532</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800295d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5522-5532&author=A.+J.+Folkesauthor=K.+Ahmadiauthor=W.+K.+Aldertonauthor=S.+Alixauthor=S.+J.+Bakerauthor=G.+Boxauthor=I.+S.+Chuckowreeauthor=P.+A.+Clarkeauthor=P.+Depledgeauthor=S.+A.+Ecclesauthor=L.+S.+Friedmanauthor=A.+Hayesauthor=T.+C.+Hancoxauthor=A.+Kugendradasauthor=L.+Lensunauthor=P.+Mooreauthor=A.+G.+Oliveroauthor=J.+Pangauthor=S.+Patelauthor=G.+H.+Pergl-Wilsonauthor=F.+I.+Raynaudauthor=A.+Robsonauthor=N.+Saghirauthor=L.+Salphatiauthor=S.+Sohalauthor=M.+H.+Ultschauthor=M.+Valentiauthor=H.+J.+A.+Wallweberauthor=N.+C.+Wanauthor=C.+Wiesmannauthor=P.+Workmanauthor=P.+Zhyvoloupauthor=M.+J.+Zvelebilauthor=S.+J.+Shuttleworth&title=The+identification+of+2-%281H-Indazol-4-yl%29-6-%284-methanesulfonyl-piperazin-1-ylmethyl%29-4-morpholin-4-yl-thieno%5B3%2C2-d%5Dpyrimidine+%28GDC-0941%29+as+a+potent%2C+selective%2C+orally+bioavailable+inhibitor+of+class+I+PI3+kinase+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span></div><div class="casAuthors">Folkes, Adrian J.; Ahmadi, Khatereh; Alderton, Wendy K.; Alix, Sonia; Baker, Stewart J.; Box, Gary; Chuckowree, Irina S.; Clarke, Paul A.; Depledge, Paul; Eccles, Suzanne A.; Friedman, Lori S.; Hayes, Angela; Hancox, Timothy C.; Kugendradas, Arumugam; Lensun, Letitia; Moore, Pauline; Olivero, Alan G.; Pang, Jodie; Patel, Sonal; Pergl-Wilson, Giles H.; Raynaud, Florence I.; Robson, Anthony; Saghir, Nahid; Salphati, Laurent; Sohal, Sukhjit; Ultsch, Mark H.; Valenti, Melanie; Wallweber, Heidi J. A.; Wan, Nan Chi; Wiesmann, Christian; Workman, Paul; Zhyvoloup, Alexander; Zvelebil, Marketa J.; Shuttleworth, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5522-5532</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-kinase (PI3K) is an important target in cancer due to the deregulation of the PI3K/Akt signaling pathway in a wide variety of tumors.  A series of thieno[3,2-d]pyrimidine derivs. were prepd. and evaluated as inhibitors of PI3 kinase p110α.  The synthesis, biol. activity, and further profiling of these compds. are described.  This work resulted in the discovery of GDC-0941 (I) which is a potent, selective, orally bioavailable inhibitor of PI3K and is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojkFv29FXqO7Vg90H21EOLACvtfcHk0ljfV7ob1uG79Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E&md5=742084954685353ceaf18660ab3a0703</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm800295d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800295d%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%2BJ.%26aulast%3DAhmadi%26aufirst%3DK.%26aulast%3DAlderton%26aufirst%3DW.%2BK.%26aulast%3DAlix%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%2BS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DDepledge%26aufirst%3DP.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHancox%26aufirst%3DT.%2BC.%26aulast%3DKugendradas%26aufirst%3DA.%26aulast%3DLensun%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DP.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPergl-Wilson%26aufirst%3DG.%2BH.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobson%26aufirst%3DA.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DZhyvoloup%26aufirst%3DP.%26aulast%3DZvelebil%26aufirst%3DM.%2BJ.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520identification%2520of%25202-%25281H-Indazol-4-yl%2529-6-%25284-methanesulfonyl-piperazin-1-ylmethyl%2529-4-morpholin-4-yl-thieno%255B3%252C2-d%255Dpyrimidine%2520%2528GDC-0941%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520orally%2520bioavailable%2520inhibitor%2520of%2520class%2520I%2520PI3%2520kinase%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5522%26epage%3D5532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="note"><p class="first last">This critical interaction with the enzyme was noted for molecules in 2 other series: </p></div><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vlahos, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matter, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. F.</span><span> </span><span class="NLM_article-title">A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4<i>H</i>-1-benzopyran-4-one (LY294002)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">5241</span><span class="NLM_x">–</span> <span class="NLM_lpage">5248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=8106507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADyaK2cXjtFGit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=5241-5248&author=C.+J.+Vlahosauthor=W.+F.+Matterauthor=K.+Y.+Huiauthor=R.+F.+Brown&title=A+specific+inhibitor+of+phosphatidylinositol+3-kinase%2C+2-%284-morpholinyl%29-8-phenyl-4H-1-benzopyran-4-one+%28LY294002%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)</span></div><div class="casAuthors">Vlahos, Chris J.; Matter, William F.; Hui, Kwan Y.; Brown, Raymond F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">5241-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Phosphatidylinositol (PtIns) 3-kinase is an enzyme implicated in growth factor signal transduction by assocg. with receptor and nonreceptor tyrosine kinases, including the platelet-derived growth factor receptor.  Inhibitors of PtdIns 3-kinase could potentially give a better understanding of the function and regulatory mechanisms of the enzyme.  Quercetin, a naturally occurring bioflavonoid, was previously shown to inhibit PtdIns 3-kinase with an IC50 of 1.3 μg/mL (3.8 μM); inhibition appeared to be directed at the ATP-binding site of the kinase.  Analogs of quercetin were investigated as PtdIns 3-kinase inhibitors, with the most potent ones exhibiting IC50 values in the range of 1.7-8.4 μg/mL.  In contrast, genistein, a potent tyrosine kinase inhibitor of the isoflavone class, did not inhibit PtdIns 3-kinase significantly (IC50 > 30 μg/mL).  Since quercetin has also been shown to inhibit other PtdIns and protein kinases, other chromones were evaluated as inhibitors of PtdIns 3-kinase without affecting PtdIns 4-kinase or selected protein kinases.  One such compd., 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (also known as 2-(4-morpholinyl)-8-phenylchromone, LY294002), completely and specifically abolished PtdIns 3-kinase activity (IC50 = 0.43 μg/mL; 1.40 μM) but did not inhibit PtdIns 4-kinase or tested protein and lipid kinases.  Analogs of LY294002 demonstrated a very selective structure-activity relationship, with slight changes in structure causing marked decreases in inhibition.  LY294002 was shown to completely abolish PtdIns 3-kinase activity in fMet-Leu-Phe-stimulated human neutrophils, as well as inhibit proliferation of smooth muscle cells in cultured rabbit aortic segments.  Since PtdIns 3-kinase appears to be centrally involved with growth factor signal transduction, the development of specific inhibitors against the kinase may be beneficial in the treatment of proliferative diseases as well as in elucidating the biol. role of the kinase in cellular proliferation and growth factor response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Ii0f457BC7Vg90H21EOLACvtfcHk0lhEhAKOkgUSkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXjtFGit78%253D&md5=2635c03af206ce35d55b899f92921477</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVlahos%26aufirst%3DC.%2BJ.%26aulast%3DMatter%26aufirst%3DW.%2BF.%26aulast%3DHui%26aufirst%3DK.%2BY.%26aulast%3DBrown%26aufirst%3DR.%2BF.%26atitle%3DA%2520specific%2520inhibitor%2520of%2520phosphatidylinositol%25203-kinase%252C%25202-%25284-morpholinyl%2529-8-phenyl-4H-1-benzopyran-4-one%2520%2528LY294002%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D5241%26epage%3D5248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hayakawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritomo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterfield, M.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase PI3KR inhibitors</span> <span class="citation_source-journal">Biorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6847</span><span class="NLM_x">–</span> <span class="NLM_lpage">6858</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm901284w&amp;key=10.1016%2Fj.bmc.2006.06.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=16837202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADC%252BD28XptFSks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=6847-6858&author=M.+Hayakawaauthor=H.+Kaizawaauthor=H.+Moritomoauthor=T.+Koizumiauthor=T.+Ohishiauthor=M.+Okadaauthor=M.+Ohtaauthor=S.+Tsukamotoauthor=P.+Parkerauthor=P.+Workmanauthor=M.+Waterfield&title=Synthesis+and+biological+evaluation+of+4-morpholino-2-phenylquinazolines+and+related+derivatives+as+novel+PI3+kinase+PI3KR+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110α inhibitors</span></div><div class="casAuthors">Hayakawa, Masahiko; Kaizawa, Hiroyuki; Moritomo, Hiroyuki; Koizumi, Tomonobu; Ohishi, Takahide; Okada, Minoru; Ohta, Mitsuaki; Tsukamoto, Shin-ichi; Parker, Peter; Workman, Paul; Waterfield, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6847-6858</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of 4-morpholino-2-phenylquinazolines and related derivs. were prepd. and evaluated as inhibitors of PI3 kinase p110α.  In this series, the thieno[3,2-d]pyrimidine deriv. 15e (I) showed the strongest inhibitory activity against p110α, with an IC50 value of 2.0 nM, and inhibited proliferation of A375 melanoma cells with an IC50 value of 0.58 μM.  Moreover, 15e was found to be selective for p110α over other PI3K isoforms and protein kinases, making it the first example of a selective PI3K p110α inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp57O4VuB9kN7Vg90H21EOLACvtfcHk0lhEhAKOkgUSkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptFSks7g%253D&md5=b75abfe42f5698d1179c90a9c33777cf</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.06.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.06.046%26sid%3Dliteratum%253Aachs%26aulast%3DHayakawa%26aufirst%3DM.%26aulast%3DKaizawa%26aufirst%3DH.%26aulast%3DMoritomo%26aufirst%3DH.%26aulast%3DKoizumi%26aufirst%3DT.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DTsukamoto%26aufirst%3DS.%26aulast%3DParker%26aufirst%3DP.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWaterfield%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25204-morpholino-2-phenylquinazolines%2520and%2520related%2520derivatives%2520as%2520novel%2520PI3%2520kinase%2520PI3KR%2520inhibitors%26jtitle%3DBiorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D6847%26epage%3D6858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Borwell, F. G.</span><span> </span><span class="NLM_article-title">Equilibrium acidities in dimethyl sulfoxide solution</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">456</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1988&pages=456-463&author=F.+G.+Borwell&title=Equilibrium+acidities+in+dimethyl+sulfoxide+solution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorwell%26aufirst%3DF.%2BG.%26atitle%3DEquilibrium%2520acidities%2520in%2520dimethyl%2520sulfoxide%2520solution%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D1988%26volume%3D21%26spage%3D456%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silber, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rance, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wastall, P.</span><span> </span><span class="NLM_article-title">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm901284w&amp;key=9336307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm901284w&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=46-58&author=R.+S.+Obachauthor=J.+G.+Baxterauthor=T.+E.+Listonauthor=B.+M.+Silberauthor=B.+C.+Jonesauthor=F.+MacIntyreauthor=D.+J.+Ranceauthor=P.+Wastall&title=The+prediction+of+human+pharmacokinetic+parameters+from+preclinical+and+in+vitro+metabolism+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span></div><div class="casAuthors">Obach, R. Scott; Baxter, James G.; Liston, Theodore E.; Silber, B. Michael; Jones, Barry C.; Macintyre, Flona; Rance, David J.; Wastall, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-58</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 35 refs.  We describe a comprehensive retrospective anal. in which the abilities of several methods by which human pharmacokinetic parameters are predicted from preclin. pharmacokinetic data and/or in vitro metab. data were assessed.  The prediction methods examd. included both methods from the scientific literature as well as some described in this report for the first time.  Four methods were examd. for their ability to predict human vol. of distribution.  Three were highly predictive, yielding, on av., predictions that were within 60% to 90% of actual values.  Twelve methods were assessed for their utility in predicting clearance.  The most successful allometric scaling method yielded clearance predictions that were, on av., within 80% of actual values.  The best methods in which in vitro metab. data from human liver microsomes were scaled to in vivo clearance values yielded predicted clearance values that were, on av., within 70% to 80% of actual values.  Human t1/2 was predicted by combining predictions of human vol. of distribution and clearance.  The best t1/2 prediction methods successfully assigned compds. to appropriate dosing regimen categories (e.g., once daily, twice daily and so forth) 70% to 80% of the time.  In addn., correlations between human t1/2 and t1/2 values from preclin. species were also generally successful (72-87%) when used to predict human dosing regimens.  In summary, this retrospective anal. has identified several approaches by which human pharmacokinetic data can be predicted from preclin. data.  Such approaches should find utility in the drug discovery and development processes in the identification and selection of compds. that will possess appropriate pharmacokinetic characteristics in humans for progression to clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAngniZ4izLVg90H21EOLACvtfcHk0lhEhAKOkgUSkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D&md5=68d1910d925e26ec4a8ef23043ffb1ed</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DBaxter%26aufirst%3DJ.%2BG.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DJones%26aufirst%3DB.%2BC.%26aulast%3DMacIntyre%26aufirst%3DF.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26aulast%3DWastall%26aufirst%3DP.%26atitle%3DThe%2520prediction%2520of%2520human%2520pharmacokinetic%2520parameters%2520from%2520preclinical%2520and%2520in%2520vitro%2520metabolism%2520data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D46%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm901284w&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-3%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm901284w" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm901284w" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799433f0f47199f","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
